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The	  completion	  of	  the	  Human	  Genome	  Project	  [1]	  was	  considered	  at	  that	  moment	  
as	  an	   important	  milestone	   for	  curing	  many	  diseases.	  With	  a	  new	  understanding	  of	  
one’s	  genes	  we	  should	  be	  able	  to	  understand	  better	  the	  underlying	  mechanisms	  of	  
complex	  diseases.	  Ultimately,	  this	  should	  lead	  to	  better	  diagnosis	  and	  treatment	  of	  
diseases[2].	   The	   great	   expectations	   bestowed	   on	   genomics	   and	   the	   sequencing	   of	  
the	   human	   genome	   were	   however	   not	   met,	   since	   (i)	   many	   genetic	   factors	   can	  
contribute	   to	   a	   disease	   and	   (ii)	  most	   diseases	   have	   not	   a	   pure	   genetic	   cause.	   For	  
example,	  individuals	  with	  the	  same	  genetic	  background,	  like	  monozygotic	  twins,	  can	  
develop	  during	  the	  course	  of	  their	  lives	  different	  diseases.	  This	  shows	  the	  need	  for	  a	  
holistic	  view	  where	  other	  biochemical	  levels,	  apart	  from	  genomics,	  are	  necessary	  to	  
understand	  biological	  systems.[3]	  
	  
Looking	   at	   an	   organism	   as	   a	   system,	   i.e.	   a	   collection	   of	   components	   like	   genes,	  
enzymes	   or	   metabolites,	   which	   are	   all	   interconnected	   at	   different	   levels	   such	   as	  
cellular,	  organ	  and	  overall	  system	  level,	  allows	  researchers	  to	  better	  understand	  the	  
causes	   of	   disease	   and	   to	   develop	   better	   diagnostics	   and,	   ultimately	   personalized,	  
treatments.[4]	   Such	   an	   approach	   does	   not	   only	   focus	   on	   genes,	   proteins	   and	  
metabolites	   but	   also	   at	   the	   interactions	   between	   all	   of	   them.	   The	   study	   of	   these	  
different	  building	  blocks	  of	  organism	  gave	  birth	  to	  systems	  biology	  and	  several	  omics	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era,	   with	   a	   plethora	   of	   fields	   such	   as	   genomics,	   proteomics,	   metabolomics,	  
peptidomics,	  transcriptomics,	  and	  many	  others.	  
Metabolomics	  is	  the	  science	  that	  studies	  metabolites,	  the	  small	  molecules	  (<1000Da)	  
involved	   in	  metabolism,	  either	  as	  substrates	  or	  as	  products	  of	  metabolic	   reactions.	  
Being	   closer	   to	   the	   phenotype	   than	   genes,	   metabolites	   are	   ideal	   read	   outs	   of	  
alterations	   like	   disease,	   including	   metabolic	   disorders,	   diet,	   lifestyle,	   and	   medical	  
interventions	  have	  on	  a	  biological	  system.[5,	  6]	  
	  
The	  aim	  of	  metabolomics	  is	  to	  measure	  qualitatively	  (which)	  and	  quantitatively	  (how	  
much)	   metabolites	   are	   present	   in	   a	   biofluid,	   tissue,	   or	   cell	   in	   order	   to	   answer	  
biological	  questions.[6]	  These	  measurements	  can	  be	  static,	  measured	  only	  once	  on	  a	  
single	  moment	  in	  time,	  or	  dynamic,	  over	  multiple	  time	  points,	  so	  that	  the	  progress	  of	  
a	  disease	  or	  the	  effect	  of	  a	  treatment	  can	  be	  monitored.	  	  
	  
Figure	  1	  Workflow	  of	  a	  metabolomics	  pipeline.	  Start	  of	  any	  experiments	  should	  be	  a	  clear	  biological	  question.	  
The	  different	  analytical	  and	  processing	  steps	  lead	  to	  biological	  data,	  which	  after	  interpretation	  should	  answer	  the	  
original	  question	  or	  suggest	  follow	  up	  experiments.	  The	  contents	  of	  this	  thesis	  contribute	  to	  the	  data	  processing	  
and	  data	  analysis	  steps.	  
Metabolites	  form	  a	  heterogeneous	  family	  of	  molecules	  for	  which	  there	  is	  not	  a	  single	  
analytical	   strategy	   yet	   available	   that	   can	   measure	   them	   all	   in	   a	   single	   run.	   As	   a	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consequence,	  different	  analytical	  platforms	  are	  being	  developed	  and	  used	   suitable	  
for	   profiling	   specific	   classes	   of	  metabolites.	  One	   of	   the	  most	   often	   used	   analytical	  
techniques	   in	   metabolomics	   is	   mass	   spectrometry,	   mostly	   after	   separation	   of	  
metabolites	   by	   liquid	   chromatography,	   capillary	   electrophoresis	   or	   gas	  
chromatography	  (MS).[7,	  8]	  
	  
Metabolite	   identification,	   the	   identification	   of	   the	   precise	   chemical	   structure	   of	   a	  
metabolite,	   is	   one	   of	   the	   major	   challenges	   in	   metabolomics.	   The	   two	   most	  
frequently	  analytical	  techniques	  used	  for	  this	  are	  nuclear	  magnetic	  resonance	  (NMR)	  
and	  mass	   spectrometry.	  While	  NMR	  can	  provide	   for	  each	  atom	  of	   a	  molecule	   rich	  
information	  about	  their	  neighbouring	  atoms	  and	  hence,	  about	  their	  structure,	  NMR	  
requires	  a	  high	  concentration	  and	  a	  high	  sample	  purity	  of	  the	  metabolite	  that	  needs	  
to	   be	   identified.	   This	   is	   not	   usually	   the	   case	   for,	   among	   others,	   human	   samples.	  




Mass	   spectrometry	   is	   commonly	   used	   in	  metabolomics	   to	   detect	  metabolites	   in	   a	  
qualitative	  manner,	  by	  measuring	  the	  mass	  of	  molecules,	  calculating	  their	  elemental	  
composition	   and	   to	   elucidate	   their	   chemical	   structures	   by	   interpretation	   of	   their	  
fragmentation	  spectra.	  And	  MS	  is	  used	  in	  a	  quantitative	  manner	  by	  determining	  the	  
abundance	   of	   metabolites	   as	   absolute	   concentrations	   or	   relative	   to	   a	   reference	  
compound.	   Usually	  MS	   instruments	   are	   composed	   of	   four	  modules:	   (i)	   an	   ionizer,	  
which	  charges	  the	  molecules	  in	  the	  sample,	  prior	  or	  after	  transfer	  into	  the	  gas	  phase;	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(ii)	  an	  extraction	  system,	  which	  transfers	  the	  ionized	  molecules	  (or	  their	  fragments)	  
from	   the	   sample	   introduction	   unit	   to	   the	   analyzer;	   (iii)	   a	   mass	   analyzer,	   which	  
separates	  the	  molecules	  according	  to	  mass;	  and	  (iv)	  a	  detector,	  which	  quantifies	  the	  
abundance	  of	  the	  ions.	  The	  information	  that	  can	  be	  obtained	  from	  MS	  is	  the	  ratio	  of	  
the	  mass	  of	  ions	  and	  their	  charge,	  the	  so-­‐called	  mass-­‐over-­‐charge	  ratio	  (m/z).	  From	  
these	  m/z	  values,	  the	  mass	  of	  the	  molecule	  can	  be	  derived	  after	  revealing	  whether	  
the	   ions	  were	   formed	  by	   protonation,	   deprotonation,	   adduct	   formation,	   etc;	   from	  
the	  mass	  of	  the	  molecule	  the	  elemental	  composition	  (EC)	  or	  a	  short-­‐list	  of	  possible	  
elemental	  compositions	  can	  be	  derived;	  from	  a	  EC	  one	  or	  multiple	  structures	  can	  be	  
proposed.	  The	  more	  accurate	  the	  mass	  is	  determined	  the	  fewer	  candidate	  elemental	  
compositions	   are	   obtained.	   The	   mass	   accuracy	   depends	   on	   the	   instrument	  
employed,	  and	  even	  for	  high	  accuracies,	  such	  as	  in	  the	  low	  part	  per	  million	  (ppm)	  or	  
sub-­‐ppm	   range,	   unique	   elemental	   compositions	   cannot	   always	   be	   obtained.	  
However,	   when	   including	   several	   constraints	   into	   accounts	   by	   including	   fragment	  
ions	   and	   their	   relations	   among	   each	   other,[9]	   the	   number	   of	   possible	   elemental	  
compositions	   for	   a	   certain	   mass	   can	   be	   reduced.	   	   Still,	   for	   a	   given	   mass	   many	  
elemental	   compositions	   can	  be	   found.	  And,	  even	  worse,	   for	   a	   given	  EC	  millions	  or	  
billions	  of	  candidate	  structures	  can	  be	  proposed.	  	  
	  
Analyzing	  metabolites	  with	  mass	   spectrometry	   poses	  many	   challenges.	   Samples	   in	  
metabolomics	  studies	  are	  complex	  and	  can	  contain	  thousands	  of	  metabolites.	  Some	  
of	   these	  metabolites	  can	  have	   identical	  atomic	  mass,	  elemental	   formula	  and/or	  be	  
structural	   isomers,	  which	  complicates	   their	   identification	  using	  mass	  spectrometry.	  
Additionally,	  other	  compounds	  that	  are	  also	  present	  in	  the	  sample	  we	  measure,	  can	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affect	   how	   well	   our	   analyte	   of	   interest	   ionizes.	   This	   process	   is	   known	   as	   ion	  
suppression	  and	  is	  the	  reason	  why	  metabolites	  in	  complex	  samples	  are	  usually	  first	  
separated	  using	   chromatography	   prior	   to	   detection	  with	  MS.	  Gas	   chromatography	  
(GC)	   is	  used	   to	   separate	  compounds	   that	  are	  volatile	  or	   that	  via	  derivatization	  can	  
become	  volatile.	  Non-­‐volatile	  (but	  also	  volatile)	  compounds	  are	  separated	  according	  
to	   their	   polarity	   using	   liquid	   chromatography	   (LC).	   In	   both	   cases	   the	   metabolites	  
present	  in	  the	  mobile	  phase,	  either	  gas	  or	  liquid,	  pass	  through	  a	  column	  and	  interact	  
with	  the	  stationary	  phase	  in	  the	  column.	  This	   interaction	  with	  the	  stationary	  phase	  
delays	   the	   elution	   of	   some	  metabolites,	   and	   thus,	   achieving	   their	   separation.	   The	  
diameter,	   length	  and	  characteristics	  of	  the	  stationary	  phase	  of	  a	  column	  determine	  
how	  the	  metabolites	  will	  be	  separated.	  The	  time	  after	  which	  a	  metabolite	  	  elutes	  is	  
called	  the	  retention	  time	  (RT).	  	  
	  
Once	  metabolites	   have	   been	   separated	   they	   need	   to	   be	   detected	   and	   quantified,	  
which	  is	  often	  achieved	  by	  a	  mass	  spectrometer.	  The	  combination	  of	  the	  information	  
obtained	  from	  the	  LC	  and	  MS	  experiments,	  RT	  and	  m/z	  respectively,	  is	  also	  referred	  
to	   as	   a	   metabolite	   feature.	   In	   metabolomics	   experiments,	   metabolites	   are	   often	  
characterized	  by	  their	  RT	  and	  m/z	  values,	  when	  their	  identity	  is	  still	  unknown.	  	  
	  
MSn	  
Ion	   traps	  are	  mass	  analyzers	   that	   can	   trap	  an	   ion,	   the	   so-­‐called	  parent	   ion,	  with	  a	  
certain	   pre-­‐specified	   mass/charge	   ratio,	   fragment	   it,	   trap	   the	   fragments	   and	  
fragment	  them	  further	  (if	  needed).	  This	  type	  of	  MS	  fragmentation	  is	  known	  as	  multi-­‐
stage	   mass	   fragmentation	   (MSn),	   where	   n	   indicates	   the	   number	   of	   consecutive	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fragmentations	   performed.	   The	   resulting	   mass	   spectral	   tree	   contains	   information	  
about	  the	  parent	  and	  fragment	  ions	  and	  the	  relationships	  between	  them.	  This	  type	  
of	  data	  contains	  valuable	  structural	   information	   for	  metabolite	   identification,	   since	  
two	   isomeric	   molecules,	   with	   the	   same	   elemental	   composition	   but	   different	  
chemical	  structures	  will	  most	  likely	  produce	  different	  mass	  spectral	  trees.	  The	  depth	  
(number	   of	   consecutive	   fragmentations)	   and	   width	   (number	   of	   fragment	   ions	  
obtained	  at	  a	  given	  level)	  is	  determined	  by	  the	  available	  amount	  of	  the	  compound,	  
by	  the	  size	  of	  the	  compound	  (a	  small	  compound	  cannot	  yield	  many	  fragments)	  and	  
by	   its	   chemical	   composition	   (some	   bonds	   are	   more	   resistant	   to	   cleavage	   than	  
others).	  	  
	  
De	  Novo	  Metabolite	  Identification	  
During	  a	  metabolomics	  study,	  one	  or	  multiple	  metabolite	  features	  can	  be	  of	  interest	  
for	   the	  biological	  question	  at	  hand.	  These	   features	  can	  be	   for	  example	  biomarkers	  
that	   indicate	   significant	   difference	   between	   the	  metabolic	   profiles	   of	   healthy	   and	  
diseased	   patients	   or	   they	   can	   be	   the	   metabolic	   end	   product	   of	   a	   gene	   knockout	  
experiment,	  or	  the	  degradation	  products	  of	  a	  newly	  tested	  drug,	  for	  instance.	  In	  all	  
these	  cases,	  knowing	  the	  chemical	  structure	  of	  those	  metabolite	  features	  is	  essential	  
to	   interpret	   the	   results	   of	   the	   metabolomics	   study.	   De	   novo	   and	   non-­‐de	   novo	  
metabolite	   identification	   are	   regarded	   as	   one	   of	   the	   major	   bottlenecks	   facing	  
metabolomics.[10–12]	  
	  
A	  critical	  step	  in	  metabolite	  identification	  is	  the	  selection	  of	  candidate	  structures	  for	  
an	   unknown	   metabolite.	   Standard	   metabolite	   identification	   methods	   retrieve	   the	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chemical	   structures	   of	   a	   compound,	   that	   is	   present	   in	   a	   library,	   by	   matching	   its	  
experimental	   mass,	   elemental	   composition	   and/or	   spectrum	   against	   those	   of	  
compounds	   in	  a	   library.	  This	  approach	  only	  allows	  the	   identification	  of	  metabolites	  
that	   have	   already	   been	   discovered,	   for	   which	   mass	   spectra	   are	   required	   in	   a	  
comparable	  manner,	   and	   that	   are	   properly	   stored	   in	   a	   database.	  However,	   such	   a	  
strategy	  will	  not	  allow	  to	  identify	  unknown	  compounds,	  which	  are	  not	  in	  a	  database	  
yet,	  or	  also	  for	  some	  known	  metabolites	  because	  the	  proper	  database	  has	  not	  been	  
selected,	   or	   the	   data	   acquisition	   conditions	   were	   different.	   As	   mentioned	   earlier,	  
with	   the	   proper	   method	   one	   or	   multiple	   elemental	   compositions	   can	   be	   derived	  
from	  the	  mass	  of	  a	  molecule,	  however,	  up	  to	  millions	  of	  structures	  can	  be	  obtained	  
for	   a	   single	   EC.	   Therefore,	   querying	   masses	   and	   ECs	   in	   databases	   will	   return	   an	  
incomplete	  list	  of	  candidate	  structures.	  	  	  
	  
De	  novo	  identification	  deals	  with	  ‘truly’	  unknown	  metabolites	  that	  are	  not	  present	  in	  
compound	   libraries.	   In	   many	   cases	   this	   means	   that	   the	   unknown	   has	   not	   been	  
identified	   before,	   which	   poses	   many	   challenges.	   Firstly,	   all	   possible	   candidate	  
structures	  have	   to	  be	  generated,	  ensuring	   that	   the	  correct	   structure	   is	  not	  missing	  
among	  the	  candidates.	  Secondly,	  this	  (usually	  very	  large)	  list	  of	  structures	  has	  to	  be	  
reduced	   by	   filtering	   unwanted	   structures.	   Ideally,	   one	   or	   a	   handful	   of	   candidate	  
structures	  will	  be	  left	  at	  the	  end,	  including	  the	  correct	  structure.	  Lastly,	  the	  proposed	  







Cheminformatics,	  also	  known	  as	  chemoinformatics,	  is	  the	  field	  of	  handling	  chemical	  
information	  electronically.	  The	  use	  of	  computers	  to	  solve	  chemical	  problems	  can	  be	  
traced	   back	   to	   1946	   when	   IBM	   accounting	   machines	   were	   used	   to	   construct	   the	  
rotational	   spectra	   of	   asymmetric	   rotors.	   Cheminformatics	   has	   been	   applied	  
extensively	   in	   drug	   discovery,	   analytical	   chemistry	   and	   structural	   biology,	   among	  
others.	  	  
	  
In	  drug	  discovery,	  chemists	  use	  cheminformatics	  to	  select	  suitable	  drug	  candidates,	  
test	   in	   silico	   their	   activity	   against	   biological	   targets,	   build	   predictive	   models	   (for	  
instance	   of	   drug-­‐likeness)	   and	   calculate	   physicochemical	   properties.	   Other	   uses	   of	  
cheminformatics	   include	   querying	   databases	   of	   small	   compounds	   (<1000Da)	   in	  
search	  for	  compounds	  that	  are	  similar	  to	  known	  active	  molecules,	  or	  for	  those	  that	  
have	   a	   high	   predictive	   activity	   against	   a	   protein	   of	   interest.	   Apart	   from	   searching	  
compounds	  that	  are	  similar	  to	  known	  compounds,	  cheminformatics	  helps	  scientists	  
to	  navigate	  the	  chemical	  space.	  The	  aim	  is	  designing	  molecules	  that	  are	  structurally	  
different	  to	  existing	  ones	  but	  with	  properties	  that	  better	  match	  properties	  ideal	  in	  a	  
certain	   situation,	   for	   instance	   having	   a	   good	   ADMET	   profile	   (administration,	  
distribution,	  metabolism,	  excretion	  and	  toxicity)	  and	  easy	  to	  be	  synthesized.	  	  
	  
Cheminformaticians	  have	  produced	  a	  plethora	  of	  predictive	  models.	   These	  models	  
try	  to	  predict	  for	  new	  molecules	  a	  property	  or	  characteristic,	  which	  have	  been	  learnt	  
from	  a	  set	  of	  molecules	  for	  which	  this	  property	  or	  characteristic	  is	  known.	  Examples	  
of	  these	  models	  are	  drug-­‐likeness	  or	  nature	  product-­‐likeness.	  In	  simple	  words,	  these	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models	   use	   machine-­‐learning	   algorithms	   to	   establish	   the	   relationship	   between	  
molecular	   properties	   (structural	   or	   physicochemical)	   and	   a	   desired	   property	   or	  
behavior.	   All	   these	   models	   rely	   on	   the	   concept	   that	   “similar	   molecules	   will	   have	  
similar	  activities”.	  An	  example	  of	  predicting	  behavior	  of	  molecules	  are	  quantitative	  
structure	   activity-­‐relationship	   (QSAR)	   models,	   which	   aim	   to	   predict	   the	   binding	  
affinity	  of	  molecules	  to	  a	  certain	  target	  based	  on	  certain	  predictor	  properties	  (via	  a	  
regression	  model),	  or	  which	  aim	  to	  predict	  whether	  a	  molecule	  is	  biologically	  active	  
or	   not	   (via	   a	   classification	   model).	   Quantitative	   structure	   property-­‐relationship	  
(QSPR)	  models	   on	   the	   other	   hand	   predict	   properties	   of	   a	  molecule	   like	   solubility,	  
mutagenicity	   or	   internal	   energy	   based	   on	   thestructural	   characteristics	   of	   the	  
molecule.	   Cheminformatics	   models	   can	   be	   used	   in	   principle	   in	   metabolite	  
identification	   strategies	   to,	   e.g.,	   reject	   candidate	   structures	   that	   do	   not	   have	   a	  
predicted	  property	  value	  close	  to	  the	  experimental,	  like	  retention	  time,	  or	  that	  they	  
do	  not	  exhibit	  a	  desired	  property,	  like	  metabolite-­‐likeness.	  
	  
In	   analytical	   chemistry,	   cheminformatics	   helps	   to	   store,	   process	   and	   compare	   all	  
sorts	  of	  spectrometry	  data.	  One	  of	  the	  oldest	  applications	  of	  chemoinformatics	  is	  to	  
assist	   in	  the	  elucidation	  of	  new	  compounds.	   In	  other	  words,	   to	  use	  computers	  and	  
algorithms	   to	   determine	   the	   chemical	   structure	   of	   a	   compound	   measured	   using	  
analytical	  chemistry	  techniques.	  
	  
Structure	  elucidation	  
In	   the	   1960s	   databases	   were	   built	   to	   store	   and	   retrieve	   mass	   spectra.	   The	   same	  
decade	  witnessed	   in	   analytical	   chemistry	   one	   of	   the	  most	   ambitious	   uses	   ever	   of	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cheminformatics	  in	  any	  field,	  the	  DENDRAL	  project.[13]	  The	  aim	  of	  DENDRAL	  was	  to	  
create	   the	   first	   expert	   system	   for	   Computer	   Assisted	   Structure	   Elucidation	   (CASE),	  
which	  would	  automatically	  predict	   the	  chemical	   structure	   from	  the	  mass	  spectrum	  
of	  an	  unknown	  compound.	  In	  the	  years	  after	  DENDRAL	  was	  introduced,	  databases	  of	  
NMR	   spectra	   and	   tools	   to	   predict	   the	   structure	   of	   unknown	  molecules	   were	   also	  
developed.	  	  
	  
Structure	   elucidation	   is	   one	   of	   the	   oldest	   areas	   in	   cheminformatics,	   and	   aims	   to	  
determine	   the	   chemical	   structure	   of	   a	   molecule	   based	   on	   its	   experimental	   data,	  
usually	  MS	  or	  NMR.[14]	  At	  the	  core	  of	  a	  structure	  elucidation	  system	  lays	  a	  structure	  
generator.	   This	   software	   tool	   takes	   as	   an	   input	   the	   elemental	   composition	   of	   the	  
molecule	   and	   optionally	   some	   constraints,	   and	   generates	   possible	   chemical	  
structures.	   Common	   constraints	   are	   prescribed	   substructures,	   forbidden	  
substructures	  and	  desired	  properties	  of	  the	  generated	  molecules.	  	  
	  
Most	   generators	   are	   deterministic	   and	   exhaustive:	   they	   generate	   all	   possible	  
molecules	  for	  a	  given	  input.	  Since	  structure	  generation	  is	  a	  combinatorial	  problem,	  it	  
can	   lead	  to	  an	  explosion	   in	  the	  number	  of	  generated	  molecules.	  To	  avoid	  this,	  one	  
can	   provide	   constraints	   that	   limit	   the	   number	   of	   molecules,	   or	   use	   a	   stochastic	  
generator,	  which	  will	  produce	  a	  subset	  of	  the	  possible	  results.	  While	  computationally	  
affordable,	  stochastic	  generators	  do	  not	  guarantee	  that	  the	  correct	  structure	  will	  be	  
included	   in	   the	   list	   of	   results.	   Therefore,	   scientists	   focused	   so	   far	   on	   the	  




Structure	   generators	   represent	   molecules	   as	   graphs	   given	   the	   resemblance	   of	  
molecules	  and	  graphs.	  Molecular	  atoms	  can	  be	  seen	  as	  graph	  vertices	  and	  molecular	  
bonds	  as	  graph	  edges.	  This	  allows	  structure	  generators	  to	  use	  graph	  theory,	  a	  sub-­‐
field	   of	   mathematics.	   Graph	   theory	   allows	   cheminformaticians	   to	   elaborate	  
theorems	   and	   theoretical	   proofs	   of	   completeness	   and	   correctness.	   From	   these	  
theorems	  algorithms	  can	  be	  developed	  to	  generate	  graphs	  (and	  molecules).	  Finally,	  
these	   algorithms	   are	   programmed	   as	   software	   tools,	   namely	   structure	   generators.	  
Several	   graph	   theory-­‐based	   algorithms	   to	   generate	   molecules	   have	   been	  
developed.[15]	  The	  choice	  of	  structure	  generator	  will	  depend	  on	  how	  complete	  one	  
wants	  the	  results	  to	  be,	  how	  fast	  the	  calculation	  the	  structures	  should	  be,	  and	  how	  
easily	  new	  constraints	  should	  be	  implemented.	  
	  
After	   decades	   of	   research	   in	   CASE,	   several	   structure	   generators	   have	   been	  
developed,	   MOLGEN[16]	   being	   the	   most	   advanced.	   Unfortunately,	   MOLGEN	   and	  
others	  are	  commercial	  and	  the	  source	  code	  of	  these	  tools	  is	  not	  available	  and	  they	  
are	   closed	   tools.	   In	   other	  words,	   they	   are	  not	   freely	   available	   neither	   can	   they	  be	  
customized	  and	  extended	  to	  fulfill	  the	  needs	  of	  metabolomics	  researchers.	  However,	  
all	   available	   structure	   generators	   so	   far	   do	  not	   fulfill	   all	   needs	   for	   identification	  of	  
metabolites,	   such	  as	  using	  only	   atom	   types	  present	   in	  biological	   systems,	   applying	  
constraints	  available	  from	  experimental	  data	  or	  using	  several	  substructures.	  	  	  
	  
Scope	  and	  outline	  of	  the	  thesis	  
The	  goal	  of	   this	   thesis	   is	   to	  design,	  develop	  and	   integrate	  new	  methodologies	  and	  
software	   tools	   such	   as	   a	   structure	   generators	   and	   chemoinformatic	   models	   in	   a	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pipeline	  that	  enables	  de	  novo	  metabolite	  identification.	  The	  ultimate	  pipeline	  should	  
propose	  candidate	  structures	  based	  on	  LC-­‐	  MSn	  for	  those	  unknown	  metabolites	  that	  
are	  not	  present	  in	  any	  database.	  LC-­‐	  MSn	  was	  chosen	  because	  this	  analytical	  platform	  
allows	   to	   detect	   a	   large	   number	   of	   metabolites	   in	   human	   samples	   also	   at	   lower	  
concentrations	   and	   yields	   structural	   information	   of	   unknown	   metabolites	   via	  
extensive	  fragmentation.	  The	  list	  of	  candidate	  structures	  for	  a	  unknown	  metabolites,	  
or	   unknown	   compound	   in	   general,	   should	   be	   exhaustive,	   i.e.	   the	   actual	   structure	  
may	  not	  be	  missed,	  but	  at	  the	  same	  time	  as	  short	  as	  possible	  due	  to	  elimination	  of	  
candidates	   using	  multiple	   filtering	   criteria.	   A	   short	   list	   of	   candidate	   structures	   can	  
then	  be	  checked	  by	  an	  expert	  to	  identify	  the	  final	  candidate	  structure.	  At	  the	  start	  of	  
this	   thesis,	   software	   tools	   to	   process	   and	   analyze	   LC-­‐MSn	   were	   scarce,	   vendor	  
dependent	   and	   not	   open	   source.	   Therefore,	   the	   first	   aim	   in	   this	   thesis	   was	   to	  
develop	   a	   structure	   generator	   and	   to	   develop	   algorithms	   to	   filter	   the	   results	  
obtained	   by	   the	   structure	   generator.	   Therefore	   a	   metabolite-­‐likeness	   predictive	  
method	  had	  to	  be	  developed.	  In	  addition,	  these	  algorithms	  should	  be	  open	  source	  to	  
allow	   others	   to	   use	   them	   and	   improve	   them	   further	   and	   on	   the	   other	   hand	   to	  
implement	   open	   source	   tools	   in	   our	   own	   pipeline.	   In	   a	   parallel	   project,	   another	  
researcher	   developed	   algorithms	   for	   the	   preprocessing	   of	   spectral	   trees	   and	  
algorithms	  to	  compare	  spectral	  trees.	  The	  second	  aim	  was	  therefore	  to	  integrate	  all	  
tools	  developed	   in	   this	   thesis	  and	   in	   the	  parallel	  project	   into	  one	  pipeline	   to	  allow	  
the	   nearly	   fully	   automated	   processing	   and	   interpretation	   of	   spectral	   trees	   of	  




In	   Chapter	   2,	   a	   structure	   generator,	   the	   Open	   Molecule	   Generator	   (OMG),	   is	  
developed.	  OMG	  is	  open	  source	  and	  at	  the	  heart	  of	  a	  de-­‐novo	  identification	  pipeline,	  
since	   it	   can	   generate	   all	   possible	   chemical	   structures	   for	   an	   unknown	  metabolite	  
with	   a	   given	   elemental	   composition.	   The	   canonical	   augmentation	   approach,	  
originally	   designed	   to	   generate	   graphs,	   was	   adapted	   to	   generate	   all	   possible	  
molecules	   for	   a	   given	   elemental	   composition	   and	   optional	   fragments	   and	  
implemented	  as	  open	  source.	  	  
	  
The	  aim	  of	  the	  research	  reported	  in	  Chapter	  3	  was	  to	  develop	  a	  method	  to	  constrain	  
the	  number	  of	  molecules	  generated	  by	  OMG.	  The	  Metabolite-­‐likeness	  filter	  has	  been	  
developed	   to	   remove	   unwanted	   molecules	   that	   do	   not	   resemble	   human	  
metabolites.	  Different	  classification	  models	  were	  developed,	  optimized	  and	  trained	  
to	   discern	   between	   human	   metabolites	   and	   non-­‐metabolite	   molecules	   based	   on	  
their	  physicochemical	  and	  structural	  properties.	  These	  models	  were	  tested	  and	  the	  
best	   performing	   one	   selected	   to	   reject	   molecules	   that	   would	   obtain	   a	   low	  
metabolite-­‐likeness	  score.	  	  
	  
In	   Chapter	   4,	   the	   tools	   developed	   in	   Chapter	   2	   and	   3	   of	   this	   thesis	   and	   in	   other	  
related	  metabolite	  identification	  research	  projects	  are	  integrated	  into	  an	  metabolite	  
identification	   pipeline	   (Figure	   2),	   optimized	   and	   applied	   to	   identify	   metabolites	  
detected	   in	   human	   urine,	   which	   could	   be	   known	   and	   unknown	  metabolites.	   MSn	  
spectra	   of	   human	   urine	   metabolites	   were	   acquired,	   processed,	   the	   elemental	  
compositions	   assigned	   to	   fragment	   ions	   and	   neutral	   losses,	   and	   the	   spectral	   trees	  
were	   compared	   using	   fragmentation	   tree	   similarity	   to	   a	   database	   of	   known	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metabolites	  in	  order	  to	  obtain	  prescribed	  substructures.	  These	  substructures	  and	  the	  
elemental	   composition	  were	   taken	  as	   input	   for	   generation	  of	   candidate	   structures	  
with	   the	   OMG.	   These	   structures	   were	   filtered	   using	   Metabolite-­‐likeness,	   internal	  
energy	   and	   fragmentation	   prediction	   filters.	   The	   performance	   of	   the	   overall	  
identification	  pipeline	  was	  discussed	  and	  possible	  future	  developments	  proposed.	  
	  
In	  Chapter	  5,	   the	  structure	  generation	  method	  was	  further	   improved	  based	  on	  the	  
experiences	   obtained	   in	   Chapter	   4,	   and	   the	   Parallel	   Molecule	   Generator	   (PMG)	  
developed.	   	   These	   improvements	   included	   the	   use	   of	   a	   faster	   algorithm,	   the	  
execution	   in	   parallel	   using	   multiple	   processors	   and	   the	   use	   of	   a	   bad	   list	   of	  
substructures	   and	   bad	   rings,	   to	   reject	   while	   generating	   unwanted	   molecules	   that	  
contained	   one	   or	   multiple	   unwanted	   moieties.	   The	   improvement	   resulted	   in	  
significant	  reduction	  of	  time	  required	  to	  create	  a	  candidate	  list,	  which	  was	  100-­‐fold	  
compared	   to	   OMG	   for	   unknown	   metabolites	   for	   which	   a	   list	   of	   prescribed	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OMG:	  Open	  Molecule	  Generator	  
Computer	  Assisted	  Structure	  Elucidation	  has	  been	  used	  for	  decades	  to	  discover	  the	  
chemical	   structure	   of	   unknown	   compounds.	   In	   this	   work	   we	   introduce	   the	   first	  
open	   source	   structure	   generator,	   Open	  Molecule	   Generator	   (OMG),	   which	   for	   a	  
given	  elemental	  composition	  produces	  all	  non-­‐isomorphic	  chemical	  structures	  that	  
match	   that	   elemental	   composition.	   Furthermore,	   this	   structure	   generator	   can	  
accept	   as	   additional	   input	   one	   or	   multiple	   non-­‐overlapping	   prescribed	  
substructures	   to	   drastically	   reduce	   the	   number	   of	   possible	   chemical	   structures.	  
Being	   open	   source	   allows	   for	   customization	   and	   future	   extension	   of	   its	  
functionality.	   OMG	   relies	   on	   a	   modified	   version	   of	   the	   Canonical	   Augmentation	  
Path,	  which	  grows	   intermediate	   chemical	   structures	  by	  adding	  bonds	  and	  checks	  
that	  at	  each	  step	  only	  unique	  molecules	  are	  produced.	  	  In	  order	  to	  benchmark	  the	  
tool,	   we	   generated	   chemical	   structures	   for	   the	   elemental	   formulas	   and	  
substructures	   of	   different	   metabolites	   and	   compared	   the	   results	   with	   a	  
commercially	  available	  structure	  generator.	  The	  results	  obtained,	   i.e.	  the	  number	  
of	  molecules	  generated,	  were	  identical	  for	  elemental	  compositions	  having	  only	  C,	  
O	  and	  H.	  For	  elemental	  compositions	  containing	  C,	  O,	  H,	  N,	  P	  and	  S,	  OMG	  produces	  
all	   the	   chemically	   valid	  molecules	  while	   the	   other	   generator	   produces	  more,	   yet	  
chemically	   impossible,	  molecules.	  The	  chemical	  completeness	  of	  the	  OMG	  results	  
comes	  at	  the	  expense	  of	  being	  slower	  than	  the	  commercial	  generator.	  In	  addition	  
to	   being	   open	   source,	   OMG	   clearly	   showed	   the	   added	   value	   of	   constraining	   the	  
solution	  space	  by	  using	  multiple	  prescribed	  substructures	  as	  input.	  We	  expect	  this	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structure	   generator	   to	   be	   useful	   in	   many	   fields,	   but	   to	   be	   especially	   of	   great	  
importance	   for	   metabolomics,	   where	   identifying	   unknown	   metabolites	   is	   still	   a	  
major	  bottleneck.	  
	  
Computer	  Assisted	  Structure	  Elucidation	  (CASE)	  of	  chemical	  compounds	  is	  one	  of	  the	  
classical	   problems	   positioned	   at	   the	   intersection	   of	   informatics,	   chemistry,	   and	  
mathematics.	   CASE	   tools	   have	   been	   employed	   during	   decades	   to	   elucidate	   the	  
chemical	   structure	   of	   small	   organic	   molecules.	   In	   its	   most	   general	   definition,	   a	  
structure	   elucidation	   system	   receives	   experimental	   chemistry	   data	   of	   an	   unknown	  
molecule	  as	   input,	  and	  outputs	  a	   list	  of	  possible	  chemical	  structures.	  The	  input	  can	  
be	  the	  elemental	  composition	  of	  the	  elusive	  molecule,	  nuclear	  magnetic	  resonance	  
(NMR)	  and/or	  mass	  spectrometry	  (MS)	  spectra	  (provided	  the	  generator	  can	  simulate	  
spectra	   and	   match	   it	   to	   the	   experimental	   ones)	   or	   information	   of	   prescribed	  
substructures.	  The	  output	  is	  a	  list	  of	  candidate	  structures	  matching	  these	  conditions,	  
ideally	   containing	   all	   possible	   structures	   without	   duplications.	   A	   small	   list	   of	  
candidates	   is	   dependent	   on	   the	   number	   of	   constraints	   derived	   from	   experimental	  
data;	  the	  higher	  the	  number	  of	  constraints	  we	  use	  the	  smaller	  the	  candidate	  list	  will	  
be.	   The	   ultimate	   goal	   for	   such	   a	   system	  being	   fully	   automated	   and	   returning	   only	  
one	  and	  correct	  molecule	  is	  not	  yet	  at	  our	  reach,	  despite	  decades	  of	  research[1].	  	  
	  
The	   DENDRAL[2]	   project	   is	   widely	   regarded	   as	   the	   initiator	   of	   the	   use	   of	   these	  
methods	  to	  provide	  a	  system	  for	  Computer	  Assisted	  Structure	  Elucidation	  (CASE).	  It	  
involved	   the	   development	   of	   artificial	   intelligence	   algorithms	   that	   would	   extract	  
heuristics	   from	   MS	   and	   NMR	   data	   and	   use	   them	   to	   constrain	   the	   output	   of	   a	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structure	   generator.	   CONGEN	   was	   the	   structure	   generator	   developed	   within	  
DENDRAL,	  which	  preceded	  a	  more	  advanced	  generator	  known	  as	  GENOA[3].	  Many	  
commercial	  structure	  generators	  were	  developed	  later,	  most	  renowned	  ones	  being	  
CHEMICS[4],	  ASSEMBLE[5],	  SMOG[6],	  and	  the	  most	  widely	  used	  of	  all	  of	   them,	   the	  
general	  purpose	  structure	  generator	  MOLGEN[7].	  These	  closed	  source	  software	  tools	  
work	   like	   a	   black	   box,	   where	   the	   user	   cannot,	   on	   the	   one	   hand,	   understand	   the	  
functioning	  of	  the	  software	  and	  on	  the	  other	  hand,	  customize	  the	  tool	  to	  his	  needs.	  
These	  drawbacks	  of	  closed	  source	  software	  (where	  the	  source	  code	  is	  not	  provided)	  
can	  be	   circumvented	  by	  open	   source	   tools.	   Two	  open	   source	   structure	   generators	  
have	   been	   developed	   that	  work	  with	  NMR	   data,	   the	   deterministic	   LSD[8]	   and	   the	  
stochastic	   SENECA[9].	   Implementation	  of	   open	   source	   stochastic	   and	  deterministic	  
structure	   generators	   have	   been	   explored	   within	   the	   Chemistry	   Development	   Kit	  
(CDK)[10,	   11].	   Unfortunately,	   these	   generators	   failed	   to	   generate	   all	   chemical	  
structures	  possible	  and	  were	  discontinued	   in	  recent	  releases	  of	  CDK.	  Despite	  these	  
efforts,	  no	  general	  purpose	  deterministic	  structure	  generator	  has	  been	  developed	  in	  
an	  open	  source	  format	  so	  far.	  	  	  
	  
The	   advance	   of	   “omics”	   sciences	   in	   the	   last	   decade,	   in	   particular	   of	  
metabolomics[12],	   has	   renewed	   the	   interest	   of	   researchers	   in	   developing	   better	  
structure	  generators.	  Metabolomics	  aims	  at	  detecting	  and	  identifying	  metabolites	  in	  
an	   organism	  and	  has	   resulted	   in	   a	   large	   list	   of	   potential	   biomarkers	   for	  which	   the	  
chemical	   structure	   is	   unknown[1,	   13].	   When	   trying	   to	   identify	   the	   structure	   of	  
unknown	  molecules,	  scientists	  first	  perform	  an	  identity	  search	  by	  querying	  reference	  
databases	  using	  their	  experimental	  information[1,	  14–16].	  In	  such	  case,	  they	  use	  the	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elemental	   composition	  of	   the	  metabolite	  derived	   from	  mass	   spectrometry	   (MS)	  or	  
the	   spectra	   of	   nuclear	  magnetic	   resonance	   (NMR).	  When	   the	  metabolite	   is	   a	   real	  
unknown	   it	   is	  not	  present	   in	  any	  database,	   therefore	   the	  query	   returns	  no	   results.	  
This	  forces	  scientists	  to	  propose	  candidate	  structures	  using	  a	  different	  approach,	  one	  
of	   them	   is	   using	   a	   structure	   generator[17,	   18]	   ,	   which	   produces	   all	   possible	  
molecules	  given	  an	  elemental	  composition	  and	  optional,	  other	  constraints.	  Examples	  
of	   constraints	   are	   prescribed	   substructures	   that	   each	   output	   molecules	   should	  
contain	  and	  that	  are	  derived	  from	  experimental	  NMR,	  MS2,	  or	  MSn	  data.	  Hence,	  the	  
need	  for	  deterministic	  and	  flexible	  structure	  generators	  in	  the	  field	  of	  metabolomics	  
presents	  should	  be	  met	  with	  new	  algorithms[1].	  	  	  
	  
The	  majority	  of	  structure	  generators	  rely	  on	  graph	  theory	  to	  produce	  their	  desired	  
output.	   Interestingly,	   compounds	   can	   be	   represented	   as	   molecular	   graphs	   where	  
atoms	   and	   bonds	   are	   translated	   into	   vertices	   and	   edges,	   respectively,	   to	   which	  
theorems	  and	  algorithms	  proposed	  by	  graph	  theory	  can	  be	  applied.	  This	  ensures	  that	  
the	  output	   is	  correct,	  exhaustive,	  and	  free	  of	   isomorphs.	  Such	  methods	  can	  be	  the	  
orderly	   enumeration	   proposed	   by	   Read[19]	   and	   Faradzev[20],	   a	   stochastic	  
generator[21],	  the	  homomorphism	  principle[22]	  used	  by	  MOLGEN,	  or	  the	  “canonical	  
augmentation	  path”	  proposed	  by	  McKay[23].	  This	  last	  method,	  originally	  intended	  to	  
generate	   simple	   graphs	   by	   adding	   vertices,	   has	   been	   applied	   to	   the	   generation	   of	  
some	  families	  of	  graphs	  and	  also	  to	  generate	  the	  chemical	  universe	  of	  molecules	  up	  
to	   11	   atoms[24]	   and	   recently	   to	   13	   atoms[25].	   Despite	   the	   goal	   was	   to	   generate	  
molecules,	  these	  two	  approaches	  initially	  employed	  canonical	  path	  augmentation	  to	  
generate	  all	  possible	  simple	  graphs	  up	  to	  11	  and	  13	  vertices,	  respectively.	  Posterior	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topological	  and	  ring	  system	  filter	  were	  used	  to	  remove	  unwanted	  graphs.	  Lastly,	  the	  
vertices	   were	   colored	   with	   chemical	   elements	   and	   the	   edges	   with	   a	   bond	   order,	  
which	   turned	   the	   graphs	   into	   molecules.	   Simple	   chemical	   constraints	   like	  
connectivity	  and	  atom	  valence	  were	  applied	  to	  reduce	  the	  list	  of	  final	  molecules.	  This	  
process,	  which	  relies	  on	  generating	  simple	  graph,	  is	  necessarily	  limited	  on	  the	  size	  of	  
the	  molecules	   that	   can	   be	   generated	   because	   a	   linear	   increase	   in	   the	   number	   of	  
atoms	   produces	   an	   exponential	   increase	   of	   both	   the	   number	   of	   graphs	   and	  
molecules.	   Here	   we	   present	   the	   Open	   Molecule	   Generator	   (OMG),	   a	   structure	  
generator	   based	   too	   on	   McKay	   augmentation	   algorithms,	   but	   rather	   than	   first	  
generating	   graphs	   and	   secondly	   transforming	   these	   graphs	   into	   molecules,	   our	  
implementation	   of	  McKay	   technique	   directly	   constructs	  molecules.	   In	   this	  way	  we	  
can	  generate	  chemical	  structures	  much	  greater	  than	  13	  atoms.	  Essential	  concepts	  of	  
graph	  theory	  will	  be	  introduced	  in	  the	  methods	  section.	  	  
	  
Chen	  mentioned	  two	  future	  challenges	  facing	  CASE	  systems[26].	  The	  first	  challenge	  
for	   elucidating	   structures	   is	   to	   have	   a	   knowledge	   system	   of	   previously	   identified	  
compounds,	  as	  well	  as	  mining	  tools	  for	  such	  data.	   In	  this	  direction,	  Rojas-­‐Chertó	  et	  
al.[27]	  developed	  a	  system	  to	  store	  spectral	  data	  and	  mine	  the	  database	  to	  extract	  
substructure	   information	   that	   can	   be	   used	   as	   prescribed	   substructures	   in	   our	  
structure	   generator.	   The	   second	   challenge	   is	   the	   need	   for	   filtering	   and	   selecting	  
candidate	   structures.	   This	   is	   often	   performed	   by	   predicting	   a	   property	   of	   the	  
candidate	  structures	  that	   is	  related	  to	  the	  field	  of	  research,	  for	   instance,	  predicting	  
the	   spectra	   in	   analytical	   chemistry,	   the	   bioactivity	   in	   ligand	   design,	   or	   the	  
Metabolite-­‐Likeness[28]	   in	  metabolomics	  studies,	  to	  name	  a	  few.	  Furthermore,	  the	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need	  of	  a	  structure	  generator	  tool	  that	  can	  be	  adapted	  to	  the	  requirements	  of	  the	  
field	  in	  which	  it	  is	  going	  to	  be	  applied,	  demonstrates	  the	  usefulness	  of	  open	  source	  
tools	  compared	  to	  commercial	  "black	  box"	  generators.	  	  
	  
In	  this	  paper	  we	  present	  the	  first	  general	  purpose	  open	  source	  structure	  generator,	  
Open	   Molecule	   Generator.	   OMG	   adapts	   methodologies	   from	   the	   field	   of	   graph	  
theory	   and	   deterministic	   graph	   enumeration	   to	   the	   classical	   problem	   of	   chemical	  
structure	  generation.	   In	   this	   sense,	  we	  have	  used	   the	  approach	  of	   “canonical	  path	  
augmentation”	   to	   ensure	   that	   we	   exhaustively	   generate	   non-­‐isomorphic	   chemical	  
structures	   for	   a	   given	   elemental	   composition.	   This	   generation	   tool	   has	   been	  
implemented	   using	   CDK[10,	   11],	   a	   widely	   used	   open	   source	   library	   for	   the	  
development	  of	  chemoinformatics	  software.	  It	  allowed	  the	  representation	  of	  entities	  
such	  as	  molecules,	  atoms,	  and	  bonds	   in	  our	  program	  and	   the	  use	  of	   functions	   like	  
removing	  hydrogen	  atoms,	  checking	  the	  saturation	  of	  a	  molecule,	  removing	  a	  bond,	  
and	   many	   more.	   The	   resulting	   tool	   generates	   all	   possible	   non-­‐duplicate	   chemical	  
structures	  for	  a	  given	  elemental	  composition,	  with	  the	  option	  to	  generate	  only	  those	  
that	   contain	   one	   or	   multiple	   non-­‐overlapping	   substructures,	   which	   is	   the	   most	  
important	  constrain	  to	  reduce	  the	  number	  of	  resulting	  candidate	  structures	  	  when	  a	  
knowledge	   system	   is	  not	  available[18].	  We	  have	  used	  OMG	  to	  generate	  molecules	  
for	   the	   elemental	   composition	   of	   well	   known	   metabolites,	   also	   including	   one	   or	  
more	   prescribed	   substructures	   as	   input.	   These	   results	   are	   compared	   to	   those	  





Materials	  and	  methods	  
Chemical	  Elements	  and	  Atom	  Types	  
We	  would	   like	   to	   describe	   some	   concepts	   related	   to	   atoms	   that	   are	   necessary	   to	  
understand	   the	   theory	   and	   algorithm	   behind	   OMG	   and	   the	   use	   of	   CDK	   to	   handle	  
chemistry.	  	  
	  
In	   nature,	   atoms	   of	   different	   chemical	   elements	   (carbon,	   nitrogen,	   oxygen,	   and	  
others)	   are	   connected	   to	   each	   other	   by	   bonds	   in	   order	   to	   form	   molecules.	   The	  
valence,	  to	  which	  we	  will	  also	  refer	  as	  degree,	  of	  these	  chemical	  elements	  determine	  
how	  many	  bonds	  each	  element	   can	  have.	  Carbon	  has	  a	   valence	  of	  4,	  oxygen	  of	  2,	  
nitrogen	   of	   3	   or	   5,	   sulfur	   of	   2,4	   or	   6,	   phosphor	   of	   3	   or	   5.	   Thus	   a	   carbon	   atom	  
becomes	  saturated	  when	  it	  has	  4	  bonds,	  where	  a	  single	  bond	  counts	  as	  one	  bond,	  a	  
double	  as	  two	  bonds,	  and	  a	  triple	  as	  three	  bonds.	  Regarding	  molecules,	  we	  consider	  
a	   molecule	   to	   be	   saturated	   when	   all	   its	   atoms	   are	   saturated.	   In	   some	   special	  
occasions,	  atoms	  are	  charged,	  which	  makes	  them	  having	  a	  different	  valence.	  In	  the	  
case	   of	   OMG,	   we	   only	   use	   neutral	   atoms	   and	   as	   a	   consequence	   only	   neutral	  
molecules	  are	  produced,	  therefore	  all	  finished	  molecules	  will	  contain	  atoms	  with	  the	  
valences	  mentioned	  before.	  	  
	  
A	  chemical	  element	  can	  have	  multiple	  atom	  types,	  also	  for	  the	  same	  valence	  of	  an	  
element,	  as	  defined	  by	  the	  dictionary	  of	  atom	  types	   in	  CDK.	  This	  dictionary	  defines	  
for	  each	  atom	  the	  number	  of	  neighbors,	  pi	  bonds,	  charges,	  lone	  electron	  pairs,	  and	  
hybridizations,	  in	  order	  to	  accommodate	  the	  different	  states	  a	  chemical	  element	  can	  
have	   due	   to	   different	   bonds,	   number	   of	   neighboring	   atoms,	   charges	   and	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hybridizations.	   These	   atom	   types	   are	   based	   on	   the	   chemical	   elements	   that	   have	  
been	  observed	  in	  nature	  for	  saturated	  molecules.	  This	  is	  why	  we	  use	  the	  CDK	  atom	  
dictionary	  to	  validate	  the	  atoms	  of	  our	  finished	  molecules.	  	  
	  
OMG	   will	   output	   only	   molecules	   that	   are	   saturated	   and	   that	   contain	   the	   atoms	  
specified	  in	  the	  elemental	  composition.	  Apart	  from	  finished	  molecules,	  OMG	  has	  to	  
represent	  during	   the	  generation	  process	   intermediate	   chemical	   structures	   that	  are	  
not	   finished	   yet.	   These	  might	   contain	   disconnected	   fragments	   and	   atoms	   that	   are	  
not	   saturated.	   CDK	   atom	   types	   are	   not	   designed	   to	   represent	   atom	   types	   of	  
unsaturated	  chemical	  elements;	  therefore	  we	  opted	  for	  implementing	  a	  simple	  atom	  
dictionary.	   For	   each	   chemical	   element,	   this	   dictionary	   defines	   its	   valence,	   in	   other	  
words,	   the	  maximum	  degree.	  Hence	   for	   intermediate	   chemical	   structures	  we	  only	  
check	  that	  the	  current	  degree	  of	  each	  atom	  does	  not	  exceed	  the	  maximum	  degree.	  
	  
MOLGEN	  can	  also	  produce	  molecules	  with	  multiple	  valences,	  but	  it	  handles	  them	  in	  
a	   different	   way.	   While	   with	   OMG	   only	   the	   elemental	   composition	   needs	   to	   be	  
provided	  to	  generate	  molecules	  with	  multiple	  valences,	  MOLGEN	  requires	  knowing	  a	  
priori	   which	   one	   of	   the	   multiple	   valences	   has	   to	   be	   used.	   It	   uses	   by	   default	   the	  
lowest	  valence,	  this	  is,	  N	  valence	  3,	  P	  valence	  3,	  and	  S	  valence	  2,	  unless	  a	  different	  
valence	  is	  specified.	   In	  Table	  1	  the	  atom	  types	  produced	  by	  OMG	  and	  MOLGEN	  for	  
non-­‐default	   valences	   are	   presented.	   Using	   sulfur	   as	   an	   example,	   OMG	  will	   output	  
molecules	  with	  containing	  sulfur	  valence	  2,	  4	  and	  6.	  For	  the	  same	  chemical	  element,	  
MOLGEN	  will	   produce	   by	   default	  molecules	   with	   sulfur	   valence	   2.	   If	   one	   sets	   the	  
valence	  of	   sulfur	   to	   6,	   it	  will	   only	   produce	   sulfur	   valence	  6	   and	  not	   valence	  2	   and	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valence	  4.	  MOLGEN	  cannot	  generate	  molecules	  with	  atoms	  of	  different	  valences	  for	  
the	  same	  chemical	  element,	  this	  is,	  if	  molecule	  has	  two	  sulfur	  atoms,	  one	  will	  not	  be	  
of	  valence	  4	  and	  the	  other	  of	  valence	  6,	  both	  will	  be	  either	  valence	  2,	  4	  or	  6.	  
	  
Valence	   MOLGEN	   OMG	  
N	  	  
valence	  5	  
	   	   	   	  
P	  	  
valence	  5	  
	   	   	  
S	  	  
valence	  4	  
	   	  
S	  	  
valence	  6	  
	   	  
Table	  1	  Atom	  types	  produced	  by	  OMG	  and	  MOLGEN	  for	  non-­‐default	  valences	  of	  N(5),	  P(5)	  and	  S(4	  and	  6).	  
	  
The	  principle	  followed	  by	  CDK	  to	  build	  its	  atom	  dictionary	  is	  to	  allow	  atom	  types	  with	  
valences	   for	   which	   there	   is	   a	   consensus	   agreement	   on	   their	   existence,	   this	   is,	   for	  
which	  known	  molecules	  exist	  with	  such	  valences.	  Conversely,	  MOLGEN	  produces	  all	  
theoretically	  possible	  combinations	  of	  bond	  orders	  for	  a	  given	  valence,	  as	   it	  can	  be	  
observed	   in	   Table	   1.	   For	   example,	   as	   it	   can	   be	   seen	   for	   P	   valence	   5	   OMG	   only	  
produces	   one	   atom	   type	   with	   one	   double	   bond	   and	   three	   single	   bonds.	   In	  
comparison,	   MOLGEN	   produces	   all	   the	   combinations	   of	   single,	   double,	   and	   triple	  
bonds	  that	  add	  to	  5.	  As	  a	  consequence,	  when	  the	  desired	  valence	  is	  unknown,	  which	  
is	  usually	  the	  case	  in	  metabolite	  identification,	  molecules	  need	  to	  be	  generated	  with	  
all	   possible	   valences.	   	   As	   a	   result,	   the	   number	   of	   output	   molecules	   by	   both	  
generators	   is	   different	   for	   elemental	   compositions	   that	   contain	   chemical	   elements	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with	  multiple	  valences.	  This	  deterministic	  generation	  of	  valences	  in	  MOLGEN	  comes	  
at	  the	  expense	  of	  generating	  molecules	  having	  unrealistic	  structures.	  	  
	  
Graph	  Theory	  and	  Chemistry	  
The	   chemical	   structure	   of	  molecules	   can	  be	   represented	   as	   a	   graph,	  where	   atoms	  
and	  bonds	  in	  molecules	  correspond	  to	  vertices	  and	  edges,	  respectively,	  in	  graphs.	  In	  
molecules,	   bonds	   connecting	   two	   atoms	   can	   have	   a	   degree	   depending	   on	   the	  
number	  of	  electrons	  they	  share.	  Such	  a	  degree	  can	  also	  be	  assigned	  to	  the	  edges	  of	  a	  
graph,	  which	  is	  called	  a	  multigraph.	  The	  different	  chemical	  elements	  present	  in	  the	  
periodic	  table	  are	  represented	  in	  graphs	  as	  colors	  assigned	  to	  the	  vertices.	  We	  define	  
a	  non-­‐directed	  colored	  multigraph	  as	   	  where	  V	  is	  a	  set	  of	  vertices	  and	  E	  is	  
a	  multiset	  of	  edges,	  where	  each	  edge	  is	  an	  unordered	  pair	  of	  vertices,	  and	  a	  function
.	   In	   this	  multigraph,	  we	   say	   that	   	   are	  n-­‐connected	   if	   there	  
are	   exactly	   n	   edges	   .	   Apart	   from	   the	   color	   function,	   a	   multigraph	   is	  
characterized	  by	  the	  function	   ,	  which	  returns	  the	  degree	  of	  the	  edge	  
connecting	   each	   couple	   of	   vertices.	   From	   now	   on	   we	   will	   indistinctively	   refer	   to	  
graphs	  and	  multigraphs.	  	  
	  
In	   chemistry,	   the	   valence	   rule	   determines	   the	   maximum	   number	   of	   bonds	   each	  
chemical	  element	  has.	   In	  order	  to	  take	  this	   into	  account,	  we	  define	   	  which	  returns	  
the	   number	   of	   edges	   of	   a	   given	   vertex	   and	   a	  max-­‐degree	   function	   ,	  
which	   returns	   the	   maximum	   number	   of	   edges	   of	   a	   given	   vertex.	   We	   say	   that	   a	  
multigraph	   is	   under-­‐saturated	   if	   	   	   there	   is	   at	   least	   one	   vertex 	   such	   that	   .	   A	  
multigraph	   is	   saturated	   if	   the	   equality	   	   holds	   for	   every	   vertex.	   In	   chemistry,	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molecules	  correspond	  to	  saturated	  colored	  multigraphs	  and	  max-­‐degree	  depends	  on	  
the	   color,	   which	   is	   the	   chemical	   element.	   For	   instance,	   for	   a	   carbon	   element,	  
	  and	  for	  an	  oxygen	  element,	   .	  	  
	  
We	  consider	  a	  multigraph	  to	  be	  connected	  if	   	  such	  that	  
	  and	   	  are	  connected	  and	  for	  each	   ,	   	  is	  connected	  to	   .	  In	  other	  
words,	  a	  multigraph	  is	  connected	   if	   for	  all	  pair	  of	  vertices,	  there	  exists	  at	   least	  one	  
path	  S{v,w}	  connecting	  both	  vertices.	  This	  condition	   is	  necessary	  for	  chemistry,	  since	  
intermediate	   chemical	   structures	   in	   the	   generation	   process	   can	   be	   composed	   of	  
disconnected	   fragments,	   it	   ensures	   that	   the	   generated	   molecules	   are	   one	   fully	  
connected	   structure	   and	   not	   made	   of	   disconnected	   substructures.	   Notice	   that	  
hydrogen	  atoms	   (the	  most	   frequently	   found	  chemical	  elements	  with	  degree	  1)	  are	  
not	   considered	   in	   the	   generation	  process,	   since	   they	   are	   terminal	   elements	  of	   the	  
molecule	   and	   they	   cannot	   connect	   two	   disconnected	   elements	   of	   the	   molecule.	  
Hydrogen	  atoms	  are	  only	  used	  to	  validate	  the	  completeness	  of	   finished	  molecules.	  
Halogen	  atoms	   like	   fluorine,	   chlorine,	   and	   iodine,	   also	  of	  degree	  1,	   are	   considered	  
during	  the	  generation	  process.	  
	  
Graph	  Labeling	  
An	  isomorphism	   	  is	  a	  function	  that	  for	  each	  vertex	   	   	  and	  
for	   each	   pair	   of	   vertices	   	   .	   A	   labeling	   function	  
	   is	   a	  bijective	  map	   from	   the	  vertices	  of	  a	   colored	  multigraph	   to	  an	  
ordered	  list	  labels	  with	  a	  cardinality	  equal	  to	  the	  number	  of	  vertices.	  Put	  simple,	   	  
assigns	  to	  each	  vertex	  a	   label.	  Let	   	  be	  the	  inverse	  function	  of	   ,	  which	  returns	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the	  vertex	  corresponding	  to	  a	  label.	  We	  say	  a	  labeling	  function	  is	  canonical	   if	  given	  
any	  two	   isomorphic	  colored	  multigraphs	   	  and	   ,	   the	  bijective	  
function	   	   defined	   as	   	   is	   an	   isomorphism	   of	   	   in	   .	  
Therefore,	   a	   canonically	   labeled	   multigraph	   is	   a	   multigraph	   whose	   vertices	   are	  
associated	   to	  an	  ordered	   list	   through	  a	  canonical	   labeling	   function.	  Furthermore,	  a	  
canonical	   hash	   of	   the	   labeling	   is	   a	   bijective	   function	   between	   the	   space	   of	   the	  
canonically	  labeled	  multigraphs	  and	  the	  value	  space	  and	  it	  is	  represented	  as	  a	  string	  
of	  integers.	  It	  is	  interesting	  to	  note	  here	  that	  two	  isomorphic	  graphs	  have	  the	  same	  
canonical	  hash,	  a	   fact	  that	  will	  be	  used	  to	  remove	  duplicated	  molecules	  during	  the	  
generation	  process.	  	  
	  
Using	  Fragments	  
A	  fragment	  or	  substructure	  of	  a	  molecule	  is	  equivalent	  to	  a	  fragment	  or	  subgraph	  of	  
a	  graph.	  We	  define	  a	  fragment	  as	  a	  subset	  of	  a	  graph	  and	  it	  is	  characterized	  by	  the	  
function	   	  where	   	   is	   the	  number	  of	  edges	  connecting	  each	  pair	  of	  
vertices	   in	   the	   subgraph.	   Such	   	   has	   to	   fulfill	   the	   condition	  
	   and	   at	   least	   for	   one	   edge	   ,	   this	   is,	   the	   fragment	  
should	  have	  fewer	  edges	  than	  the	  graph.	  	  
	  
Canonical	  Augmentation	  
An	  augmentation	  of	  a	  multigraph	   	  is	  a	  multigraph	   ,	  defined	  on	  
the	  same	  set	  of	  vertices,	  such	  that	   ,	  except	  for	  one	  and	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only	  one	  pair	  where	   .	  Let	   	  be	  the	  edge	  which	  degree	  has	  
been	  increased,	   .	  
	  
Let	  	  	  be	  the	  last	  edge	  of	  	  and	  	  the	  vertices	  of	  .	  Consider	  	  	  to	  vertices	  of	  	  ,	  a	  copy	  of	  ,	  to	  
which	   a	   bond	   order	   decrease	   is	   performed	   .	   The	   resulting	   multigraph	   	   after	   this	  
decrease	   in	  bond	  order,	   can	  be	   seen	  as	   the	   result	  of	   a	   canonical	  deletion	  on	   ,	   the	  
reverse	   operation	   of	   a	   canonical	   augmentation.	   In	   our	   definition	   of	   canonical	  
augmentation	  we	   consider	   a	  multigraph	   	   to	  be	   canonically	   augmented	  
from	   	  if	   it	   is	  an	  augmentation	  and	  .	   In	  other	  words,	  we	  consider	  	  to	  be	  a	  
canonical	  augmentation	  of	  	  if	  a	  canonical	  deletion	  in	  	  results	  in	  .	  
	  
Description	  of	  the	  algorithm	  
The	   generation	   of	   structures	   can	   be	   seen	   as	   a	   tree	   of	   intermediate	   chemical	  
structures	  that	  our	  tool	  explores.	  At	  the	  root	  of	  the	  tree	  we	  find	  a	  collection	  of	  fully	  
isolated/disconnected	  atoms.	  One	  bond	  is	  added	  at	  each	  level	  of	  the	  tree,	  resulting	  
in	   fully	   connected/finished	   molecules	   at	   the	   leaves.	   The	   canonical	   augmentation	  
path	   is	  a	  depth-­‐first	  backtracking	  algorithm,	  where	  the	  recursive	   function	  generate	  
described	  in	  Algorithm	  1,	   implements	  the	  addition	  of	  one	  bond	  in	  all	  possible	  ways	  
for	   a	   given	   intermediate	   chemical	   structure,	   and	   evaluates	   for	   each	   extended	  
molecule	   that	   this	  extension	  has	  been	  performed	   in	  a	   canonical	  way,	   as	  described	  
before.	   Here	   adding	   one	   bond	  means	   increasing	   the	   degree	   of	   the	   bond	   between	  
two	   atoms,	   hence	   a	   single	   bond	   becomes	   a	   double	   bond	   and	   a	   double	   bond	  
becomes	   a	   triple	   bond.	   If	   there	   is	   no	   bond	   between	   two	   atoms,	   a	   single	   bond	   is	  
created.	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1:	  generate(M)	  
2:	   If	  saturated(M)	  AND	  are_all_H_used(M)	  
3:	   	   If	  connected_fragments(M)	  ==	  1	  
4:	   	   	   store_to_file(M)	  
5:	   	   	   Nmols	  =	  Nmols	  +	  1	  
6:	   	   	   If	  degree(M)	  <	  max_degree(M)	  
7:	   	   	   	   generate(M)	  
8:	   	   	   Endif	  
9:	   	   Endif	  
10:	   Else	  
11:	   	   New	  Map	  
12:	   	   List_of_bonds	  =	  extend(M)	  
13:	   	   Foreach	  bond	  in	  list_of_bonds	  
14:	   	   	   M’	  =	  add_bond(bond,M)	  
15:	   	   	   canonM’	  =	  canonize(M’)	  
16:	   	   	   If	  not	  is_present(map,canonM’)	  
17:	   	   	   	   add(map,canonM’)	  
18:	   	   	   	   If	  is_canonical_augmentation(canonM’,M’,M)	  
19:	   	   	   	   	   generate(M’)	  
20:	   	   	   	   EndIf	  
21:	   	   	   EndIf	  
22:	   	   End	  




Between	  lines	  2	  and	  9	  of	  Algorithm	  1,	  the	  molecule	   is	  stored	  if	   it	   is	  finished,	  which	  
occurs	   when	   the	   molecule	   is	   saturated	   and	   all	   the	   atoms	   of	   the	   elemental	  
composition,	   including	   the	   hydrogen	   atoms,	   have	   been	   used,	   all	   the	   atoms	   are	  
validated	   by	   the	   CDK	   atom	   dictionary	   and	   are	   connected	   forming	   one	   single	  
structure	  and	  not	  multiple	  disconnected	  fragments.	  	  
	  
In	  the	  case	  the	  molecule	  is	  not	  finished,	  it	  would	  be	  extended	  in	  all	  possible	  ways	  by	  
adding	  one	  bond.	  If	  there	  exists	  a	  bond	  between	  a	  pair	  of	  atoms	  function	  extend,	  in	  
line	  12	  of	  Algorithm	  1,	  will	  increase	  the	  multiplicity.	  The	  generation	  of	  new	  bonds	  is	  
controlled	   by	   OMG	   atom	   type	   definitions	   for	   intermediate	   chemical	   structures,	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which	  guarantee	  that	  the	  degree	  of	  the	  atoms	  does	  not	  exceed	  the	  maximum	  degree	  
allowed	  for	  its	  chemical	  element.	  	  
	  
Function	   canonize,	   in	   line	   15	   of	   Algorithm	   1,	   returns	   the	   canonical	   version	   of	   the	  
molecule.	   We	   modified	   the	   graph	   canonizer	   Nauty[23,	   29]	   in	   order	   to	   allow	  
multigraphs	   and	   not	   only	   simple	   graphs.	   Other	   canonizers	   for	   graphs	   exist	   like	  
MOLGEN-­‐CID[30]	   or	   the	   Signature	   Canonizer[31],	   but	   Nauty	   has	   been	   the	   most	  
widely	  used	  for	  graphs	  as	  well	  as	  for	  chemistry	  problems,	  like	  InChI[32]	  codes.	  Nauty	  
is	   the	   canonizer	   of	   choice	   because	   it	   is	   the	   fastest	   of	   all	   available	   canonizers	   for	  
bounded	   valence	   graphs	   below	   100	   vertices[33]	   (molecules	   are	   examples	   of	   this	  
class	  of	  graphs).	  Firstly,	  the	  function	  canonize	  translates	  the	  molecule	  into	  a	  colored	  
multigraph.	   Secondly,	   it	   utilizes	   Nauty	   to	   calculate	   the	   canonical	   labeling	   of	   the	  
multigraph.	  	  Thirdly,	  this	  canonical	  labeling	  is	  used	  to	  construct	  the	  canonical	  version	  
of	  the	  input	  molecule.	  Lastly,	  the	  canonical	  hash	  string	  of	  each	  augmented	  molecule	  
is	  stored	  in	  a	  hash	  map,	  lines	  16	  and	  17,	  in	  order	  to	  remove	  duplicated	  extensions	  at	  
each	  level	  of	  the	  tree.	  Each	  unique	  extension	  is	  checked	  for	  canonical	  augmentation,	  
line	   18,	   using	   Algorithm	   2,	   or	   Algorithm	   3	   in	   case	   prescribed	   substructures	   were	  
provided.	   If	   this	   extension	   is	   successful,	   the	   function	  generate	   is	   called,	   line	   19	   of	  
Algorithm	   1,	   and	   the	   molecule	   we	   want	   to	   continue	   extending	   is	   passed	   as	   a	  
parameter.	   When	   a	   molecule	   cannot	   be	   extended	   any	   further,	   the	   recursion	   is	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1:	  Is_canonical_augmentation(canonM’,	  M’,	  M)	  
2:	   last_bond	  =	  get_last_bond(canonM’)	  
3:	   M”	  =	  remove_bond(M’,	  last_bond)	  




1:	  Is_canonical_augmentation_fragments(canonM’,	  M’,	  M)	  
2:	   last_bond	  =	  get_last_bond(canonM’)	  
3:	   While	  bond_belongs_to_fragment(last_bond,	  canonM’)	  
4:	   	   last_bond	  =	  get_previous_bond(canonM’)	  
5:	   Endwhile	  
6:	   M”	  =	  remove_bond(M’,	  last_bond)	  




Input	  and	  Output	  
The	   minimum	   input	   required	   is	   the	   elemental	   composition	   of	   the	   structures	   that	  
have	   to	   be	   generated.	   Optionally,	   a	   structure-­‐data	   file	   (SDF)	   can	   be	   provided	  
containing	  one	  or	  more	  prescribed	  substructures	  that	  we	  want	  our	  output	  molecules	  
to	   contain.	   Since	   OMG	   does	   not	   take	   hydrogen	   atoms	   into	   account	   during	   the	  
generation	  of	  intermediate	  chemical	  structures,	  the	  hydrogen	  atoms	  present	  in	  the	  
substructures	   will	   be	   removed	   before	   the	   generation	   process	   begins.	   These	  
substructures	  should	  be	  non-­‐overlapping,	  i.e.	  they	  should	  not	  share	  any	  atoms.	  This	  
limitation	   is	   due	   to	   the	   fact	   that	   our	   algorithm	   grows	  molecules	   by	   adding	   bonds	  
and,	  if	  two	  atoms	  in	  different	  fragments	  were	  in	  fact	  the	  same	  atom,	  our	  algorithm	  
would	   create	   bonds	   between	   those	   atoms,	   which	   would	   clearly	   lead	   to	   incorrect	  
results.	   In	   practice,	  multiple	   substructures	   can	  be	   available,	   but	   the	  user	   does	   not	  
know	   if	   they	   overlap.	   This	   limitation	   can	   be	   circumvented	   by	   using	   the	   largest	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substructure	  as	  constraint	   for	   the	  generation	  and	  the	  remaining	  substructures	  as	  a	  
posterior	  filtering,	  only	  keeping	  the	  molecules	  with	  those	  substructures.	  
	  
By	   default,	   the	   structure	   generator	   returns	   the	   count	   of	   molecules	   it	   generated.	  
Optionally,	   it	  can	  store	  all	   the	  molecules	   in	  an	  SDF	   file.	   If	  prescribed	  fragments	  are	  
provided,	   OMG	   outputs	   only	   the	   molecules	   containing	   such	   fragments.	   We	   have	  
opted	   to	  use	   SDF	   as	   our	   input	   and	  output	   format,	   but	   via	   CDK,	   other	   formats	   can	  
easily	  be	  implemented	  in	  OMG.	  
	  
Data	  
As	   mentioned	   in	   the	   introduction,	   the	   identification	   of	   the	   chemical	   structure	   of	  
metabolites	   is	   one	   of	   the	   current	   bottlenecks	   of	   metabolomics.	   	   In	   this	   sense,	   a	  
structure	  generator	  can	  contribute	  to	  overcome	  this	  bottleneck,	  since	  it	  can	  provide	  
candidate	  structures	   for	  an	  unknown	  metabolite.	  Therefore,	  metabolites	  appear	  to	  
be	   a	   relevant	   family	   of	   compounds	   to	   test	   our	   structure	   generator.	   A	   list	   of	  
metabolites	  was	  selected	  and	  their	  elemental	  composition	  was	  compiled	  to	  evaluate	  
the	  performance	  of	  our	   structure	  generator	  on	  different	   inputs.	   The	   source	  of	   the	  
compounds	   employed	   was	   the	   Human	  Metabolome	   Database	   (HMDB)[34],	   which	  
contains	   almost	   8,000	   metabolites	   and	   is	   the	   most	   comprehensive	   database	   of	  
human	  metabolites.	   	  A	  study	  of	  the	  human	  metabolite	  space	  and	  the	  properties	  of	  
the	   metabolites	   that	   occupy	   it,	   has	   been	   previously	   reported[28].	   The	   selection	  
criteria	  were	  to	  include	  cyclic	  and	  acyclic	  compounds,	  of	  different	  molecular	  weights,	  
and	   containing	   different	   chemical	   elements	   like	   C,	   O,	   N,	   P,	   and	   S.	   A	   first	   test	   set	  
included	   metabolites	   with	   C,	   O,	   and	   H,	   chemical	   elements	   with	   one	   valence.	   A	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second	   test	   set	   included	  metabolites	  with	   C,O,H	   and	   also	   chemical	   elements	  with	  
multiple	   valences,	   like	   N,	   P,	   and	   S.	   Furthermore,	   for	   some	   of	   these	   metabolites,	  
several	   substructures	   were	   drawn	   and	   provided	   to	   the	   structure	   generator	   as	  
additional	   input.	  These	  substructures	  are	  easily	   identified	  by	  an	  expert	   from	  direct	  
inspection	  of	  MS2	  or	  MSn	  experimental	  data.	  	  The	  aim	  was	  to	  assess	  the	  importance	  
of	  having	  fragment	  information	  to	  reduce	  the	  list	  of	  generated	  structures.	  	  
	  
Results	  and	  discussion	  
Structure	  Generation	  from	  Elemental	  Formula	  
The	  algorithm	  presented	  in	  this	  work,	  the	  Open	  Molecule	  Generator,	  was	  tested	  and	  
compared	  with	  the	  commercial	  structure	  generator,	  MOLGEN.	  Both	  generators	  take	  
resonance	  into	  account	  producing	  all	  the	  contributing	  structures.	  As	  a	  result,	  the	  two	  
resonant	  forms	  of	  benzene	  will	  be	  considered	  as	  different	  molecules.	  Both	  OMG	  and	  
MOLGEN	   are	   not	   limited	   to	   acyclic	   structures[35,	   36],thus	   the	   two	   structure	  
generators	   tested	   can	   generate	   molecules	   with	   rings.	   Furthermore,	   both	   tools	  
generate	  molecules	  containing	  common	  chemical	  elements	  present	   in	  metabolites,	  
like	  C,	  O,	  N,	  H,	  P,	  and	  S,	  and	  are	  not	   limited	  to	  only	  4	  chemical	  elements[36].	  Both	  
structure	   generators	   generate	   molecules	   for	   a	   given	   elemental	   composition	   by	  
exhaustively	  producing	  all	  non-­‐redundant	  chemical	  structures.	  	  
	  
The	   number	   of	   molecules	   produced	   after	   using	   the	   elemental	   compositions	   of	   a	  
diverse	  selection	  of	  metabolites	  containing	  only	  C,	  O	  and	  H,	  is	  presented	  in	  Table	  2.	  
For	   all	   these	   metabolites,	   the	   same	   number	   of	   molecules	   is	   generated	   by	   both	  
generators.	  While	  both	  generators	  produce	  complete	  results,	  MOLGEN	  does	  it	  in	  less	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time.	   The	   time	   between	   initialization	   and	   finalization	   was	   measured	   using	   time	  
functions	  in	  JAVA	  for	  OMG	  and	  equivalent	  functions	  in	  python	  for	  MOLGEN.	  We	  can	  
observe	  in	  Table	  2	  the	  time	  in	  seconds	  to	  generate	  all	  the	  candidate	  structures	  and	  
the	  time	  to	  generate	  each	  molecule	  in	  milliseconds.	  If	  we	  look	  at	  time	  per	  molecule,	  
MOLGEN	  is	  4	  times	  faster	  than	  OMG	  for	  small	  molecules	  like	  pyruvic	  acid.	  For	  larger	  
molecules	  MOLGEN	  obtains	  a	  constant	  time	  per	  molecule	  between	  0.008	  and	  0.009	  
milliseconds,	   while	   OMG	   ranges	   from	   18	   to	   45	   milliseconds	   depending	   on	   the	  
elemental	  composition.	  Lightweight	  profiling	  of	  OMG	  was	  performed	  using	  VisualVM	  
(version	   1.3.4),	   in	   order	   to	   have	   an	   understanding	   of	   the	   limiting	   points	   in	   the	  
performance	  of	  OMG.	  The	  most	  relevant	  finding	  was	  that	  the	  canonization	  process,	  
which	  uses	  Nauty,	  took	  half	  of	  the	  total	  running	  time.	  	  
	  
We	   observed	   that	   MOLGEN	   stops	   the	   generation	   of	   molecules	   after	   two	   billion	  
molecules,	  as	  it	  can	  be	  observed	  for	  a	  large	  molecule	  like	  cholic	  acid	  (Table	  2).	  Since	  
both	  generators	  produce	   the	  same	  molecules	   for	  elemental	   composition	  with	  C,	  O	  
and	   H,	   we	   can	   only	   assume	   that	   more	   than	   two	   billion	   molecules	   could	   be	  
generated.	  In	  the	  case	  of	  phenyllactic	  acid,	  MOLGEN	  produces	  more	  than	  48	  million	  
molecules	   in	  404	  seconds.	  Due	  to	  excessive	  computational	   time,	  no	  results	   for	  this	  
elemental	   composition	   are	   reported	   for	   OMG,	   though	   the	   same	   number	   of	  
molecules	   is	  expected	  (if	  executed	  for	  enough	  time)	  as	   is	   the	  case	  for	  all	   the	  other	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*	  More	  than	  
2,147,483,646	  




*	  More	  than	  
2,147,483,646	  
*	  not	  	  
available	  







48,496,265	   404.052	   0.008	  
**	  More	  than	  
48,496,265	  
**	  not	  	  
available	  
**	  not	  	  
available	  
Table	   2	  Number	   of	   chemical	   structures	   generated	   by	   OMG	   and	   MOLGEN	   using	   as	   input	   only	   the	   elemental	  
compositions	  of	  metabolites	  containing	  C,O	  and	  H	  elements.	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*	   Results	   were	   not	   generated	   due	   to	   excessive	   computational	   time	   needed	   to	   generate	   all	   the	   candidate	  
structures.	  However,	  we	  expect	  OMG	  to	  generate	  more	  molecules	  than	  MOLGEN,	  due	  to	  the	   larger	  amount	  of	  
atom	  types	  produced	  by	  OMG.	  
**	   Results	   were	   not	   generated	   due	   to	   excessive	   computational	   time	   needed	   to	   generate	   all	   the	   candidate	  
structures.	  
	  
As	   stated	   in	   Methods,	   both	   generators	   treat	   atoms	   having	   multiple	   valences	   in	  
different	  ways,	  this	  is	  the	  reason	  to	  use	  a	  second	  set	  of	  molecules	  containing	  also	  N,	  
P	  and	  S.	  The	  default	  valences	  used	  by	  MOLGEN	  for	  N	  is	  3,	  for	  P	   is	  3,	  and	  for	  S	   is	  2,	  
unless	  stated	  otherwise.	  The	  results	  for	  these	  molecules	  are	  presented	  in	  Table	  3.	  As	  
expected,	  the	  number	  of	  candidate	  structures	  differs	  between	  both	  generators.	  For	  
the	  elemental	  composition	  of	  glycine,	  MOLGEN	  produces	  84	  molecules	  only	  with	  N	  
valence	   3	   and	   162	   molecules	   only	   with	   N	   valence	   5.	   For	   the	   same	   elemental	  
composition,	  OMG	  produces	  97	  molecules	  with	  valence	  3	  and	  5	  for	  N,	  which	  include	  
the	   84	   of	   MOLGEN	   N	   valence	   3	   and	   13	   additional	   molecules	   with	   valence	   5,	  
containing	  N	  with	  the	  atom	  types	  depicted	  in	  Table	  1	  for	  OMG-­‐CDK.	  The	  difference	  
in	   the	   number	   of	   candidate	   structures	   is	   larger	   for	   elemental	   compositions	  
containing	  many	  atoms	  with	  multiple	  valences,	  as	  is	  the	  case	  of	  creatinine.	  For	  this	  
metabolite,	  MOLGEN	  generates	  93,323	  candidate	  structures	  with	  the	  default	  valence	  
3	  for	  N.	  On	  the	  contrary,	  OMG	  produces	  303,601	  candidate	  structures,	  containing	  N	  
valence	  3	  and	  5.	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97	   0.452	   4.660	  











277,810,163	   2227.796	   0.008	  












































464,899,034	   3488.097	   0.008	  
*	  More	  than	  	  
464,899,034	  




















5078.132	   0.009	  
*	  More	  than	  
82,000,000	  




Table	   3	  Number	   of	   chemical	   structures	   generated	   by	   OMG	   and	   MOLGEN	   using	   as	   input	   only	   the	   elemental	  
compositions	  of	  metabolites	  containing	  C,	  O,	  H,	  N,	  P	  and	  S	  elements.	  	  
*	   Results	   were	   not	   generated	   due	   to	   excessive	   computational	   time	   needed	   to	   generate	   all	   the	   candidate	  
structures.	  We	  expect	  OMG	  to	  generate	  more	  molecules	  than	  MOLGEN,	  due	  to	  the	  larger	  amount	  of	  atom	  types	  
produced	  by	  OMG.	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In	  the	  case	  of	  phosphoenolpyruvic	  acid,	  we	  require	  P	  valence	  5	  to	  be	  considered.	  On	  
the	   one	   hand,	   running	   MOLGEN	   with	   the	   default	   valence	   for	   P	   yields	   51,323	  
candidate	  structures	  but	  the	  correct	  molecule	  is	  missing.	  On	  the	  other	  hand,	  forcing	  
the	   valence	   of	   P	   to	   be	   5,	   returns	   129,421	   candidate	   structures,	   with	   the	   correct	  
molecule	  also	  produced	  but	  also	  an	  excessive	  quantity	  of	  unrealistic	  molecules	  due	  
to	   unrealistic	   atom	   types	   for	   P.	   Alternatively,	   OMG	   generates	   83,977	   candidate	  
structures	  with	  P	  valence	  3	  and	  5,	  including	  the	  desired	  molecule,	  where	  all	  of	  them	  
are	  valid	  molecules	  as	  defined	  by	  the	  CDK	  atom	  dictionary.	  
	  
We	  observe	   in	   Table	   3	   that	   the	   running	   time	  per	   generated	  molecule	   now	   ranges	  
between	  0.008	  and	  0.041	  milliseconds,	  while	  OMG	  requires	  between	  4.8	  and	  26.6	  
milliseconds.	  Such	  difference	  in	  execution	  speed	  between	  MOLGEN	  and	  OMG	  makes	  
that	  for	  some	  large	  elemental	  compositions,	  only	  results	  are	  reported	  for	  MOLGEN.	  
This	   is	  the	  case	  of	  phenylalanine,	  uric	  acid	  and	  p-­‐cresol	  sulfate.	  However,	  for	  these	  
metabolites,	  we	  assume	  that	  the	  number	  of	  candidate	  structures	  would	  have	  been	  
higher	  with	  OMG	  than	  the	  one	  reported	  by	  MOLGEN	  using	  the	  default	  valences.	  	  	  
	  
Structure	  Generation	  from	  Elemental	  Formula	  and	  Prescribed	  Substructures	  
Structure	   generation	   is	   a	   combinatorial	   problem	   where	   the	   number	   of	   output	  
molecules	  grows	  exponentially	  with	  to	  the	  number	  of	  input	  atoms.	  When	  using	  one	  
or	  more	  prescribed	  substructures	  as	  input	  to	  the	  generators	  in	  addition	  to	  elemental	  
composition,	  less	  candidate	  structures	  are	  obtained	  (Table	  4).	  Whereas	  MOLGEN	  can	  
only	  accept	  one	  substructure,	  OMG	  can	  accept	  multiple	  substructures	  as	  input	  with	  
the	   constraint	   that	   these	   do	   not	   overlap,	   i.e.,	   they	   should	   not	   share	   any	   atom.	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Phenylalanine	   is	   a	   good	   example	   how	   the	   number	   of	   generated	   structures	   can	   be	  
reduced	  by	  using	  more	  prescribed	  substructures,	  as	  will	  be	  discussed	  below	  in	  more	  
detail.	  	  

























C2H5NO2	   	  




C3H7NO2S	   	  






76,247	   52.774	   0.692	   107,155	   19386.019	   180.916	  








595	   271.809	   456.822	  








289	   172.655	   597.422	  
	   	  
	  
*	  not	  	  
possible	  
















334	   120.519	   360.835	  
	   	  
	  
*	  not	  	  
possible	  










C4H6O5	   	  











C9H10O3	   	  
21,040	   15.674	   0.745	   26,164	   163.904	   6.264	  













C7H8O4S	   	  
S_6	  	  
13,177	  
65.667	   4.983	   13,177	   63.047	   4.785	  




94.898	   1.349	   17,232	   1204.357	   69.891	  
Table	   4	   Number	   of	   chemical	   structures	   generated	   by	   OMG	   and	   MOLGEN	   using	   as	   input	   an	   elemental	  
composition	  and	  one	  or	  more	  prescribed	  and	  non-­‐overlapping	  fragments.	  	  
*	  MOLGEN	   can	  only	   accept	   one	  prescribed	   substructure,	  while	  OMG	  accepts	  multiple	   substructures,	   provided	  
that	  these	  do	  not	  overlap,	  this	  is,	  they	  do	  not	  share	  any	  atom.	  
**	  MOLGEN	   is	  not	  able	   to	  generate	  molecules	  using	   this	   large	   substructure	  as	   input.	  The	   reason	  could	  not	  be	  
found.	  
Substructure	   information	   is	   of	   great	   relevance	   for	   metabolomics	   experiments	  
involving	   MSn	   data,	   where	   often	   the	   only	   information	   available	   of	   an	   unknown	  
metabolite	   that	   needs	   to	   be	   identified	   is	   the	   elemental	   composition	   and	   in	   some	  
cases	   substructures.	   Provided	   that	   no	   database	   entries	   exist	   for	   this	   experimental	  
information,	   one	   is	   forced	   to	   generate	   the	   structures	   via	   CASE.	   The	   inclusion	   of	  
substructure	   information	   brings	   the	   list	   of	   candidate	   structures	   to	   a	   manageable	  
size.	  For	  p-­‐cresol	  sulfate,	  using	  the	  sulfate	  group	  with	  both	  generators	  as	  prescribed	  
substructure,	   produces	   13,177	   molecules.	   When	   benzene	   is	   the	   prescribed	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substructure,	  OMG	  generates	  17,232	  candidate	  structures	  and	  MOLGEN	  70,330,	  all	  
containing	  sulfur	  with	  valence	  6,	  hence	  the	  difference	  between	  both	  generators.	  	  
	  
Whereas	   only	   the	   elemental	   composition	   of	   phenylalanine	   as	   input	   generates	   277	  
million	  structures	  with	  MOLGEN	  and	  for	  OMG	  an	  even	  higher	  number	  of	  candidate	  
structures	   is	  expected	  as	  both	  nitrogen	  valences	  of	  3	  and	  5	  are	  taken	   into	  account	  
(Table	  3),	  using	  benzene	  as	  a	  substructure	  provides	  only	  107,155	  (OMG)	  and	  76,247	  
(MOLGEN)	   candidate	   structures	   (Table	  4).	   The	  number	  of	   generated	  molecules	   for	  
the	  elemental	  composition	  of	  phenylalanine	   is	  even	  further	  reduced	  by	  prescribing	  
multiple	   fragments	  as	   input:	  OMG	  outputs	  595	  molecules	  when	  provided	  with	  two	  
fragments	   and	   289	   molecules	   for	   three	   fragments	   (Table	   4).	   The	   use	   of	   large	  
fragments	  yields	  the	  larger	  reduction	  in	  output	  molecules,	  as	  it	  can	  be	  seen	  for	  the	  
last	   example	   of	   phenylalanine,	   where	   two	   big	   fragments	   describe	   most	   of	   its	  
structure	  and	  return	  only	  26	  chemical	  structures.	  
	  
For	   larger	   molecules	   containing	   ten	   or	   more	   carbon	   atoms,	   which	   is	   a	   common	  
situation	   in	   chemistry,	   it	   is	   not	   practical	   for	   the	   identification	   of	   metabolites	   to	  
exhaustively	   generate	   candidate	   structures	  without	   using	   substructure	   constraints,	  
with	  MOLGEN	  and	  OMG,	   due	   to	   the	   large	  number	   of	   results.	  Using	   the	   elemental	  
composition	  of	  a	  large	  metabolite	  like	  cholic	  acid,	  both	  structure	  generators	  cannot	  
produce	  all	  possible	  candidate	  structures,	  which	  are	  expected	  in	  the	  order	  of	  billions.	  
This	   was	   only	   possible	   using	   substructure	   information	   to	   reduce	   the	   size	   of	   the	  
search	   tree:	   when	   providing	   a	   substructure	   that	   describes	   a	   large	   part	   of	   the	  
molecule,	   OMG	   generates	   only	   334	   structures	   (Table	   4).	   When	   using	   two	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substructures,	   OMG	   returned	   2,505	   candidate	   structures.	   However,	  MOLGEN	  was	  
unable	  to	  return	  results	  using	  the	  same	   large	  substructure	  or	   two	  substructures	  as	  
an	  input	  and	  the	  reason	  could	  not	  be	  found	  by	  us.	  	  
	  
The	  use	  of	  prescribed	   substructures	  affected	   the	   running	   time	  of	  both	  generators.	  
For	  MOLGEN,	   the	   time	   per	  molecule	   ranged	   between	   0.16	   and	   27.8	  milliseconds,	  
which	   represents	   in	   some	   cases	   a	   10,000-­‐fold	   increase	   in	   computation	   time	  
compared	   to	   using	   only	   elemental	   compositions.	   Concerning	   OMG,	   the	   time	   per	  
molecule	  ranged	  between	  3.3	  and	  967.	  2	  milliseconds,	  a	  100-­‐fold	  increase	  in	  running	  
time.	   Despite	   this	   deterioration	   of	   execution	   time,	   the	   advantage	   of	   using	   one	   or	  
ideally	   multiple	   prescribed	   substructures	   is	   clear:	   the	   number	   of	   candidate	  
substructures	   is	   significantly	   reduced	   and	   the	   total	   time	   to	   calculate	   candidate	  
structures	  is	  also	  reduced	  compared	  to	  not	  using	  any	  substructure.	  
	  
The	  results	  here	  presented	  show	  that	   if	  we	  want	  MOLGEN	  to	  generate	  the	  correct	  
molecule	   when	   the	   valence	   of	   some	   atoms	   is	   not	   the	   default	   one,	   like	  
phosphoenolpyruvic	   acid	   or	   p-­‐cresol	   sulfate,	   we	   need	   to	   know	   the	   valence	   in	  
advance.	  Otherwise,	  MOLGEN	  should	  be	  executed	  using	  all	  possible	  valences	  for	  all	  
atoms.	  This	   limitation	  is	  not	  present	  in	  OMG,	  which	  can	  produce	  different	  valences	  
in	   the	   same	  execution.	  Unfortunately,	   the	   atom	  dictionary	  provided	  by	  CDK	   is	   not	  
comprehensive	  concerning	  non-­‐standard	  valences.	  On	  the	  positive	  side,	  the	  dynamic	  
open	  source	  community	  of	  CDK	  keeps	  adding	  new	  atom	  types	  with	  each	  release	  of	  
the	  library	  and	  we	  expect	  that	  this	  will	  improve	  the	  capabilities	  of	  OMG.	  	  This	  open	  
source	  nature	  of	  CDK	  allows	  users	  to	  suggest	  or	  implement	  new	  atom	  types.	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The	  generation	  of	  the	  molecules	  in	  the	  Open	  Molecule	  Generator	  has	  the	  shape	  of	  a	  
tree.	   As	   stated	   by	   McKay[23],	   the	   check	   for	   canonical	   augmentation	   is	   branch-­‐
independent,	   which	   would	   allow	   to	   process	   branches	   of	   the	   generation	   trees	   in	  
parallel.	  Theoretically	  the	  algorithm	  allows	  for	  parallelization,	  in	  practice	  this	  has	  not	  
been	  implemented	  but	  it	  is	  one	  future	  extension	  of	  this	  work.	  
	  
However,	  we	  have	  observed	  that	  OMG	  is	  in	  most	  of	  the	  cases	  slower	  than	  MOLGEN	  
and	  this	  fact	  was	  more	  noticeable	  when	  generating	  millions	  of	  candidate	  molecules.	  
The	   speed	   of	  OMG	   could	   be	   improved	   and	  we	   see	   several	   possibilities	   to	   achieve	  
this,	   i.e.	   the	   use	   of	   a	   different	   canonizer	   or	   a	   less	   computationally	   demanding	  
canonicity	  test	  for	  intermediate	  chemical	  structures,	  could	  significantly	  speed	  up	  the	  
execution.	  Actually,	  obtaining	  millions	  of	  molecules	  as	  a	  result,	  quickly	  or	  slowly,	   is	  
not	  desirable,	  but	   ideally,	   the	  goal	  of	  metabolite	   identification	   is	   to	  obtain	  a	   list	  of	  
candidate	   structures	   that	   is	   short	   in	   order	   to	   examine	   it	   and	   find	   the	   structure	  
belonging	   to	   the	   unknown	   metabolite.	   Exhaustive	   profiling,	   covering	   both	   on	  
execution	   time	   and	   memory	   use,	   would	   be	   beneficial	   to	   discover	   improvement	  
points	  for	  OMG.	  Fortunately,	  OMG	  allows	  multiple	  prescribed	  substructures	  and	  can	  
handle	   large	   fragments,	   which	   reduced	   the	   number	   of	   generated	   molecules	  
significantly.	  Handling	  multiple	  substructures	  allows	  OMG	  to	  provide	  a	  short	   list	  of	  
candidate	   structures	   and	   additionally,	   its	   open	   source	   nature	   permits	   users	   to	  
implement	  specific	  constraints	  to	  further	  reduce	  the	  candidate	  list,	  both	  during	  and	  
after	   the	   generation	   process.	   Examples	   of	   such	   constraints	   would	   reject	  
intermediate	   chemical	   structures	   with	   high	   steric	   energy	   values	   or	   other	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physicochemical	   properties.	   Therefore	   we	   expect	   OMG	   to	   be	   useful	   in	   different	  
application	  areas	  and	  its	  functionality	  to	  be	  extended	  in	  the	  near	  future.	  
	  
Conclusion	  
In	   this	  work	  we	  have	  presented	   the	  Open	  Molecule	  Generator,	   to	   the	  best	   of	   our	  
knowledge,	   the	   first	   implementation	   to	   chemical	   structure	   generation	   of	   the	  
Canonical	   Path	   Augmentation	   approach,	   originally	   designed	   for	   simple	   graph	  
enumeration	   adding	   vertices.	   We	   have	   adapted	   it	   to	   generate	   organic	   chemical	  
structures	   and	   extended	   so	   that	   (i)	   it	   grows	  molecules	   by	   adding	   bonds,	   (ii)	   it	   can	  
handle	   multigraphs,	   and	   (iii)	   accepts	   one	   or	   multiple	   non	   overlapping	   prescribed	  
substructures.	   In	   addition,	   this	   is	   the	   first	   open	   source	   implementation	   of	   a	  
deterministic	   structure	   generator.	   This	   will	   enable	   future	   developments	   like	  
parallelization	   or	   the	   inclusion	   of	   constraints	   that	   are	   specific	   to	   the	   class	   of	  
compounds	  being	  generated.	  
	  
Our	   results	   show	   that	   the	   implementation	   of	   our	   algorithm	   generates	   all	   possible	  
and	   valid	   chemical	   structures	   for	   a	   given	   elemental	   composition	   and	   optionally	  
prescribed	   substructures.	   It	   is	   as	   complete	   as	   the	   best	   commercially	   available	  
generator.	  Moreover,	  the	  current	  implementation	  of	  the	  OMG	  program	  presents	  an	  
extra	   advantage	   over	   existing	   generators	   when	   large	   or	   multiple	   fragments	   are	  
available	   to	   be	   used	   as	   constraints:	   we	   have	   demonstrated	   the	   benefit	   of	  
incorporating	   constraints	   to	   reduce	   the	   number	   of	   output	  molecules	   significantly.	  
The	   ability	   of	   OMG	   to	   generate	   multiple	   valences	   for	   an	   atom	   has	   proven	   to	   be	  
useful	  as	  often	  no	  prior	  information	  is	  known	  on	  the	  desired	  chemical	  elements	  and	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multiple	  valences	  of	  an	  element	  can	  be	  present	   in	  a	  molecule.	  When	  compared	  to	  
MOLGEN,	   the	   only	   disadvantage	   of	  OMG	   is	   its	   speed,	  which	   is	  more	   severe	  when	  
using	  only	  elemental	  compositions	  and	  less	  when	  including	  prescribed	  substructures.	  
This	  issue	  will	  be	  addressed	  in	  future	  improvements	  of	  the	  program.	  We	  expect	  this	  
tool	  to	  be	  used	  in	  various	  fields,	  one	  of	  them	  being	  metabolomics,	  where	  there	  is	  a	  
clear	   need	   for	   flexible	   structure	   generators.	   We	   have	   successfully	   used	   OMG	   to	  
propose	   candidate	   structures	   using	   prescribed	   substructures,	   in	   several	   on-­‐going	  
metabolite	  identification	  projects	  in	  our	  lab.	  
	  
References	  
1.	  Kind	  T,	  Fiehn	  O:	  Advances	  in	  structure	  elucidation	  of	  small	  molecules	  using	  mass	  spectrometry.	  
Bioanalytical	  reviews	  2010,	  2:23–60.	  
2.	  Lindsay	  RK,	  Buchanan	  BG,	  Feigenbaum	  EA,	  Lederberg	  J:	  Applications	  of	  Artificial	  Intelligence	  for	  
Organic	  Chemistry:	  The	  DENDRAL	  Project.	  New	  York:	  McGraw-­‐Hill	  Book;	  1980.	  
3.	  Carhart	  RE,	  Smith	  DH,	  Gray	  NAB,	  Nourse	  JG,	  Djerassi	  C:	  GENOA:	  A	  computer	  program	  for	  structure	  
elucidation	  utilizing	  overlapping	  and	  alternative	  substructures.	  Journal	  of	  Organic	  Chemistry	  1981,	  
46:1708	  –	  1718.	  
4.	  Funatsu	  K,	  Miyabayaski	  N,	  Sasaki	  S:	  Further	  development	  of	  structure	  generation	  in	  the	  automated	  
structure	  elucidation	  system	  CHEMICS.	  Journal	  of	  Chemical	  Information	  and	  Modeling	  1988,	  28:18–
28.	  
5.	  Badertscher	  M,	  Korytko	  A,	  Schulz	  K-­‐P,	  Madison	  M,	  Munk	  ME,	  Portmann	  P,	  Junghans	  M,	  Fontana	  P,	  
Pretsch	  E:	  Assemble	  2.0:	  a	  structure	  generator.	  Chemometrics	  and	  Intelligent	  Laboratory	  Systems	  
2000,	  51:73–79.	  
6.	  Molchanova	  MS,	  Shcherbukhin	  VV,	  Zefirov	  NS:	  Computer	  Generation	  of	  Molecular	  Structures	  by	  
the	  SMOG	  Program.	  Journal	  of	  Chemical	  Information	  and	  Modeling	  1996,	  36:888–899.	  
7.	  Kerber	  A,	  Laue	  R,	  Grüner	  T,	  Meringer	  M:	  MOLGEN	  4.0.	  Match	  1998,	  37:205	  –	  208.	  
8.	  Ley	  S	  V.,	  Doherty	  K,	  Massiot	  G,	  Nuzillard	  JM:	  Connectivist	  approach	  to	  organic	  structure	  
determination.	  LSD-­‐program	  assisted	  NMR	  analysis	  of	  the	  insect	  antifeedant	  azadirachtin.	  
Tetrahedron	  1994,	  50:12267–12280.	  
9.	  Steinbeck	  C:	  SENECA:	  A	  platform-­‐independent,	  distributed,	  and	  parallel	  system	  for	  computer-­‐
assisted	  structure	  elucidation	  in	  organic	  chemistry.	  Journal	  of	  chemical	  information	  and	  computer	  
sciences	  2001,	  41:1500–7.	  
10.	  Steinbeck	  C,	  Han	  Y,	  Kuhn	  S,	  Horlacher	  O,	  Luttmann	  E,	  Willighagen	  E:	  The	  Chemistry	  Development	  
Kit	  (CDK):	  an	  open-­‐source	  Java	  library	  for	  Chemo-­‐	  and	  Bioinformatics.	  Journal	  of	  Chemical	  Information	  
and	  Computer	  Siences	  2003,	  43:493–500.	  
11.	  Steinbeck	  C,	  Hoppe	  C,	  Kuhn	  S,	  Floris	  M,	  Guha	  R,	  Willighagen	  EL:	  Recent	  Developments	  of	  the	  
Chemistry	  Development	  Kit	  (CDK)	  -­‐	  An	  Open-­‐Source	  Java	  Library	  for	  Chemo-­‐	  and	  Bioinformatics.	  
Current	  Pharmaceutical	  Design	  2006,	  12:2111–2120.	  




13.	  Scalbert	  A,	  Brennan	  L,	  Fiehn	  O,	  Hankemeier	  T,	  Kristal	  BS,	  Van	  Ommen	  B,	  Pujos-­‐Guillot	  E,	  Verheij	  E,	  
Wishart	  D,	  Wopereis	  S:	  Mass-­‐spectrometry-­‐based	  metabolomics:	  limitations	  and	  recommendations	  
for	  future	  progress	  with	  particular	  focus	  on	  nutrition	  research.	  Metabolomics	  2009,	  5:435–458.	  
14.	  Dunn	  WB,	  Broadhurst	  D,	  Begley	  P,	  Zelena	  E,	  Francis-­‐McIntyre	  S,	  Anderson	  N,	  Brown	  M,	  Knowles	  
JD,	  Halsall	  A,	  Haselden	  JN,	  Nicholls	  AW,	  Wilson	  ID,	  Kell	  DB,	  Goodacre	  R:	  Procedures	  for	  large-­‐scale	  
metabolic	  profiling	  of	  serum	  and	  plasma	  using	  gas	  chromatography	  and	  liquid	  chromatography	  
coupled	  to	  mass	  spectrometry.	  Nature	  Protocols	  2011,	  6:1060–1083.	  
15.	  Mohamed	  R,	  Varesio	  E,	  Ivosev	  G,	  Burton	  L,	  Bonner	  R,	  Hopfgartner	  G:	  Comprehensive	  analytical	  
strategy	  for	  biomarker	  identification	  based	  on	  liquid	  chromatography	  coupled	  to	  mass	  spectrometry	  
and	  new	  candidate	  confirmation	  tools.	  Analytical	  chemistry	  2009,	  81:7677–94.	  
16.	  Zhang	  T,	  Creek	  DJ,	  Barrett	  MP,	  Blackburn	  G,	  Watson	  DG:	  Evaluation	  of	  Coupling	  Reversed	  Phase,	  
Aqueous	  Normal	  Phase,	  and	  Hydrophilic	  Interaction	  Liquid	  Chromatography	  with	  Orbitrap	  Mass	  
Spectrometry	  for	  Metabolomic	  Studies	  of	  Human	  Urine.	  Analytical	  Chemistry	  2012,	  84:1994–2001.	  
17.	  Schymanski	  EL,	  Meinert	  C,	  Meringer	  M,	  Brack	  W:	  The	  use	  of	  MS	  classifiers	  and	  structure	  
generation	  to	  assist	  in	  the	  identification	  of	  unknowns	  in	  effect-­‐directed	  analysis.	  Analytica	  Chimica	  
Acta	  2008,	  615:136–147.	  
18.	  Schymanski	  EL,	  Meringer	  M,	  Brack	  W:	  Automated	  Strategies	  To	  Identify	  Compounds	  on	  the	  Basis	  
of	  GC/EI-­‐MS	  and	  Calculated	  Properties.	  Analytical	  Chemistry	  2011,	  83:903–912.	  
19.	  Colbourn	  C,	  Read	  R:	  Orderly	  algorithms	  for	  graph	  generation.	  International	  Journal	  of	  Computer	  
Mathematics	  1979,	  7:167–172.	  
20.	  Faradzev	  IA:	  Constructive	  Enumeration	  of	  Combinatorial	  Objects.	  in	  Problèmes	  combinatoires	  et	  
théorie	  des	  graphes,	  University	  of	  Paris,	  Orsay	  1978:131–135.	  
21.	  Faulon	  J-­‐L:	  Stochastic	  Generator	  of	  Chemical	  Structure.	  1.	  Application	  to	  the	  Structure	  Elucidation	  
of	  Large	  Molecules.	  Journal	  of	  Chemical	  Information	  and	  Modeling	  1994,	  34:1204–1218.	  
22.	  Kerber	  A,	  Laue	  R:	  Group	  Actions,	  Double	  Cosets,	  and	  Homomorphisms:	  Unifying	  Concepts	  for	  the	  
Constructive	  Theory	  of	  Discrete	  Structures.	  Acta	  Applicandae	  Mathematicae	  1998,	  52:63–90.	  
23.	  McKay	  B:	  Isomorph-­‐Free	  Exhaustive	  Generation.	  Journal	  of	  Algorithms	  1998,	  26:306–324.	  
24.	  Fink	  T,	  Reymond	  J-­‐L:	  Virtual	  exploration	  of	  the	  chemical	  universe	  up	  to	  11	  atoms	  of	  C,	  N,	  O,	  F:	  
assembly	  of	  26.4	  million	  structures	  (110.9	  million	  stereoisomers)	  and	  analysis	  for	  new	  ring	  systems,	  
stereochemistry,	  physicochemical	  properties,	  compound	  classes,	  and	  drug	  discove.	  Journal	  of	  
Chemical	  Information	  and	  Modeling	  2007,	  47:342–53.	  
25.	  Blum	  LC,	  Reymond	  J-­‐L:	  970	  Million	  Druglike	  Small	  Molecules	  for	  Virtual	  Screening	  in	  the	  Chemical	  
Universe	  Database	  GDB-­‐13.	  Journal	  of	  the	  American	  Chemical	  Society	  2009,	  131:8732–8733.	  
26.	  Chen	  WL:	  Chemoinformatics:	  past,	  present,	  and	  future.	  Journal	  of	  Chemical	  Information	  and	  
Modeling	  2006,	  46:2230–55.	  
27.	  Rojas-­‐Chertó	  M,	  Peironcely	  JE,	  Kasper	  PT,	  Van	  der	  Hooft	  JJJ,	  De	  Vos	  RCH,	  Vreeken	  R,	  Hankemeier	  
T,	  Reijmers	  T:	  Metabolite	  Identification	  Using	  Automated	  Comparison	  of	  High-­‐Resolution	  Multistage	  
Mass	  Spectral	  Trees.	  Analytical	  Chemistry	  2012,	  84:5524–5534.	  
28.	  Peironcely	  JE,	  Reijmers	  T,	  Coulier	  L,	  Bender	  A,	  Hankemeier	  T:	  Understanding	  and	  Classifying	  
Metabolite	  Space	  and	  Metabolite-­‐Likeness.	  PLoS	  ONE	  2011,	  6:e28966.	  
29.	  Mckay	  BD:	  Nauty	  User’s	  Guide	  (	  Version	  2.4	  ).	  2009.	  
30.	  Braun	  J,	  Gugisch	  R,	  Kerber	  A,	  Laue	  R,	  Meringer	  M,	  Rücker	  C:	  MOLGEN-­‐CID-­‐-­‐A	  canonizer	  for	  
molecules	  and	  graphs	  accessible	  through	  the	  Internet.	  Journal	  of	  Chemical	  Information	  and	  Computer	  
Siences	  2004,	  44:542–8.	  
31.	  Faulon	  J-­‐L,	  Collins	  MJ,	  Carr	  RD:	  The	  signature	  molecular	  descriptor.	  4.	  Canonizing	  molecules	  using	  
extended	  valence	  sequences.	  Journal	  of	  chemical	  information	  and	  computer	  sciences	  2004,	  44:427–
36.	  
32.	  IUPAC	  International	  Chemical	  Identifier	  (InChI),	  Technical	  Manual	  [http://www.inchi-­‐
trust.org/sites/default/files/inchi-­‐1.04/InChI_TechMan.pdf].	  
33.	  Foggia	  P,	  Sansone	  C,	  Vento	  M:	  A	  Performance	  Comparison	  of	  Five	  Algorithms	  for	  Graph	  
Isomorphism.	  In	  3rd	  IAPR	  TC-­‐15	  Workshop	  on	  Graph-­‐based	  Representations	  in	  Pattern	  Recognition.	  
2001:188–199.	  
34.	  Wishart	  DS,	  Knox	  C,	  Guo	  AC,	  Eisner	  R,	  Young	  N,	  Gautam	  B,	  Hau	  DD,	  Psychogios	  N,	  Dong	  E,	  Bouatra	  
S,	  Mandal	  R,	  Sinelnikov	  I,	  Xia	  J,	  Jia	  L,	  Cruz	  JA,	  Lim	  E,	  Sobsey	  CA,	  Shrivastava	  S,	  Huang	  P,	  Liu	  P,	  Fang	  L,	  
Peng	  J,	  Fradette	  R,	  Cheng	  D,	  Tzur	  D,	  Clements	  M,	  Lewis	  A,	  Souza	  A	  De,	  Zuniga	  A,	  Dawe	  M,	  Xiong	  Y,	  
Clive	  D,	  Greiner	  R,	  Nazyrova	  A,	  Shaykhutdinov	  R,	  Li	  L,	  Vogel	  HJ,	  Forsythe	  I:	  HMDB:	  a	  knowledgebase	  
for	  the	  human	  metabolome.	  Nucleic	  Acids	  Research	  2009,	  37:D603–610.	  
OMG: Open Molecule Generator 
59 
35.	  Fujiwara	  H,	  Wang	  J,	  Zhao	  L,	  Nagamochi	  H,	  Akutsu	  T:	  Enumerating	  treelike	  chemical	  graphs	  with	  
given	  path	  frequency.	  Journal	  of	  Chemical	  Information	  and	  Modeling	  2008,	  48:1345–57.	  
36.	  Imada	  T,	  Ota	  S,	  Nagamochi	  H,	  Akutsu	  T:	  Efficient	  enumeration	  of	  stereoisomers	  of	  tree	  structured	  






























Published	  in	  PLoS	  ONE	  2011,	  6:e28966.	  
 
 
Understanding	   and	   classifying	  
metabolite	   space	   and	   metabolite-­‐
likeness	  
	  
While	   the	  entirety	  of	   ‘Chemical	  Space’	   is	  huge	   (and	  assumed	  to	  contain	  between	  
1063	  and	  10200	  ‘small	  molecules’),	  distinct	  subsets	  of	  this	  space	  can	  nonetheless	  be	  
defined	  according	  to	  certain	  structural	  parameters.	  An	  example	  of	  such	  a	  subspace	  
is	   the	   chemical	   space	   spanned	  by	   endogenous	  metabolites,	   defined	   as	   ‘naturally	  
occurring’	  products	  of	  an	  organisms’	  metabolism.	  In	  order	  to	  understand	  this	  part	  
of	   chemical	   space	   in	  more	   detail,	  we	   analyzed	   the	   chemical	   space	   populated	   by	  
human	  metabolites	   in	  two	  ways.	  Firstly,	   in	  order	  to	  understand	  metabolite	  space	  
better,	  we	  performed	  Principal	  Component	  Analysis	   (PCA),	  hierarchical	   clustering	  
and	  scaffold	  analysis	  of	  metabolites	  and	  non-­‐metabolites	  in	  order	  to	  analyze	  which	  
chemical	  features	  are	  characteristic	  for	  both	  classes	  of	  compounds.	  Here	  we	  found	  
that	  heteroatom	   (both	  oxygen	  and	  nitrogen)	   content,	   as	  well	   as	   the	  presence	  of	  
particular	   ring	   systems	   was	   able	   to	   distinguish	   both	   groups	   of	   compounds.	  
Secondly,	  we	  established	  which	  molecular	  descriptors	  and	  classifiers	  are	  capable	  of	  
distinguishing	  metabolites	  from	   non-­‐metabolites,	   by	   assigning	   a	   ‘metabolite-­‐
likeness’	  score.	  It	  was	  found	  that	  the	  combination	  of	  MDL	  Public	  Keys	  and	  Random	  
Forest	   exhibited	   best	   overall	   classification	   performance	   with	   an	   AUC	   value	   of	  
99.13%,	   a	   specificity	   of	   99.84%	   and	   a	   selectivity	   of	   88.79%.	   This	   performance	   is	  
slightly	   better	   than	   previous	   classifiers;	   and	   interestingly	   we	   found	   that	   drugs	  
occupy	   two	  distinct	   areas	   of	  metabolite-­‐likeness,	   the	   one	   being	  more	   ‘synthetic’	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and	  the	  other	  being	  more	  ‘metabolite-­‐like’.	  Also,	  on	  a	  truly	  prospective	  dataset	  of	  
457	   compounds,	   95.84%	   correct	   classification	   was	   achieved.	   Overall,	   we	   are	  
confident	  that	  we	  contributed	  to	  the	  tasks	  of	  classifying	  metabolites,	  as	  well	  as	  to	  
understanding	  metabolite	  chemical	  space	  better.	  This	  knowledge	  can	  now	  be	  used	  
in	   the	  development	  of	  new	  drugs	   that	  need	   to	   resemble	  metabolites,	  and	   in	  our	  
work	   particularly	   for	   assessing	   the	   metabolite-­‐likeness	   of	   candidate	   molecules	  
during	  metabolite	  identification	  in	  the	  metabolomics	  field.	  
	  
The	   area	   of	   ‘Metabolomics’	   is	   relatively	   young	   [1,	   2]	   and	   describes	   the	   large-­‐scale	  
analysis	   of	   (often	   human	   and	   endogenous)	   metabolites.	   It	   comprises	   both	   the	  
analytical	   approaches	   employed,	   such	   as	   mass	   spectroscopy	   (MS)	   as	   well	   as	   the	  
analysis	  of	  the	  resulting	  data	  on	  a	  network-­‐	  and	  phenotype	  level.	  Metabolomics	  is	  a	  
particularly	   interesting	   research	   field	   as	   it	   allows	   the	   determination	   of	   biological	  
phenotypes	  on	  a	  chemical	  basis,	  since	  endogenous	  metabolites	  are	  closer	  phenotype	  
of	   an	   organism	   than	   for	   example	   gene	   expression	   [3].	   As	   a	   consequence,	   new	  
knowledge	  on	  biological	  processes	  can	  be	  obtained	  by	  investigating	  metabolites.	  	  
	  
Various	   experimental	   techniques,	   most	   commonly	   MS	   and	   nuclear	   magnetic	  
resonance	   (NMR),	   have	   been	   devised	   to	   detect	   and	   identify	   metabolites,	   with	  
different	   approaches	   being	   necessary	   to	   cover	   different	   parts	   of	   the	   metabolite	  
spectrum.	   In	   practice	   it	   is	   found	   that	   some	  metabolites	  with	   different	   lipophilicity	  
can	  only	  be	  detected	  by	  one	  of	  the	  experimental	  techniques	  but	  not	  by	  others	  [4–9].	  
Different	   techniques	   might	   also	   be	   used	   depending	   on	   the	   type	   and	   quantity	   of	  
sample	  to	  be	  analyzed,	  as	  well	  as	  the	  concentration	  and	  the	  molecular	  properties	  of	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the	  metabolites.	  In	  general	  terms,	  NMR	  allows	  for	  a	  detailed	  characterization	  of	  the	  
chemical	  structure	  of	  the	  (un)known	  compound,	  and	  it	  is	  the	  preferred	  technique	  for	  
unambiguous	  identification	  of	  a	  chemical	  structure.	  On	  the	  downside,	  NMR	  requires	  
abundant	   and	   pure	   sample,	   yielding	   low	   sensitivity.	   Conversely,	   MS	   offers	   high	  
sensitivity	   and	   specificity,	   requiring	   less	   amounts	   of	   sample,	   but	   providing	   less	  
information	   about	   the	   chemical	   structure,	   namely	   its	   elemental	   composition	   and	  
some	  structural	  fragments.	  
	  
However,	   despite	   its	   ability	   to	   describe	   a	   phenotype	   in	   many	   cases	   in	   a	   more	  
relevant	  manner	  than	  other	  approaches,	  in	  metabolomics	  studies	  a	  major	  challenge	  
exists,	   namely	   metabolite	   identification	   [10–12].	   While	   many	   endogenous	  
metabolites	  can	  be	  detected	  (and	  their	  spectrum	  determined),	  also	  elucidating	  their	  
chemical	   structures	   is	   essential	   to	   properly	   interpret	   results,	   and	   to	   utilize	   the	  
analytical	   data	   to	   finally	   answer	   biological	   questions	   [13].	  However,	   the	   step	   from	  
the	  analytical	  readout	  to	  the	  structural	  formula	  is	  often	  fraught	  with	  problems.	  
	  
In	   the	  commonly	  employed	  MS-­‐based	  profiling	  approaches	   (which	  are	  also	  used	   in	  
our	  group),	  once	  metabolites	  are	  detected	  their	  elemental	  composition	  (or	  multiple	  
elemental	  compositions)	  [14,	  15]	  can	  be	  derived	  directly	  from	  MS	  data.	  Based	  on	  this	  
elemental	  composition,	  matching	  chemical	  structures	  can	  be	  proposed	  following	  two	  
approaches.	  In	  the	  first	  approach,	  molecular	  databases	  are	  queried	  for	  the	  presence	  
of	  molecules	  with	   the	   same	   elemental	   composition	   (or	   similar	   spectral	   data),	   and	  
hits	  are	  returned	  as	  candidate	  structures	  [13,	  16].	  However,	  the	  major	  shortcoming	  
of	  this	  approach	  is	  that	  one	  can	  only	  find	  in	  databases	  what	  has	  been	  found	  before,	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making	   the	   elucidation	   of	   novel	   metabolites	   impossible.	   In	   the	   second	   approach,	  
which	  is	  meant	  to	  cover	  this	  shortcoming,	  the	  elemental	  composition	  and	  optionally	  
other	  experimental	  data	  are	  provided	  to	  a	  ‘structure	  elucidator’,	  which	  will	  generate	  
in	   silico	   all	   possible	   chemical	   structures	   which	   match	   the	   analytical	   constraints	  
provided	  to	  the	  algorithm	  [17–19].	  While	  one	  of	  the	  structures	  generated	  will	  be	  the	  
metabolite	   of	   interest,	   depending	   on	   the	   elemental	   formula	   provided,	   the	   latter	  
method	   in	  particular	  yields	  a	   large	  number	  of	  possible	  solutions.	   (For	  example,	   the	  
elemental	   composition	   of	   phenylalanine,	   C9H11NO2,	   yields	   277,810,163	   possible	  
candidate	  structures.)	  
	  
Due	  to	  the	  above	  reasons,	  molecular	  databases	  compiling	  structural	  information	  on	  
endogenous	  metabolites	  are	  currently	  limited	  in	  size	  and	  they	  certainly	  do	  not	  cover	  
metabolite	  space	  exhaustively.	  The	  number	  of	  possible	  metabolites	   is	  yet	  unknown	  
[20].	   While	   lipids	   alone	   are	   estimated	   to	   exist	   in	   the	   order	   of	   20,000	   different	  
structures	  [21]	  plants	  are	  thought	  to	  contain	  around	  200,000	  metabolites	  [3].	  Given	  
these	  figures,	  the	  experimental	  data	  obtained	  until	  today	  is	  relatively	  scarce.	  A	  large	  
database	   of	   metabolites	   such	   as	   the	   Human	   Metabolome	   Database	   (HMDB)	   [21]	  
contains	  in	  its	  current	  version	  about	  8,000	  structures,	  which	  is	  only	  a	  fraction	  of	  the	  
above	   numbers.	   Still,	   HMDB	   is	   the	   most	   comprehensive	   dataset	   to	   represent	   the	  
Metabolite	   Space	   from	   a	   human	   point	   of	   view.	   Plant	  metabolomics	  makes	   use	   of	  
different	  databases	  [12].	  In	  addition	  metabolomics	  databases	  exist	  [22]	  that	  contain	  
metabolites	  and	  the	  enzymatic	  reactions	  that	  connect	  them	  to	  pathways,	  such	  as	  in	  
KEGG	   [23];	   some	   databases	   contain	   metabolites	   grouped	   by	   organism	   such	   as	   in	  
BioCyc	   [24]	   and	   other	   database	   relate	  metabolites	  with	   experimental	   information,	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such	  as	  Metlin	  [25].	  Still,	  given	  its	  number	  of	  data	  entries,	  the	  approach	  to	  match	  the	  
MS	  or	  NMR	  spectrum	  to	  database	  spectra	  can	  only	  succeed	  in	  a	  fraction	  of	  cases.	  	  
	  
Hence,	  solutions	  need	  to	  be	  ranked,	  based	  on	  the	  likelihood	  of	  a	  molecular	  structure	  
to	  be	  a	  metabolite	  [26]	  –	  and,	  as	  we	  will	  outline	  in	  more	  detail	  below,	  this	  is	  one	  of	  
the	  main	  aims	  of	  the	  current	  work	  of	  implementing	  a	  ‘metabolite-­‐likeness’	  model.	  In	  
addition,	   our	   goal	  was	   to	   understand	  metabolites	   better	   from	  a	   chemical	   point	   of	  
view,	  and	  this	  is	  what	  we	  will	  discuss	  in	  the	  remainder	  of	  this	  work,	  after	  setting	  our	  
approach	  in	  context	  with	  the	  ‘prior	  art’	  in	  the	  field	  of	  metabolite	  classification.	  	  
	  
Focusing	  on	  metabolites	  of	  E.	  coli,	  Nobeli	  et	  al.	  [27]	  studied	  745	  metabolites	  of	  this	  
organism	   by	   analyzing	   physiochemical	   descriptors,	   the	   diversity	   of	   scaffolds,	   and	  
similarity-­‐based	   compound	   clustering.	   It	   was	   observed	   that	   most	   of	   the	   E.	   coli	  
metabolites	  are	   found	  between	   the	  100	  and	  300	  Da	  molecular	  weight	   region,	   that	  
they	  contain	  up	  to	  20	  heavy	  atoms,	  and	  that	  they	  are	  mostly	  hydrophilic.	  In	  addition	  
the	   low	   diversity	   of	   molecular	   scaffolds	   was	   observed.	   The	   clustering	   analysis	  
performed	   revealed	   that	   it	   is	   difficult	   to	   use	   molecular	   similarity	   to	   group	  
metabolites	  in	  ‘sub-­‐classes’,	  since	  there	  is	  not	  a	  natural	  separation	  according	  to	  their	  
two-­‐dimensional	  structure	  similarity,	  concluding	  that	  the	  metabolite	  space	  of	  E.	  coli	  
is	  homogeneous.	  	  
	  
While	   Nobeli	   et	   al.	   focused	   on	   the	   metabolome	   of	   E.	   Coli,	   Gupta	   et	   al.	   [28]	  
represented	   the	   chemical	   space	   of	  metabolites	   using	   the	   KEGG/LIGAND	   database,	  
which	   includes	   metabolites	   from	   different	   species	   as	   well	   as	   xenobiotics.	   The	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chemical	  space	  of	  non-­‐metabolites	  was	  approximated	  by	  ZINC	  database	  [29],	  which	  
contains	  small	  molecules	  that	  are	  commercially	  available.	  These	  molecules	  are	  often	  
used	   as	   the	   search	   space,	   in	   virtual-­‐screening	   research,	   or	   as	   background	   set	   in	  
classification	  projects.	  
	  
In	  this	  work	  it	  was	  concluded	  that	  hydroxyl	  groups,	  aromatic	  systems,	  and	  molecular	  
weight	  are	  discriminating	  features	  between	  metabolite	  and	  non-­‐metabolite	  chemical	  
space.	   Furthermore,	   Self	   Organizing	   Maps	   (SOM),	   Random	   Forests	   (RF),	   and	  
Classification	   Trees	   (CT)	  were	   employed	   to	   distinguish	   between	   the	   two	   classes	   of	  
compounds,	  which	  were	  represented	  by	  3D	  descriptors,	  topological	  descriptors,	  and	  
global	  molecular	  descriptors,	  respectively.	  The	  best	  classification	  accuracy	  was	  97%,	  
achieved	   by	   the	   combination	   of	   RF	   and	   global	  molecular	   descriptors.	   (No	   external	  
validation	  of	  such	  models	   is	  reported	  in	  their	  work,	  as	  opposed	  to	  our	  novel	  study,	  
which	  includes	  a	  prospective	  validation	  set.)	  
	  
While	   trying	   to	   discriminate	   metabolites	   from	   non-­‐metabolites	   was	   the	   obvious	  
starting	  point,	  it	  was	  then	  noted	  that	  also	  bioactive	  compounds,	  notably	  drugs,	  could	  
be	  related	  to	  the	  metabolite/non-­‐metabolite	  chemical	  spaces.	  All	  three	  of	  those	  sets	  
were	   hence	   analyzed	   by	   Dobson	   et	   al.	   in	   a	   subsequent	   study	   [30].	   Endogenous	  
metabolites	  were	  selected	  from	  the	  HMDB,	  BioCyc,	  BiGG,	  and	  Edinburgh	  databases	  
while	  drugs	  were	  compiled	   from	  DrugBank	  and	  KEGG	  DRUG.	   In	  addition,	  screening	  
molecules	  from	  ZINC	  were	  the	  source	  for	  the	  background	  compound	  set.	  Molecules	  
were	  represented	  using	  connectivity	  and	  path	  fingerprints,	  MDL	  Public	  Keys	  and	  E-­‐
state,	  and	  the	  similarity	  between	  them	  was	  determined	  by	  the	  Tanimoto	  coefficient.	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In	  this	  work	  the	  authors	  concluded	  that	  drugs	  are	  more	  similar	  to	  metabolites	  than	  
to	   screening	   compounds.	   Furthermore	   the	   distribution	   of	   molecular	   properties	  
among	   the	   different	   families	   of	   compounds	   was	   studied	   and	   it	   was	   noticed	   that	  
metabolites	   tend	   to	   have	   fewer	   heavy	   atoms	   than	   the	   other	   two	   groups	   of	  
compounds.	  Another	  relevant	  physicochemical	  property	   identified	  was	   lipophilicity,	  
which	   showed	   a	   bias	   in	   metabolites	   towards	   hydrophilicity,	   whereas	   drugs	   and	  
screening	  compounds	  were	  more	  hydrophobic.	  
	  
In	  the	  current	  study	  we	  are	  extending	  previous	  work	  by,	  compared	  to	  Gupta	  et	  al.,	  
focusing	   on	   a	   large	   set	   of	   human	   metabolites	   obtained	   from	   HMDB,	   instead	   of	  
metabolites	   from	   multiple	   species,	   and	   an	   updated	   collection	   of	   background	  
compounds	   from	   ZINC.	   We	   make	   use	   of	   different	   molecular	   descriptors	   such	   as	  
ECFP_4	  [31],	  FCFP_4,	  MDL	  Public	  Keys	  [32],	  and	  physicochemical	  properties,	  as	  well	  
as	  classifiers	  like	  Support	  Vector	  Machines	  (SVM)	  [33],	  Random	  Forest	  (RF)	  [34]	  and	  
Naïve	  Bayes	   (NB)	   [35]	  and	  evaluate	   their	  applicability	   to	  distinguishing	  metabolites	  
from	  non-­‐metabolites.	  In	  addition	  we	  include	  a	  prospective	  validation	  set	  to	  further	  
assess	  model	  performance.	  Furthermore,	  Dobson	  et	  al.	  used	  molecular	  similarity	  to	  
metabolites	   as	   an	   indicator	   of	   metabolite-­‐likeness.	   In	   comparison,	   we	   assign	   our	  
score	   based	   on	   the	   predictions	   given	   by	   different	   classification	   methods.	   The	  
classifier	   presented	   here	   employs,	   at	   the	   time	   of	   publication,	   the	   most	  
comprehensive	   collection	   of	   human	   metabolites	   and	   purchasable	   compounds.	  
Furthermore	   we	   also	   make	   use	   of	   PCA	   and	   hierarchical	   clustering	   to	   understand	  
which	   physicochemical	   properties	   as	   well	   as	   chemical	   functionalities	   are	  
characteristic	   of	   metabolites,	   and	   discriminate	   them	   from	   non-­‐metabolites.	   The	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principal	  aim	  of	  this	  work	  is	  to	  establish	  a	  reliable	  metabolite	  classifier	  for	  candidate	  
structures	  that	  need	  to	  be	  identified	  in	  metabolomics	  studies;	  however,	  apart	  from	  
the	  classifier	  itself,	  also	  understanding	  metabolite	  space	  better	  was	  a	  second	  major	  
aim	  of	  this	  work.	  
	  
Methods	  
Datasets	  and	  Data	  Preprocessing	  
The	  Human	  Metabolome	  Database	  (HMDB)	  version	  2.5	  [21]	  served	  as	  source	  of	  the	  
metabolite	  set.	  This	  database	  contains,	  in	  its	  original	  form,	  7,886	  human	  metabolites	  
as	   determined	   by	   experimental	   analytical	   methods.	   The	   ZINC	   Database	   (ZINC)	  
release	   8	   [29]	   was	   chosen	   to	   represent	   non-­‐metabolite	   chemical	   space.	   From	   the	  
different	  datasets	  provided	  by	  ZINC,	  we	  selected	  the	  subset	  “everything	  #10”	  (date	  
2010-­‐06-­‐17),	   since	   it	   includes	  21.6	  million	  compounds	  and	   it	  was	   the	   largest	  set	  at	  
the	  time,	  and,	  hence,	  most	  representative	  of	  ‘all’	  chemical	  space.	  	  
	  
Molecules	   from	   the	   two	   datasets	   were	   standardized	   with	   PipelinePilot	   Student	  
Edition	  6.1	  [36]	  using	  the	  'washing'	  workflow	  suggested	  by	  Dobson	  et	  al.	  [30],	  which	  
involved	  the	  selection	  of	  the	  largest	  fragment	  in	  the	  structure,	  the	  removal	  of	  salts	  
and	   hydrogen	   atoms	   and	   the	   standardization	   of	   charges	   and	   stereochemistry.	  
Because	  the	  ZINC	  database	  mainly	  contains	  molecules	  with	  a	  low	  molecular	  weight,	  
a	   value	   of	   1000	   Daltons	   was	   set	   as	   the	   maximum	   molecular	   weight	   of	   any	  
compound,	   metabolite	   or	   not,	   in	   this	   study.	  While	   this	   removes	   part	   of	   chemical	  
space	   from	   the	   metabolite	   dataset,	   this	   step	   was	   necessary	   to	   avoid	   molecular	  
weight	  to	  appear	  as	  a	  major	  discriminant	  between	  metabolites	  and	  non-­‐metabolites	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(which	   would	   not	   be	   relevant	   in	   the	   context	   of	   our	   future	   application	   of	  
distinguishing	   metabolites	   from	   non-­‐metabolites	   in	   cases	   of	   structures	   with	   an	  
identical	  sum	  formula).	  Furthermore,	  when	  employing	  fingerprints	  for	  classification,	  
the	   chemical	   distribution	  of	   features	   (as	  opposed	   to	   the	  molecular	  weight)	  will	   be	  
used	   for	   classification,	   hence	  making	   the	   classification	   (in	   this	   feature	   space)	   size-­‐
independent.	   This	   filter	   removed	   775	   metabolites	   from	   the	   HMDB	   dataset.	  
Furthermore,	  the	  constraint	  imposed	  on	  molecules	  to	  contain	  three	  or	  more	  atoms	  
(in	   order	   to	   retain	   only	   small	   organic	  molecules	   in	   the	   dataset)	   removed	   65	   small	  
molecules	  and	  ions	  from	  HMDB.	  Metabolites	  from	  HMDB	  that	  are	  considered	  drugs	  
were	   also	   removed	   from	   the	   dataset,	   based	   on	   annotations	   as	   drugs	   in	   the	   fields	  
“Taxonomy	   Family”	   and	   “Taxonomy	   Sub	   Class”	   provided	   by	   HMDB,	   removing	   92	  
drugs	  from	  the	  dataset	  and	  reducing	  the	  metabolite	  dataset	  to	  6,954	  molecules.	  The	  
number	  of	  molecules	  contained	  in	  ZINC	  was	  excessively	   large	  to	  perform	  clustering	  
and	   classification,	   concerning	   the	   computational	   resources	   needed	   for	   such	   tasks,	  
therefore	   selecting	   a	   subset	  was	   necessary.	   Such	   a	   subset	  was	   randomly	   selected	  
from	  ZINC,	  which	   contained	  194,350	  molecules.	   All	   of	   these	  molecules	   passed	   the	  
filtering	   based	   on	  molecular	  weight	   and	   the	  minimum	   number	   of	   atoms.	   The	   last	  
dataset	  preprocessing	  step	  was	  the	  removal	  of	  metabolites	  (molecules	  contained	  in	  
the	  HMDB	  database)	  from	  the	  ZINC	  dataset,	  where	  8	  molecules	  were	  removed	  from	  
the	  non-­‐metabolite	  set.	  
	  
Training	  and	  Test	  Sets	  
Diversity	   selection	   [37,	   38]	   was	   used	   in	   this	   work	   to	   prepare	   representative	  
compound	   datasets	   for	   metabolites	   and	   non-­‐metabolites	   with	   the	   intention	   of	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reducing	   the	   bias	   that	   overrepresented	   families	   of	   molecules	   could	   have	   on	   the	  
classification	  step.	  This	  initially	  appeared	  particularly	  crucial	  since	  lipids	  were	  hugely	  
overrepresented	   in	   the	  HMDB	  database.	  After	  giving	   it	  more	   thought	   it	  was	  noted	  
that	   this	   step	   certainly	   involves	   subjective	   elements	   since	   it,	   on	   the	   one	   hand,	  
removes	  information	  about	  the	  distribution	  of	  data	  points	  in	  the	  original	  set.	  On	  the	  
other	  hand,	  we	  assumed	  that	  there	  was	  a	  significant	  bias	  present	  in	  particular	  in	  the	  
metabolite	   dataset	   not	   only	   due	   to	   ‘natural’	   causes,	   but	   also	   due	   to	   the	   bias	  
introduced	   by	   experimental	   techniques	   (such	   as	  MS	   and	  NMR),	  which	   are	   able	   to	  
detect	  and	  identify	  compounds	  rather	  selectively.	  Hence,	  we	  came	  to	  the	  conclusion	  
that	   close	   analogues	   should	   be	   removed	   carefully	   from	   the	   dataset.	   In	   this	   spirit,	  
each	   dataset	   was	   independently	   clustered	   using	   the	   maximal	   dissimilarity	  
partitioning	  algorithm	  implementation	  from	  the	  'Cluster	  Molecules'	  component	  from	  
PipelinePilot	   Student	   Edition	   6.1	   [36].	   Molecules	   were	   represented	   by	   ECFP_4	  
fingerprints	  and	   the	  distance	  between	  each	  pair	  of	  molecules	  was	  calculated	  using	  
the	   Tanimoto	   coefficient.	   The	   maximum	   dissimilarity	   of	   a	   cluster	   member	   to	   the	  
cluster	   centre	   was	   0.6,	   (that	   is,	   molecules	   from	   the	   same	   cluster	   possess	   a	  
ECFP_4/Tanimoto	  similarity	  of	  at	   least	  0.4).	  Finally	  cluster	  centers	  were	  selected	  as	  
representatives	   of	   each	   cluster,	   which	   yielded	   532	   representatives	   for	   HMDB	   and	  
more	   than	  12,000	   for	   ZINC.	   In	  order	   to	  have	  balanced	   training	  datasets	   for	  model	  
building	   (where	   some	   algorithms	   are	   prone	   to	   majority	   class	   predictions),	   532	  
random	  molecules	  were	   selected	   from	   ZINC.	   These	   two	   subsets	   of	   532	  molecules	  
each	   were	   used	   for	   building	   the	   classification	   models.	   While	   these	   datasets	   are	  
small,	   they	   were	   intended	   to	   remove	   much	   of	   the	   bias	   present	   in	   the	   original	  
datasets.	  We	  also	  still	  made	  use	  of	   the	  additional	   compound	   information	  available	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since	  from	  the	  remaining	  molecules	  not	  included	  in	  the	  training	  datasets	  the	  test	  set	  
was	  built,	  where	  the	  remaining	  6,422	  metabolites	  as	  well	  as	  6,422	  randomly	  selected	  
non-­‐metabolites	  were	  joined	  to	  form	  an	  initial	  test	  set	  of	  12,844	  molecules.	  Hence,	  
this	   very	   large	   test	   set	   was	   used	   to	   evaluate	   whether	  model	   generation	  with	   our	  
training	   dataset	   assembled	   in	   the	   way	   just	   described	   would	   produce	   viable	  
metabolite-­‐likeness	  models.	  
	  
Prospective	  Validation	  Sets	  
Predictive	   models	   are	   meant	   to	   be	   applied	   to	   novel,	   unseen	   molecules,	   and	   to	  
estimate	   the	   performance	   on	   those	   new	   molecules	   the	   utilization	   of	   external	  
validation	   sets	   is	   crucial.	   In	   order	   to	   determine	   prospective	   performance	   of	   our	  
model,	  an	  external	  validation	  set	  was	  compiled,	  which	  includes	  563	  metabolites	  not	  
yet	   part	   of	   HMDB	   (which	  were	   provided	   by	   the	   database	   curators).	   After	   filtering	  
using	   the	   standardization	   protocol	   described	   above,	   the	   resulting	   prospective	  
validation	   set	   contained	   457	   metabolites	   that	   were	   not	   included	   in	   any	   of	   the	  
previous	   preprocessing	   steps	   (diversity	   selection,	   model	   building,	   and	   model	  
evaluation).	   Furthermore,	   two	   other	   datasets	   of	   molecules	   were	   assembled	   for	  
evaluation	   with	   the	   metabolite-­‐likeness	   model,	   namely	   one	   of	   drugs,	   and	   one	   of	  
bioactive	   compounds	   (as	   determined	   by	   experimental	   assays).	   To	   represent	   drugs	  
DrugBank	  release	  2.5	  (date	  23-­‐11-­‐2010)	  [39]	  was	  used,	  comprising	  6,532	  molecules.	  
To	   represent	   bioactive	   molecules,	   ChEMBL	   [40]	   release	   8	   (date	   09-­‐12-­‐2010)	   was	  
employed.	  Both	  datasets	  were	  normalized	  using	   the	  protocol	  described	  above	  and	  
from	   the	   635,933	   compounds	   in	   ChEMBL,	   6,312	   were	   randomly	   selected	   (the	  
DrugBank	  dataset	  was	  used	   in	   full	  due	   to	   its	   smaller	   size).	  With	   these	  datasets	  we	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evaluated	   if	   our	   metabolite-­‐likeness	   model	   is	   able	   to	   detect	   the	   biogenic	   bias	   of	  
drugs	  and	  bioactive	  compounds	  in	  general.	  With	  these	  three	  prospective	  validation	  
sets	   (external	   validation	   set,	   drug	   set,	   bioactive	   compound	   set)	   we	   evaluated	   our	  
best	  model,	  as	  derived	   in	  the	  parameter	  exploration,	   in	  two	  different	  ways.	  Firstly,	  
the	  quality	  of	  the	  predictions	  for	  metabolites	  that	  were	  not	  involved	  at	  any	  stage	  of	  
the	   model	   creation	   by	   employing	   an	   external	   validation	   set,	   was	   determined.	  
Secondly,	   we	   tested	   the	   hypothesis	   that	   drugs	   (and,	   possibly	   to	   a	   lesser	   extent,	  
bioactive	  molecules)	  are	  more	  similar	  to	  metabolites	  than	  to	  non-­‐metabolites.	  This	  
hypothesis	   could	   either	   be	   rejected	   or	   not	   from	   the	   distribution	   of	   metabolite-­‐
likeness	  scores	  as	  assigned	  by	  our	  model.	  
	  
Molecular	  Descriptors	  
Molecular	  descriptors	  should	  be	  chosen	  with	  care	  depending	  for	  which	  problem	  they	  
are	   going	   to	   be	   used	   [41,	   42].	   In	   this	   case	   different	   descriptor	   sets	  were	   used	   for	  
classification	  as	  follows.	  
	  
a)	  Atom	  Counts	  and	  Physicochemical	  Molecular	  Descriptors	  
Atom	  counts	  and	  physicochemical	  descriptors	  are	  rather	  simple,	  intuitive	  and	  easy	  to	  
interpret	  by	  chemists.	  On	   the	  downside,	   they	  usually	   result	   in	  poorer	  classification	  
results	  than	  more	  complex	  descriptors	  since	  no	  structural	  information	  is	  captured.	  In	  
this	   study	   our	   descriptor	   set	   based	   on	   atom	   counts	  was	   called	   ‘Atom	  Counts’	   and	  
contained	  counts	  of	  the	  most	  common	  atom	  types	  in	  metabolites,	  namely	  H_Count,	  
C_Count,	  N_Count,	  O_Count,	  F_Count,	  P_Count,	  S_Count,	  Cl_Count.	   'Atom	  Counts'	  
descriptors	  were	  computed	  using	  the	  component	  'Element	  Count'	  from	  PipelinePilot	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Student	  Edition	  6.1	  [36].	  The	  physicochemical	  properties	  used	  were	  the	  Atom	  Counts	  
descriptors	  mentioned	  above	  together	  with	  the	  following	  properties:	  the	  number	  of	  
atoms	   (Num_Atoms	   in	   PipelinePilot),	   a	   calculated	   logP	   value	   (ALogP),	   a	   calculated	  
logD	  value	  (LogD),	  the	  number	  of	  hydrogen	  donors	  (Num_H_Donors)	  and	  acceptors	  
(Num_H_Acceptors),	   the	   number	   of	   rotatable	   bonds	   (Num_RotatableBonds),	   the	  
number	  of	  rings	  (Num_Rings),	  the	  number	  of	  aromatic	  rings	  (Num_AromaticRings),	  a	  
calculated	  value	  of	   solubility	   (Molecular_Solubility),	   a	   calculated	  value	  of	   the	  polar	  
surface	  area	  (Molecular_PolarSurfaceArea),	  and	  a	  calculated	  value	  for	  the	  minimized	  
energy	   (Minimized_Energy).	   All	   these	   properties,	   listed	   in	   detail	   in	   Table	   1,	   were	  
calculated	   with	   the	   components	   'Element	   Count',	   'Calculate	   Properties',	   'ALogP',	  
'LogD',	  'Surface	  Area	  and	  Volume',	  	  
'Molecular Energy' as implemented in PipelinePilot Student Edition 6.1 [36].  
Descriptors	   Properties	  
Atom	  Counts	   H_Count,	  C_Count,	  N_Count,	  O_Count,	  F_Count,	  P_Count,	  S_Count,	  Cl_Count	  
PP_desc	   Atom	  Counts,	  Molecular_Weight,	  Num_Atoms,	  ALogP,	  LogD,	  Num_H_Donors,	  
Num_H_Acceptors,	  Num_RotatableBonds,	  Num_Rings,	  Num_AromaticRings,	  
Molecular_Solubility,	  Molecular_PolarSurfaceArea,	  Minimized_Energy	  
Table	  2	  List	  of	  atom	  counts	  and	  physicochemical	  properties	  used	  to	  describe	  the	  molecules	  of	  this	  study.	  PP_desc	  
include	  Atom	  Counts	  and	  the	  listed	  physicochemical	  properties.	  
	  
b)	  Fingerprints	  
2D	   ECFP_X	   and	   FCFP_X	   are	   “Extended	   Connectivity”	  molecular	   fingerprints	   where	  
features	  are	  descriptions	  of	  the	  neighborhood	  of	  the	  atoms	  up	  to	  a	  certain	  distance	  
or	   radius	  X.	   In	   the	  ECFP	   fingerprint	   the	  atom	   identifier	   is	  based	  on	   the	  atom	  type,	  
while	  in	  FCFP	  it	  is	  based	  on	  the	  functional	  class	  of	  the	  atom	  [31].	  In	  this	  work,	  ECFP	  
and	  FCFP	  fingerprints	  with	  radius	  4	  were	  calculated	  using	  the	  component	  'Molecular	  
Properties'	   in	   PipelinePilot	   Student	   Edition	   6.1	   [36]	   with	   the	   parameter	   'Convert	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Fingerprint	   To'	   set	   to	   'Leave	   As-­‐Is'.	   These	   fingerprints	   can	   produce	   thousands	   of	  
features	   for	   a	   molecular	   library,	   including	   features	   that	   are	   present	   in	   very	   few	  
molecules,	  which	  can	  easily	  lead	  to	  over	  fitting.	  Hence,	  we	  folded	  the	  fingerprints	  to	  
a	   fixed	   length	  of	  1024	  bits,	  using	  PipelinePilot	  Student	  Edition	  6.1	   [36]	   component	  
'Convert	   Fingerprint',	   to	  an	  output	   format	  of	   'Fixed	   length	  Array	  of	  Bits',	   'Fixed	  Bit	  
Length'	  of	  1024,	  and	  'Output	  Bit	  Order'	  of	  'Pack	  Least-­‐Significant	  First'.	  	  
	  
MDL	  keys	  [32]	  were	  used	  as	  well	  for	  classification.	  MDL	  Public	  Keys	  are	  a	  key-­‐based	  
molecular	   representation	   defined	   by	   the	   presence	   or	   absence	   of	   166	   predefined	  
keys,	  or	  molecular	  substructures.	  Since	  the	  size	  of	  this	  key	  set	  is	  only	  166	  bits,	  folding	  
is	  not	  necessary.	  	  
	  
Principal	  Component	  Analysis	  
Principal	  Component	  Analysis	   (PCA)	   is	  a	  mathematical	   transformation	  that	  projects	  
the	  dataset	  onto	  a	  lower	  dimension	  defined	  by	  uncorrelated	  variables,	  the	  so-­‐called	  
‘principal	   components’	   [43].	   Such	   components	   are	   ordered	   according	   to	   the	  
percentage	  of	  variance	   in	  the	  dataset	  that	  they	  explain,	  which	  means	  that	  the	  first	  
principal	   component	   explains	   the	   highest	   variance.	   We	   performed	   a	   PCA	   on	   the	  
training	   set	  of	  metabolites	   and	  non-­‐metabolites	   in	  order	   to	  understand	  better	   the	  
nature	  of	   the	  chemistry	  contained	   in	  both	  classes.	  PCA	  was	  performed	  using	   the	  R	  







Hierarchical	   Clustering	   groups	   objects	   together	   that	   are	   close	   in	   the	   particular	  
representation	  chosen	  and	  assigns	  a	  hierarchy	  to	  the	  resulting	  clusters.	  This	  grouping	  
can	   be	   agglomerative,	   where	   initially	   each	   object	   is	   a	   cluster	   by	   itself	   and	   where	  
clusters	  are	  subsequently	  combined,	  or	  divisive,	  where	  the	  whole	  dataset	  is	  assigned	  
to	   a	   single	   cluster	   initially	   which	   is	   then	   iteratively	   split	   into	   smaller	   clusters.	  
Furthermore,	  two	  other	  factors	  determine	  the	  output	  of	  the	  clustering,	  the	  distance	  
metric	  between	  objects	  and	   the	  method	  used	   to	   link	   two	  clusters,	   i.e.	   the	  method	  
used	   to	   calculate	   the	   distance	   between	   clusters.	  We	  have	   used	   the	   agglomerative	  
hierarchical	   clustering	   offered	   by	   FactoMineR	   [44]	   on	   the	   results	   of	   the	   PCA	   as	  
described	   above	   in	   combination	   with	   an	   Euclidean	   distance	   metric	   and	   Ward's	  
linkage	  method.	  Finally,	  the	  hierarchy	  of	  clusters	  is	  presented	  on	  a	  dendogram	  that	  
needs	  to	  be	  cut	  at	  some	  point	  to	  split	  the	  clusters.	  The	  criteria	  employed	  to	  cut	  the	  
dendogram	  was	  the	  default	   in	  FactoMineR,	  which	  splits	  the	  clusters	  at	  the	  point	  of	  
maximal	   loss	   of	   intra-­‐cluster	   inertia.	   The	   clustering	   results	   are	   used	   to	   evaluate	   if	  
some	   natural	   grouping	   emerges	   from	   the	   data;	   in	   our	   case,	   whether	   metabolite	  
space	  actually	  contains	  several	  distinct	  subspaces.	  
	  
Classification	  Trees	  
Classification	  trees	  are	  machine-­‐learning	  methods	  that	  use	  a	  univariate	  partition	  to	  
split	   the	  dataset	   in	   subsets	   [45].	  At	  each	   step	   the	  data	   is	   split	  using	   the	  predicting	  
variable	   that	   optimizes	   a	   certain	   criteria.	   In	   our	   case,	  we	  make	   use	   of	   conditional	  
inference	   trees	   (CIT)	   as	   implemented	   in	   the	   R	   package	   party	   [46].	   Conditional	  
inference	   trees	  perform	  a	   covariate	   selection	   that	   relies	   on	  permutation	   tests	   and	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statistical	  significance.	  Applying	  CIT	  to	  a	  two-­‐class	  classification	  problem	  can	  be	  seen	  
as	  a	  binary	  tree	  where	  at	  each	  node	  the	  dataset	   is	  split	   into	  two	  subsets	  using	  the	  
covariate	  that	  has	  the	  strongest	  association	  to	  the	  response	  variable.	  In	  the	  case	  that	  
features	   are	   binary	   fingerprints,	   the	   presence	   or	   absence	   of	   a	   given	   feature	  
determines	   the	   data	   split	   performed.	   Variables	   are	   selected	   if	   they	   maximize	   the	  
‘purity’	  of	  the	  split,	  this	  is,	  that	  each	  subset	  contains	  mostly	  objects	  of	  one	  class.	  The	  
result	   is	   a	   tree	   that	   depicts	   the	   best	   variables	   to	   split	   the	   data	   and	   provides	  
information	  about	   relevant	  variables	   for	  each	  class	  of	  objects.	   In	   the	  course	  of	   the	  
present	  study,	  classification	  trees	  were	  applied	  particularly	  to	  ECFP_4	  fingerprints,	  in	  




In	  this	  part	  of	  the	  work,	  we	  further	  analyzed	  the	  fragment	  composition	  of	  metabolite	  
and	   ‘purchasable	   chemistry’	   spaces	   as	   a	   means	   to	   better	   understand	   the	  
composition	  of	  (and	  differences	  between)	  both	  compound	  spaces.	  From	  the	  point	  of	  
view	   of	   a	   chemist,	   molecular	   fragments	   are	   easier	   to	   interpret	   and	   convey	   more	  
meaning	   than	   a	   fingerprint	   or	   a	   sensitivity	   percentage.	   Therefore	   we	   used	   the	  
component	   'Generate	   Fragments'	   from	   PipelinePilot	   Student	   Edition	   6.1	   [36]	   to	  
enumerate	   (in	   PipelinePilot	   terminology)	   rings,	   ring	   assemblies,	   bridge	   assemblies,	  
chains,	  and	  Murcko	  assemblies	  (scaffolds	  that	  contain	  ring	  systems	  and	  ring	  systems	  
connected	  by	  linkers,	  but	  no	  side	  chains)	  [47].	  The	  top	  20	  most	  frequent	  fragments	  
from	   our	   two	   datasets,	   human	   metabolites	   and	   purchasable	   compounds	   were	  
collected	  and	  analyzed.	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Machine	  Learning	  	  
Three	  machine-­‐learning	  algorithms	  were	  used	  to	  generate	  the	  models	  of	  metabolite-­‐
likeness,	  namely	  Support	  Vector	  Machines	  (SVM)	  [33],	  Random	  Forests	  (RF)	  [34],	  and	  
the	   Naïve	   Bayes	   Classifier	   (NB)	   [48].	   We	   used	   the	   implementations	   of	   these	  
algorithms	   in	   the	   statistical	   software	   package	   R	   [49].	   For	   SVM,	   we	   employed	   the	  
library	  e1071	   [50],	  which	   is	  an	   implementation	  of	   the	  standard	  C++	   libsvm	   [51].	  As	  
for	  RF,	  we	  opted	  for	  the	  library	  randomForest	  [52],	  an	  R	  port	  of	  the	  original	  code	  of	  
Breiman	  [34].	  Again	  e1071	  was	  the	  library	  chosen	  for	  NB.	  	  
	  
SVM	  is	  one	  of	  the	  most	  robust	  and	  widely	  used	  algorithms	  in	  machine	  learning	  and	  it	  
belongs	  to	  the	  class	  of	  maximum	  margin	  classifiers	  [33,	  53].	  In	  a	  two-­‐class	  problem,	  
SVM	   tries	   to	   define	   a	   boundary	   that	   maximizes	   the	   separation	   between	   the	   two	  
classes.	  Provided	  the	  classes	  are	  linearly	  separable,	  SVM	  builds	  a	  hyperplane	  with	  a	  
maximal	   margin	   to	   neighboring	   objects	   of	   the	   two	   classes.	   When	   the	   linear	  
separation	   is	   not	   feasible,	   a	   kernel	   function	   executes	   a	   nonlinear	  mapping	   of	   the	  
data	   to	   a	   higher	   dimension	   where	   it	   can	   be	   linearly	   separated.	   SVM	   requires	   the	  
tuning	   of	   two	   metaparameters,	   gamma,	   which	   regulates	   the	   level	   of	   non-­‐linear	  
behavior	   of	   the	   kernel,	   and	   C,	   the	   cost	   of	   violating	   the	   constraints,	   in	   order	   to	  
achieve	   an	   optimal	   performance.	   The	   kernel	   type	  was	   set	   to	   the	   default	   Gaussian	  
Radial	   Basis	   Function	   (RBF).	   SVMs	   have	   been	   successfully	   used	   in	   molecular	  
classification	  before,	  such	  as	  for	  classifying	  ‘drug-­‐likeness’	  [54,	  55].	  
	  
RF	   is	  an	  ensemble	  of	  classification	  trees	  [34]	   in	  which	  each	  tree	  classifies,	  or	  votes,	  
the	  class	  of	  an	  object	  given	  a	  randomly	  chosen	  subset	  of	  the	  full	  variable	  set.	  Many	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of	  such	  trees	  are	  grown	  (as	  determined	  by	  the	  variable	  ntree)	  and	  majority	  voting	  is	  
used	   to	   obtain	   one	   final	   classification	   result.	   RF	   requires	   the	   tuning	   of	   the	  
metaparameter	  mtry,	  which	  determines	  the	  number	  of	  variables	  randomly	  sampled.	  	  
	  
The	  last	  classification	  algorithm	  is	  the	  Naïve	  Bayes	  algorithm	  [48],	  which	  relies	  on	  the	  
assumption	  that	  the	  variable	  values	  are	  conditionally	  independent	  of	  the	  class	  label.	  
This	   strong	   assumption	   usually	   does	   not	   hold,	   but	   in	   practice	   this	   approach	   still	  
allows	  building	  good	  models	  for	  multidimensional	  data,	  as	  was	  shown	  for	  bioactivity	  
datasets	  before	  [56,	  57].	  Compared	  to	  SVM	  and	  RF,	  NB	  only	  requires	  one	  parameter	  
to	   be	   tuned,	   the	   cut-­‐off	   value	   for	   the	   class	  membership	   probability	   (equivalent	   to	  
changing	  the	  choice	  of	  the	  ‘prior’),	  which	  was	  however	  not	  explored	  in	  this	  work	  and	  
it	   was	   set	   to	   its	   theoretical	   optimum	   (it	   was	   set	   to	   50%	   in	   the	   case	   of	   balanced	  
datasets,	  as	  proposed	  previously)	  [58].	  According	  to	  this,	  a	  molecule	  with	  a	  predicted	  
metabolite-­‐likeness	  of	  50%	  of	  higher	  is	  considered	  to	  be	  a	  metabolite,	  and	  with	  less	  
than	  50%	  metabolite-­‐likeness,	  a	  non-­‐metabolite.	  
	  
Cross	  Validation	  and	  Model	  Generation	  
Concerning	  RF	  and	  SVM,	  k-­‐fold	  cross	  validation	  [59–61]	   is	  a	  recommended	  method	  
to	   tune	  metaparameters	   and	   avoid	   over	   fitting.	  We	   opted	   to	   apply	   a	   5	   fold	   cross	  
validation,	  a	  previously	  recommended	  value	  for	  k	  [62,	  63],	  to	  the	  1,064	  molecules	  in	  
the	  training	  dataset.	  In	  the	  case	  of	  RF,	  for	  each	  cross	  validation	  split	  a	  range	  of	  values	  
for	  mtry	  metaparameter	  were	  tested,	  while	  the	  number	  of	  trees	  in	  the	  forest,	  ntree,	  
was	  set	  to	  the	  default	  value	  of	  500.	  The	  mtry	  giving	  the	  highest	  averaged	  Area	  Under	  
the	  Curve	  (AUC)	  and	  smallest	  classification	  error	  was	  chosen	  as	  the	  optimal	  value	  for	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building	   the	  model.	   Cross	   validation	   was	   performed	   in	   the	   same	   fashion	   for	   SVM	  
(Table	  S1	  shows	  the	  best	  values	  obtained	  for	  the	  metaparameters).	  Once	  the	  optimal	  
metaparameters	   were	   selected,	   final	   RF	   (RF	   variable	   importance	   of	   PP_desc	  
descriptors	  are	  listed	  in	  Table	  S2,	  and	  for	  MDL	  Public	  Keys	  in	  Table	  S3),	  SVM,	  and	  NB	  
models	  were	   generated	   using	   the	   complete	   set	   of	   1,064	  molecules	   in	   the	   training	  
dataset.	   This	   process	   of	   metaparameter	   determination	   and	   model	   building	   was	  
performed	   for	   each	   pair	   of	   three	   different	   classifiers	   (RF,	   SVM,	   and	   NB)	   and	   five	  
molecular	  representations	  (PP_desc,	  Atom	  Counts,	  ECFP_4,	  FCFP_4,	  and	  MDL	  Public	  
Keys),	  resulting	  in	  a	  total	  of	  15	  different	  classification	  exercises.	  	  
	  
Model	  Benchmarking	  
Once	   the	   training	   step	  was	   finished,	  we	  needed	   to	  evaluate	  what	  pair	   of	   classifier	  
and	  representation	  gave	  the	  best	  results	  on	  the	  test	  set,	  consisting	  of	  an	  additional	  
6,422	  metabolites	  as	  well	  as	  6,422	  non-­‐metabolites	  that	  were	  not	  used	  at	  any	  stage	  
during	   model	   training.	   To	   evaluate	   model	   performance	   we	   used	   sensitivity	   and	  
specificity	  values	  derived	  from	  the	  confusion	  matrices,	  together	  with	  ROC	  curves	  and	  
their	   associated	   AUC.	   After	   applying	   the	   models	   to	   the	   test	   set,	   the	   final	   step	  
involved	   classification	   of	   the	   molecules	   contained	   to	   the	   prospective,	   external	  
validation	   sets	   described	   above.	   The	   distribution	   of	   the	  metabolite-­‐likeness	   scores	  
for	   these	  datasets	   as	  well	   as	   the	  percentage	  of	   correctly	   classified	   compounds	  are	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Results	  and	  Discussion	  
PCA	  and	  Hierarchical	  Clustering	  
PCA	  was	  performed	  to	  the	  training	  set	  and	  the	  loadings	  and	  scores	  plots	  for	  the	  first	  
four	   dimensions	   are	   presented	   in	   Figure	   1.	   For	   this	   PCA,	   we	   focus	   on	  
physicochemical	  properties	  (PP_desc)	  for	  the	  sake	  of	  interpretability	  (PCA	  results	  for	  
MDL	   Public	   Keys	   are	   presented	   in	   Figure	   S1	   and	   Figure	   S2,	   and	   the	   percentage	   of	  
variance	  explained	  in	  Table	  S4).	  Almost	  71%	  of	  the	  variance	  is	  explained	  in	  the	  first	  
four	  components.	  A	  slight	  separation	  between	  metabolites	  and	  non-­‐metabolites	  can	  
be	  observed	   in	   the	   score	  plots	  of	  PP_desc	   (Figure	  1A	  and	  Figure	  1C).	   The	   loadings	  
plots	   for	   PP_desc	   (Figure	   1B	   and	   Figure	   1D)	   one	   can	   see	   which	   variables	   are	  
correlated	  or	   inversely	   correlated	  with	   each	   class	   of	   compounds.	   For	   the	   first	   two	  
dimensions	   (Figure	  1B),	   the	   variables	   that	   contribute	   the	  most	   to	   the	   variance	  are	  
Molecular	  Solubility,	  Molecular	  Weigh,	  Molecular	  Polar	  Surface	  Area	  (PSA),	  and	  the	  
number	  of	  carbon	  atoms	  per	  molecule	   (C_Count).	  Metabolites	  hence	   tend	   to	  have	  
higher	  water	  solubility,	  lower	  molecular	  weight,	  and	  fewer	  carbon	  atoms	  than	  non-­‐
metabolites.	  These	  observations	  are	  in	  accordance	  to	  the	  work	  of	  Nobeli	  et	  al.	  [27]	  
and	  Dobson	   et	   al.	   [30],	  who	   concluded	   that	  metabolites	   are	   hydrophilic	   and	   have	  
less	  heavy	  atoms	  than	  non-­‐metabolites.	  PSA	  tends	  to	  be	  bigger	  than	  the	  one	  of	  non-­‐
metabolites,	   suggesting	   that	   metabolites	   do	   not	   penetrate	   cell	   membranes	   as	  
efficiently	  as	  the	  non-­‐metabolites.	  Furthermore,	  the	   loadings	  plot	   for	  the	  third	  and	  
fourth	  dimensions	  (Figure	  1D),	  shows	  that	  the	  most	  contributing	  variables	  are	  Num	  
Rings,	  Num	  Rotatable	  Bonds,	  N	  Count,	  S	  Count,	  and	  Minimized	  Energy.	  The	  number	  
of	  rings,	  rotatable	  bonds,	  and	  minimized	  energy,	  for	  which	  metabolites	  obtain	  lower	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values	  than	  non-­‐metabolites,	  are	  indicators	  of	  molecular	  complexity,	  and,	  therefore,	  
one	   can	   conclude	   that	   metabolites	   have	   simpler	   chemical	   structures	   than	   non-­‐
metabolites.	   Interestingly,	   metabolites	   also	   have	   fewer	   nitrogen	   and	   sulfur	   atoms	  
than	   non-­‐metabolites,	   as	   is	   the	   case	   for	   all	   atom	   types	   except	   for	   oxygen	   and	  
phosphor,	  which	  are	  more	  frequent	  for	  metabolites	  as	  opposed	  to	  non-­‐metabolites.	  
	  
Figure	  1	  Principal	  Components	  Analysis	  of	  the	  PP_desc	  training	  set.	  PCA	  plots	  (A,C)	  and	  variable	  contributions	  
(B,D)	  for	  the	  training	  datasets	  PP_desc.	  
	  
The	  results	  of	  the	  PCA	  of	  PP_desc	  and	  MDL	  Public	  Keys	  were	  subject	  to	  hierarchical	  
clustering.	  (Plots	  are	  presented	  in	  Figure	  S3).	  In	  both	  cases	  the	  optimal	  cluster	  split,	  
according	  to	  the	  loss	  of	  intra-­‐cluster	  inertia,	  returned	  3	  clusters.	  The	  distribution	  of	  
metabolites	  and	  non-­‐metabolites	   in	  each	  cluster	   is	   listed	   in	  Table	  2.	   It	  can	  be	  seen	  
that	   for	   PP_desc	   and	  MDL	   Public	   Keys	   2	   large	   clusters	   and	   a	   third	   small	   one	   are	  
formed,	  each	  of	  them	  containing	  one	  dominant	  class	  of	  compounds.	  The	  first	  cluster	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for	  PP_desc	  has	  a	  purity	  of	  70.2%	   (370	  metabolites	  and	  157	  non-­‐metabolites),	   the	  
second	  cluster	  has	  a	  purity	  of	  89.65%	  (52	  metabolites	  and	  6	  non-­‐metabolites),	  and	  
the	  third	  cluster	  has	  a	  purity	  of	  77.03%	  (110	  metabolites	  and	  369	  non-­‐metabolites).	  
Using	  MDL	  Public	  Keys,	  the	  first	  cluster	  has	  a	  purity	  of	  78.81%	  (372	  metabolites	  and	  
100	   non-­‐metabolites),	   the	   second	   cluster	   has	   a	   purity	   of	   73.03%	   (134	  metabolites	  
and	   363	   non-­‐metabolites),	   and	   the	   third	   cluster	   has	   a	   purity	   of	   72.63%	   (26	  
metabolites	  and	  69	  non-­‐metabolites).	  However,	  the	  purity	  of	  each	  cluster	  is	  not	  high	  
and	  this,	  together	  with	  the	  lack	  of	  separation	  observed	  in	  the	  PCA,	  leads	  us	  to	  think	  
that	   the	  separation	  of	  metabolites	   from	  non-­‐metabolites	  requires	  the	  utilization	  of	  
more	   sophisticated	  methods	   like	   random	   forests,	   or	   other	   nonlinear	   classifiers	   as	  
explored	  in	  the	  following.	  	  
Cluster	   Type	   	  PP_desc	   MDL	  Public	  Keys	  
1	   HMDB	   370	   372	  
1	   ZINC	   157	   100	  
2	   HMDB	   52	   134	  
2	   ZINC	   6	   363	  
3	   HMDB	   110	   26	  
3	   ZINC	   369	   69	  
Table	  2	  Cluster	  distribution	  of	   the	  molecules	   in	   the	  training	  datasets,	  using	  PP_desc	  and	  MDL	  Public	  Keys.	  The	  
clustering	  performed	  was	  a	  hierarchical	   clustering	  and	   the	  dendogram	  was	  cut	  at	   the	  point	  of	  maximal	   inertia	  
loss.	  
Fingerprint	  Features	  and	  Fragment	  Analysis	  
A	  classification	  tree	  was	  built	  upon	  the	  training	  set,	  which	  was	  described	  using	  non-­‐
hashed	   ECFP_4	   fingerprints	   (Figure	   2).	   The	   results	   give	   a	   general	   idea	   of	   which	  
chemical	  moieties	   are	   characteristic	   of	   each	   class	  of	   compounds.	  As	   expected,	   the	  
most	  discriminating	  feature	  was	  the	  hydroxyl	  group,	  in	  agreement	  with	  the	  work	  by	  
Gupta	  et	  al.	   [28],	  with	  a	  higher	   frequency	  among	  metabolites.	  On	   the	  other	  hand,	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the	   presence	   of	   chemical	   moieties	   containing	   nitrogen,	   in	   particular	   secondary	  
amines	   and	   secondary	   imines,	   is	   highly	   correlated	  with	   a	   class	  membership	  of	   the	  
non-­‐metabolites.	   Finally,	   in	   the	   case	   a	   molecule	   lacks	   hydroxyl	   functionalities	  
(demonstrated	  to	  be	  metabolite-­‐like	  moieties),	  but	  it	  also	  lacks	  five	  or	  three	  member	  
rings,	  ether-­‐like	  features,	  and	  primary	  amines,	  it	  will	  likely	  be	  a	  metabolite	  (which	  is	  
the	  combination	  of	  features	  in	  the	  left-­‐most	  branch	  of	  the	  tree	  in	  Figure	  3).	  
	  
Figure	  2	  Conditional	   inference	   tree	  of	   the	  ECFP_4	   features	   in	   the	   training	   set.	  Hydroxyls,	   carboxylic	   acids,	   and	  
linear	   structures	   are	   associated	   with	   metabolites,	   whereas	   secondary	   amines	   and	   secondary	   imines	   are	  
associated	  with	  non-­‐metabolites.	  
When	   looking	   at	   the	   frequent	   fragments	   of	   metabolites	   (Figure	   3)	   and	   non-­‐
metabolites	   (Figure	   4),	  we	   corroborate	   this	   finding.	   Among	  metabolites,	   hydroxyls	  
and	   carboxylic	   acids	   are	   frequent	   as	  well	   as	   rings	   containing	  oxygen	  atoms.	   In	   the	  
case	   of	   non-­‐metabolites,	   either	   rings	   or	   linear	   fragments	   containing	   nitrogen	   and	  
sulfur	  abound,	  which	  is	  in	  accordance	  to	  the	  classification	  tree	  results,	  in	  accordance	  
to	  the	  findings	  of	  Hert	  et	  al.	   [64].	  Other	  frequent	  fragments	  of	  metabolites	  are	  the	  
phosphate	  group,	  characteristic	  of	  some	  classes	  of	  metabolites	  like	  nucleotides	  and	  
phospholipids,	  as	  well	  as	  the	  steroid	  and	  adenine	  scaffolds.	  This	  importance	  of	  class-­‐
specific	   fragments	   can	  make	   two	  metabolites	   from	  different	   classes	  very	  different,	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and	   it	   hence	   poses	   a	   challenge	   when	   building	   models	   that	   aim	   to	   capture	   such	  
diversity	  within	  a	  given	  class.	  One	  option	  is	  to	  build	  local	  models	  for	  each	  subclass	  of	  
metabolites;	  but	   in	  this	  study	  we	  aimed	  at	  building	  a	  global	  model	  for	  metabolites,	  
and	  as	  a	  result,	  we	  rely	  on	  complex	  classifiers	  to	  predict	  the	  metabolite-­‐likeness	  of	  
molecules.	   These	   classification	   models	   were	   built	   using	   the	   methods	   and	   data	  
described	  in	  the	  methods	  section	  and	  they	  were	  applied	  to	  our	  test	  set.	  
	  
Figure	  3	  Top	  20	  most	   frequent	   fragments	   in	  HMDB.	  The	  20	  most	   frequent	  ring	  systems,	  chain	  assemblies,	  and	  
Murcko	  assemblies	   in	   the	  metabolite	  data	  set	   (HMDB	  compounds).	   ‘H’	   refers	   to	  the	  frequency	  of	   fragments	   in	  
the	  HMDB	  dataset,	  ‘Z’	  to	  the	  frequency	  of	  fragments	  in	  the	  ZINC	  dataset.	  Fragments	  with	  less	  than	  4	  heavy	  atoms	  
were	   excluded.	  Oxygen	   containing	   rings,	   phosphate	   group,	   hydroxyl,	   carboxylic	   acid,	   and	   the	   steroid	   scaffold,	  
among	  others,	  are	  common	  fragments	  in	  metabolites.	  
	  
Figure	   4	  Top	   20	  most	   frequent	   fragments	   in	   ZINC.	   The	   20	  most	   frequent	   ring	   systems,	   chain	   assemblies,	   and	  
Murcko	   assemblies	   among	   the	   ZINC	   compounds,	   here	   chosen	   as	   a	   non-­‐metabolite-­‐like	   set.	   ‘H’	   refers	   to	   the	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frequency	  of	  fragments	  in	  the	  HMDB	  dataset,	  ‘Z’	  to	  the	  frequency	  of	  fragments	  in	  the	  ZINC	  dataset.	  Fragments	  
with	  less	  than	  4	  heavy	  atoms	  were	  excluded.	  Nitrogen	  containing	  rings	  dominate	  the	  most	  frequent	  fragments.	  
	  
Test	  Set	  
In	  this	  study	  we	  used	  5	  molecular	  representations	  and	  3	  classifiers.	  Our	  aim	  was	  to	  
select	  which	  combination	  of	  molecular	  representation	  and	  classifier	  yielded	  the	  best	  
classification	   results	   for	   metabolites.	   The	   classification	   results	   on	   the	   test	   set	   for	  
each	   combination	   are	   presented	   in	   Table	   3	   and	   visualized	   graphically	   in	   Figure	   5.	  
MDL	  Public	  Keys	  and	  RF,	  reporting	  99.84%	  sensitivity	  and	  88.79%	  specificity,	  achieve	  
best	   results.	   ECFP_4	   is	   the	   best	   performing	   molecular	   representation	   when	   used	  
with	  SVM,	  achieving	  99.55%	  sensitivity,	  while	  PP_desc	  achieves	  the	  highest	  AUC	  of	  
98.66%.	  MDL	  Public	  Keys	  also	  outperformed	  the	  other	  representations	  for	  NB,	  with	  a	  
sensitivity	   of	   96.71%,	   specificity	   of	   86.97%,	   and	   an	   AUC	   of	   97.99%.	   Another	  
representation	   that	  exhibits	  a	   solid	  performance	  across	   the	  whole	   study	   is	  ECFP_4	  
(which	   is	   in	   line	   with	   previous	   studies	   [65,	   66]).	   This	   fingerprint	   has	   the	   best	  
sensitivity	   for	   SVM,	   99.55%,	   the	   second	   best	   AUC	   for	   RF,	   99.07%,	   and	   the	   second	  
best	  sensitivity,	  97.15%,	  and	  AUC,	  94.25%	  for	  NB.	  A	  conceptually	  related	  fingerprint,	  
namely	   FCFP_4,	   shows	   surprisingly	   worse	   performance	   than	  MDL	   Public	   Keys	   and	  
ECFP_4	   fingerprints	   by	   having	   smaller	   AUC	   values	   for	   RF,	   SVM,	   and	   NB,	   98.16%,	  
94.19%,	   and	   80.80%	   respectively.	   Molecular	   descriptors,	   both	   PP_desc	   and	   Atom	  
Counts,	   perform	   well:	   PP_desc	   reports	   better	   AUC	   for	   RF	   and	   SVM,	   98.93%	   and	  
98.66%	   respectively,	   than	   FCFP_4,	   98.13%	   and	   94.19%	   respectively.	   Atom	   Counts	  
descriptors	  also	  outperform	  FCFP_4	  in	  SVM	  in	  terms	  of	  AUC,	  98.02%	  the	  former	  and	  
94.19%	   the	   latter.	  On	   the	  other	   hand,	   PP_desc	   and	  Atom	  Counts	   underperformed	  
when	  used	  with	  NB,	  where	  the	  AUC	  obtained	  was	  61.57%	  and	  58.95%,	  respectively.	  






Figure	  5	  Classification	  accuracy	  on	   the	   test	   set.	  Percentage	  of	   correctly	   classified	  molecules	  of	   the	   test	   set	   for	  
each	  combination	  of	  fingerprint	  and	  classifier.	  Sensitivity	  is	  in	  most	  cases	  larger	  than	  90%,	  except	  for	  FCFP_4	  and	  
SVM,	  and	  Atom	  Counts	  and	  PP_desc	  and	  NB.	  Specificity	  is	  larger	  than	  80%	  in	  most	  cases,	  except	  FCFP_4	  and	  NB.	  
It	  can	  be	  observed	  that	  metabolites	  are	  classified	  more	  accurately	  than	  non-­‐metabolites	  when	  using	  RF	  and	  SVM.	  
	  
	  
	   Random	  Forest	   SVM	   Naïve	  Bayes	   Average	  
	   Sensitivity	   Specificity	   AUC	   Sensitivity	   Specificity	   AUC	   Sensitivity	   Specificity	   AUC	   Sensitivity	   Specificity	   AUC	  
PP_desc	   99.17%	   88.60%	   98.93%	   96.82%	   88.93%	   98.66%	   42.51%	   86.56%	   61.57%	   79.50%	   88.03%	   86.39%	  
Atom	  
Counts	  
97.91%	   85.57%	   97.33%	   98.05%	   84.10%	   98.02%	   36.66%	   92.90%	   58.95%	   77.54%	   87.52%	   84.77%	  
ECFP4	   99.80%	   86.27%	   99.07%	   99.55%	   83.43%	   98.23%	   97.15%	   83.29%	   94.25%	   98.83%	   84.33%	   97.18%	  
FCFP4	   99.55%	   87.84%	   98.16%	   81.89%	   86.53%	   94.19%	   99.75%	   44.80%	   80.80%	   93.73%	   73.06%	   91.05%	  
MDL	   99.84%	   88.79%	   99.13%	   98.54%	   86.48%	   97.45%	   96.71%	   86.97%	   97.99%	   98.36%	   87.41%	   98.19%	  
Average	   99.26%	   87.41%	   98.52%	   94.97%	   85.90%	   97.31%	   74.56%	   78.90%	   78.71%	   89.59%	   84.07%	   91.52%	  
Table	   3	   Classification	   results	   of	   the	   test	   set.	   Results	   for	   the	   test	   set,	   including	   the	   percentage	   of	   correctly	  
classified	  metabolites	   (Sensitivity),	   the	   percentage	   of	   correctly	   classified	   non-­‐metabolites	   (Specificity)	   and	   the	  
Area	  Under	   the	  Curve	   (AUC).	   It	   can	  be	  observed	   that	   the	  best	   combination	  of	  descriptor	  and	  classifier	   is	  MDL	  
Public	   Keys	   and	   Random	   Forest	   and	   that	   the	   second	   best	   is	   ECFP_4	   fingerprints	   and	   Random	   Forest.	  
Interestingly,	  physicochemical	  descriptors	  (PP_desc)	  perform	  well	  both	  with	  Random	  Forest	  and	  Support	  Vector	  
Machines	  classifiers.	  (A	  molecule	  is	  considered	  metabolite	  if	  its	  metabolite-­‐likeness	  >	  50%)	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By	  looking	  at	  the	  average	  AUC	  results	  for	  the	  different	  representations	  we	  conclude	  
that	   MDL	   Public	   Keys	   (with	   98.19%)	   and	   ECFP_4	   (with	   97.18%)	   are	   the	   best	  
performing	   representations	   overall.	   If	  we	   observe	   the	   average	   results	   obtained	   by	  
the	   classifiers,	   RF	   outperforms	   SVM	   and	   NB	   in	   each	   category	   with	   averages	   of	  
99.26%	  sensitivity,	  87.41%	  specificity,	  and	  98.52%	  AUC.	  	  
	  
From	  the	  results	  presented	  in	  this	  work	  we	  see	  that	  with	  the	  optimal	  combination	  of	  
molecular	   descriptors	   and	   classifier,	   MDL	   Public	   Keys	   and	   RF,	   99.84%	   of	   the	  
metabolites	   and	   88.79%	   of	   the	   non-­‐metabolites	   in	   the	   test	   set	   are	   classified	  
correctly.	  These	  results	  are	  slightly	  better	  than	  those	  presented	  by	  Gupta	  et	  al.	  [28],	  
who	   reported	   97%	   correct	   predictions	   for	   KEGG	   metabolites	   using	   RF	   and	   global	  
molecular	   descriptors,	   which	   are	   similar	   to	   the	   PP_desc	   descriptors	   used	   in	   the	  
current	   work.	  While	   these	   97%	   correct	   predictions	   were	   achieved	   on	   the	   dataset	  
used	   to	   train	   the	   model,	   our	   99.84%	   correctly	   classified	   metabolites	   were	   not	  
employed	   in	  training	  the	  model.	   Interestingly,	   it	   is	  also	  observed	   in	  our	  predictions	  
that	   metabolites	   have	   a	   smaller	   false	   positive	   rate	   than	   non-­‐metabolites,	   which	  
reinforces	   the	   idea	   that	   it	   is	   easier	   to	   determine	   what	   makes	   a	   metabolite	   a	  
metabolite,	   than	   what	   makes	   a	   non-­‐metabolite	   a	   non-­‐metabolite.	   The	   ZINC	  
molecules	   that	  have	  been	  classified	  as	  metabolites	   (some	  of	   them	  shown	   in	  Figure	  
S4),	  form	  an	  interesting	  set	  for	  further	  research,	  since	  according	  to	  the	  models	  they	  
exhibit	  metabolite-­‐like	   features,	  which	  would	   give	   them	  an	   increased	   likelihood	  of	  
being	  bioactive	  in	  experimental	  screening	  [64].	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With	  respect	  to	  the	  classification	  algorithms,	  RF	  and	  SVM	  have	  demonstrated	  their	  
status	  as	   the	   ‘state	  of	   the	  art’	   in	  machine	   learning,	  as	  applied	   to	   this	  dataset.	  This	  
good	   performance	   comes	   however	   at	   the	   expense	   of	   having	   to	   optimize	  
metaparameters,	  which	  is	  more	  demanding	  for	  SVM,	  where	  finding	  the	  right	  gamma	  
and	  cost	  results	   in	  changing	  the	  value	  ranges	  multiple	  times.	  From	  this	  experience,	  
when	  facing	  a	  classification	  problem	  where	  objects	  are	  described	  by	  a	  large	  number	  
of	   variables	   and	   only	   a	   modest	   computational	   power	   is	   available,	   RF	   is	   a	   good	  
compromise.	  	  
	  
As	  seen	  in	  previous	  research,	  ECFP_4	  is	  a	  solid	  ‘all-­‐round	  performer’	  [65,	  66],	  which	  
obtains	  good	  results	  in	  combination	  with	  the	  different	  classification	  approaches.	  The	  
most	  surprising	  feature	  is	  that	  with	  simpler	  molecular	  representations	  than	  ECFP_4,	  
like	  MDL	  Public	   Keys	  or	   PP_desc	  molecular	   descriptors,	   one	   can	   achieve	   similar	   or	  
slightly	   improved	  results	   from	  the	  above,	  as	   it	  has	  been	  observed	  before	  [67].	  This	  
finding	  confirms	  the	   idea	  that	  (at	   least	  known)	   ‘Metabolite	  Space’	   is	  a	  well-­‐defined	  
subset	   of	   all	   ‘Chemical	   Space’,	   and	   that	   hence	   its	   diversity	   can	   be	   modeled	   with	  
success	  using	  either	  1D	  or	  2D	  descriptors.	  	  
	  
Apart	  from	  the	  discussion	  of	  general	  model	  performance	  we	  also	  investigated	  cases	  
where	   our	   model	   failed,	   which	   may	   be	   either	   due	   to	   wrong	   data	   annotation	   or	  
wrong	  predictions	  of	  the	  model.	  Figure	  6	  depicts	  false	  negative	  predictions,	  i.e.	  those	  
metabolites	   with	   a	   metabolite-­‐likeness	   value	   of	   50%	   or	   lower,	   and	   which	   were	  
therefore	  being	  considered	  as	  non-­‐metabolites	  in	  combination	  with	  the	  MDL	  Public	  
Keys	   and	   the	   RF	   classification	   method.	   Although	   these	   molecules	   would	   be	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considered	  non-­‐metabolites	  by	  our	  model,	  9	  out	  of	  10	  obtain	  a	  metabolite-­‐likeness	  
of	   40%	   or	   more.	   It	   is	   interesting	   to	   note	   that	   the	   lowest	   scoring	   compound,	  
debrisoquine	  with	  a	  score	  of	  35.4%,	   is	   in	   fact	  a	  drug.	  Since	   it	  was	  not	  described	  as	  
such	  by	  the	  HMDB	  taxonomy,	  our	  filtering	  step	  did	  not	  eliminate	  it.	  The	  same	  occurs	  
for	  entacapone,	  which	   is	   a	  drug	  and	  has	  a	  predicted	  metabolite-­‐likeness	  of	  48.8%.	  
Nevertheless,	  our	  classification	  method	  was	  able	  to	  assign	  to	  both	  drugs	  the	  lowest	  
metabolite-­‐likeness	   scores.	   Non-­‐endogenous	   compounds	   are	   also	   present	   in	   this	  
group	   of	   compounds,	   such	   as	   nicotine	   glucuronide,	   and	   4b-­‐Hydroxystanozolol,	   a	  
metabolite	  of	  the	  synthetic	  anabolic	  steroid	  stanozolol.	  In	  the	  same	  fashion,	  we	  find	  
in	   this	   set	   vanillylamine,	   with	   49%	   of	   predicted	   metabolite-­‐likeness,	   which	   is	   a	  
metabolite	   of	   the	   natural	   product	   Vanillin	   and	   which	   structure	   resembles	   the	  
endogenous	   metabolite	   4-­‐Methoxytyramine,	   which	   obtains	   a	   metabolite-­‐likeness	  
score	  of	  48.8%.	  Unfortunately,	  some	  endogenous	  metabolites	  like	  Uroporphyrin	  II,	  3-­‐
Methylhistamine,	   Melatonin,	   and	   Vitamin	   K1	   2,3-­‐epoxide,	   received	   a	   low	   score	  
without	   an	   obvious	   reason,	   and	   they	   are	   hence	   false-­‐negative	   predictions	   of	   our	  
model	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Figure	  6	  Metabolites	   in	  the	  test	  set	  predicted	  as	  non-­‐metabolites.	  The	  10	  only	  false	  negative	  metabolites	  from	  
the	  test	  set.	  These	  metabolites	  obtained	  a	  Metabolite-­‐likeness	  score	  smaller	  than	  50%,	  therefore	  being	  classified	  
as	  non-­‐metabolites,	  using	  the	  best	  model,	  MDL	  Public	  Keys	  and	  Random	  Forest.	  Debrisoquine	  obtains	  the	  lowest	  
score;	   it	   is	   a	   drug	   that	   was	   not	   taxonomically	   described	   as	   such.	   9	   out	   of	   10	   compounds	   have	   40%	   or	  more	  
metabolite-­‐likeness,	  which	  is	  very	  close	  to	  our	  cut-­‐off	  used	  to	  predict	  metabolites.	  
	  
Prospective	  Validation	  
Three	  prospective	  datasets	  containing	  metabolites,	  drugs,	  and	  small	  molecules,	  were	  
next	  classified	  using	  our	  two	  best	  performing	  models,	  using	  RF	  and	  either	  MDL	  Public	  
Keys	  or	  PP_desc.	  The	  results	  are	  displayed	  in	  Table	  4	  and	  indicate	  that	  95.84%	  of	  the	  
new	   metabolites	   (obtained	   after	   model	   training	   has	   been	   finished)	   are	   correctly	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classified	  as	  metabolites,	  indicating	  the	  generalizability	  of	  our	  model	  to	  classify	  new	  
data.	  As	  for	  the	  drugs	  (represented	  by	  DrugBank	  compounds),	  54.37%	  are	  assigned	  a	  
metabolite-­‐likeness	   of	   50%	  or	   higher,	  which	   is	   in	   accordance	  with	   our	   assumption	  
that	  many	  drugs	  indeed	  resemble	  metabolites	  (as	  has	  been	  presented	  before	  [64]).	  
For	  the	  third	  dataset,	  the	  screening	  compounds	  from	  ChEMBL,	  molecules	  predicted	  
to	   be	   metabolites	   only	   represent	   22.39%	   of	   the	   total	   dataset,	   hence	   a	   smaller	  
percentage	  than	  for	  drugs.	  	  
	  
	   RF	  Prediction	  
	   Metabolites	   Non-­‐Metabolites	  
HMDB_unofficial	   95.84%	   4.15%	  
DrugBank	   54.37%	   45.62%	  
ChEMBL	   22.39%	   77.61%	  
Table	  4	  Percentage	  of	  molecules	  classified	  as	  metabolites	  or	  non-­‐metabolites	  for	  three	  independent	  sets.	  95.84%	  
of	   independent	  metabolites	   are	   correctly	   classified.	  More	   than	   half	   of	   the	   drugs	   in	   DrugBank	   are	   considered	  
metabolites.	  Only	  22.39%	  of	  the	  screening	  compounds	   in	  ChEMBL	  are	  predicted	  as	  metabolites.	   (A	  molecule	   is	  
considered	  metabolite	  if	  its	  metabolite-­‐likeness	  >	  50%)	  
	  
In	   Figure	  7	   the	  distributions	  of	  metabolite-­‐likeness	   for	  each	  dataset	   are	   visualized.	  
We	  see	  that	  most	  of	  the	  new	  HMDB	  compounds	  (HMDB_unofficial)	  show	  high	  values	  
of	   metabolite-­‐likeness,	   while	   the	   ChEMBL	   molecules	   give	   values	   that	   are	  
accumulating	  at	  the	  lower-­‐scoring	  end	  of	  the	  distribution.	  The	  DrugBank	  molecules	  
on	  the	  other	  hand	  are	  evenly	  distributed	  among	  all	  the	  metabolite-­‐likeness	  ranges,	  
with	  slight	  peaks	  at	  both	  the	  metabolite-­‐like,	  as	  well	  as	  the	  non-­‐metabolite-­‐like	  end	  
of	  the	  spectrum.	  This	  result	  is	  in	  accordance	  to	  the	  work	  of	  Ertl	  et	  al.	  [68],	  where	  a	  
Natural	  Product-­‐Likeness	  score	  was	  reported	  after	  studying	  natural	  products,	  drugs,	  
and	   screening	   compounds.	   Natural	   products	   are	   molecules	   produced	   by	   living	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organisms,	   and	   therefore	   they	   can	   be	   regarded	   as	   to	   some	   extend	   similar	   to	   the	  
human	  metabolites	  we	  employed	   in	  our	  work.	   Ertl	   et	   al.	   concluded	   that	  drugs	  are	  
more	   similar	   to	   natural	   products	   than	   screening	   compounds,	   a	   similar	   finding	   to	  
what	  we	  have	  presented.	  This	  biogenic	  bias	  is	  also	  present	  in	  screening	  libraries,	  as	  
presented	  by	  Hert	  et	  al.	  [64];	  however,	  the	  wide	  spread	  of	  drugs	  along	  the	  spectrum	  
of	  metabolite-­‐likeness	  (in	  particular	  with	  slight	  peaks	  at	  either	  end	  of	  the	  scale)	  has	  
not	  been	  previously	  reported.	  
	  
Figure	  7	  Metabolite-­‐likeness	  distribution	  of	  the	  prospective	  validation	  sets.	  Distribution	  of	  predicted	  metabolite-­‐
likeness	  for	  the	  three	  classes	  of	  molecules	  in	  the	  prospective	  evaluation	  set	  using	  our	  best	  predicting	  model,	  RF	  
and	  MDL	   Public	   Keys	   (namely	  metabolites	   from	  HMDB,	   drugs	   from	  DrugBank	   and	   bioactive	   compounds	   from	  
ChEMBL).	   Most	   of	   the	   metabolites	   are	   predicted	   at	   a	   metabolite-­‐likeness	   of	   60%	   or	   higher.	   Most	   of	   non-­‐
metabolites	  from	  ChEMBL	  obtain	  low	  values.	  Drugs	  from	  DrugBank	  are	  spread	  across	  the	  whole	  range	  of	  values,	  
with	   higher	   concentrations	   at	   both	   ends,	   which	   indicate	   a	   presence	   of	   synthetic	   drugs,	   for	   low	   values,	   and	  
metabolite-­‐like	  drugs	  at	  high	  values.	  
While	   numerical	   performance	   is	   one	   thing,	   the	   chemical	   interpretation	   of	   model	  
predictions	   remains	   crucial.	   Hence,	   in	   order	   to	   explore	   further	   the	   results	   of	   the	  
prospective	  validation,	  molecules	  of	  the	  three	  different	  classes	  (metabolites,	  drugs,	  
bioactive	   compounds),	   which	   fall	   into	   different	   bins	   of	  metabolite-­‐likeness	   scores,	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are	  presented	  in	  Figure	  8.	  The	  first	  noticeable	  feature	  is	  the	  absence	  of	  a	  metabolite	  
with	  a	  predicted	  metabolite-­‐likeness	  smaller	  than	  10%,	  underlining	  the	  homogeneity	  
of	  metabolites	  as	  a	  class	   (as	  opposed	  to	  non-­‐metabolites).	  As	  a	  matter	  of	   fact,	   the	  
metabolite	  HMDB13193	  obtained	  the	  lowest	  metabolite-­‐likeness,	  17%,	  contains	  two	  
chlorine	  atoms,	  which	   is	  not	  common	   in	  metabolites.	  Another	   interesting	  situation	  
occurs	   with	   molecules	   that	   have	   a	   steroid	   scaffold,	   a	   common	   fragment	   in	  
endogenous	   metabolites.	   Metabolite	   HMDB12524	   and	   drug	   DB00180	   (flunisolide)	  
obtain	  metabolite-­‐likeness	   values	   of	   60.6%	   and	   52%,	   respectively.	   Here	   flunisolide	  
possesses	   a	   fluorine	   atom,	  which	   is	   not	   frequent	   in	  metabolites,	   and	  which	  might	  
have	   hence	   reduced	   its	  metabolite-­‐likeness	   score.	   Conversely,	   ChEMBL	   compound	  
CHEMBL1163241	  also	  has	  the	  steroid	  scaffold	  but	  obtains	  a	  score	  of	   just	  35.2%	  on	  
the	  metabolite-­‐likeness	   scale,	   corresponding	   related	   to	   having	   two	   fluorine	   atoms	  
and	  a	  secondary	  amine,	  features	  that	  the	  classification	  tree	  revealed	  to	  be	  common	  
in	   non-­‐metabolites.	   Finally,	   examples	   of	   compounds	  with	   high	   values	   of	   predicted	  
metabolite-­‐likeness	   are	   DB00131	   (adenosine	   monophosphate),	   DB00125	   (L-­‐
arginine),	  CHEMBL6422,	  and	  CHEMBL14568,	  which	  receive	  84.2%,	  99%,	  82.8%,	  and	  
96.8%	   respectively.	   Adenosine	   monophosphate	   includes	   the	   phosphate	   group,	  
frequently	   found	   in	   metabolites	   together	   with	   two	   hydroxyl	   groups.	   Metabolite-­‐
likeness	   features	   of	   L-­‐Arginine,	   like	   linearity	   and	   a	   carboxylic	   group,	   outweigh	   the	  
non-­‐metabolite	   features	   like	   the	  nitrogen	  containing	   functional	   groups.	  Compound	  
CHEMBL6422	   possesses	   a	   carboxylic	   acid	   and	   hydroxyl	   functionalities,	   while	   and	  
CHEMBL14568	  is	  small,	   linear,	  and	  also	  exhibits	  a	  hydroxyl	  group,	   leading	  to	  a	  very	  
high	  metabolite-­‐likeness	  score.	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Figure	   8	   Molecules	   of	   the	   prospective	   validation	   sets	   with	   different	   predicted	   metabolite-­‐likeness	   values.	  
Compounds	  of	   the	  3	  classes	  present	   in	   the	  prospective	  evaluation	  set	  using	  our	  best	  predicting	  model,	  RF	  and	  
MDL	   Public	   Keys,	   sorted	   according	   to	   their	   predicted	  metabolite-­‐likeness.	   Non-­‐metabolite	   compounds	   exhibit	  
moieties	  characteristic	  of	  metabolites	  like	  carboxylic	  acids	  and	  phosphate	  groups,	  which	  make	  them	  obtain	  high	  
values	  of	  metabolite-­‐likeness.	  	  
	  
The	  results	  obtained	  from	  the	  prospective	  validation	  demonstrate	  that	  our	  model	  is	  
successful	  at	  identifying	  whether	  a	  molecule	  is	  a	  metabolite	  or	  not,	  which	  we	  expect	  
to	   help	   studies	   that	   involve	   metabolite	   identification	   in	   the	   future.	   Furthermore,	  
metabolite-­‐likeness	   helps	   to	   detect	   non-­‐metabolites	   that	   exhibit	   features	  
characteristic	   of	   metabolites,	   which	   can	   be	   of	   interest	   for	   drug	   discovery	   In	   our	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future	  work,	  we	  will	  explore	  both	  of	  those	  avenues	  with	  results	  to	  be	  communicated	  
shortly.	  	  
	  	  
In	   this	   work	   we	   evaluated	   various	   machine-­‐learning	   models	   with	   respect	   to	   their	  
ability	  to	  discriminate	  metabolites	  from	  non-­‐metabolites,	  and	  hence,	  to	  calculate	  the	  
metabolite-­‐likeness	  score	  of	  a	  given	  molecule.	  Our	  best	  model	  detects	  99.84%	  of	  the	  
metabolites	   from	   the	   test	   set	   and	   95.84%	   of	   the	   metabolites	   from	   a	   prospective	  
validation	  set,	  hence	  underlining	  the	  applicability	  of	  the	  classifier	  to	  the	  majority	  of	  
novel	  metabolites.	  While	  we	  confirm	  that	  drugs	  are,	  on	  average,	  more	  metabolite-­‐
like	   than	  other	  compound	  classes,	  we	  noted	  a	  considerable	  spread	  of	  drugs	  across	  
the	  metabolite-­‐likeness	  spectrum,	  with	  two	  small	   (but	  distinct)	  peaks	  at	  either	  end	  
of	   the	   spectrum,	   illustrating	   that	   both	   synthetic	   molecules	   and	   metabolite-­‐like	  
compounds	  may	  become	   successful	   drugs.	  As	   for	   the	   application	   side,	  metabolite-­‐
likeness	  is	  a	  tool	  to	  rank	  compounds	  that	  ‘need’	  to	  resemble	  metabolites,	  which	  may	  
be	   (as	   above)	   certain	   types	   of	   drugs,	   but	   also	   in	   particular	   candidate	   structures	   in	  
metabolite	   identification.	   Given	   the	   performance	   of	   our	   model,	   we	   will	   now	  
continue	  with	  our	  work	  to	  apply	  our	  model	  in	  precisely	  those	  areas.	  Accordingly,	  we	  
expect	  to	  use	  this	  tool	   in	  metabolomics	  studies	  where	  no	  database	  match	   is	   found	  
for	   the	   unknown	   compound	   and	   therefore,	   candidate	   structures	   are	   generated	  
based	   on	   mass	   spectrometry	   data,	   e.g.	   elemental	   composition,	   using	   a	   structure	  
generation	   tool.	   These	   output	  molecules	  would	   be	   then	   ranked	   according	   to	   their	  
Metabolite-­‐Likeness.	   Furthermore,	   we	   have	   also	   studied	   which	   functional	   groups,	  
fragments,	  and	  physicochemical	  properties	  help	  describe	  the	  Metabolite	  Space.	  Our	  
findings	  give	  a	  general	   idea	  of	  what	  metabolites	  look	  like,	  but	  also	  encourage	  us	  to	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look	  closer	  at	  the	  different	  subclasses	  of	  metabolites	  and	  to	  explore	  the	  applicability	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   mtry	   Gamma	   Cost	  
PP_desc	   9	   4.768372e-­‐07	   32768	  
Atom	  Counts	   2	   4.882812e-­‐04	   262144	  
ECFP4	   10	   3.051758e-­‐05	   16	  
FCFP4	   30	   1.907349e-­‐06	   8192	  
MDL	   30	   1.907349e-­‐06	   8192	  
Table	  S1	  Optimal	  metaparameters	  for	  classifiers.	  mtry	  for	  Random	  Forest,	  Gamma	  and	  Cost	  for	  Support	  Vector	  
Machines,	  obtained	  after	  performing	  Cross	  Validation	  on	  the	  training	  set.	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   HMDB	   ZINC	   MeanDecreaseAccuracy	   MeanDecreaseGini	  
N_Count	   1.3067688	   1.2609013	   1.0014388	   46.898305	  
Molecular_Solubility	   1.2788442	   1.02582	   0.9656276	   96.271476	  
LogD	   1.2191826	   1.0680953	   0.9642439	   50.24542	  
Num_H_Donors	   1.3046778	   0.8545617	   0.9567927	   29.876567	  
Num_RotatableBonds	   1.012057	   1.17285022	   0.8988967	   26.85855	  
Molecular_Weight	   1.1004754	   0.99654993	   0.8885767	   31.778377	  
Minimized_Energy	   1.1796855	   0.69780848	   0.8681832	   32.409426	  
H_Count	   1.2011563	   0.24332713	   0.8579638	   24.73855	  
Molecular_PolarSurfaceArea	   1.1207631	   0.70494526	   0.8549427	   23.351115	  
ALogP	   0.9248217	   0.72155958	   0.7985026	   25.724204	  
Num_Atoms	   0.7790244	   0.76550378	   0.7354873	   20.597452	  
Num_H_Acceptors	   0.9853438	   0.35682066	   0.7293065	   10.555502	  
F_Count	   1.0559811	   -­‐0.08105052	   0.7200118	   5.685859	  
Num_Rings	   0.8475657	   0.73452855	   0.7184914	   24.290726	  
C_Count	   0.9386965	   0.62885999	   0.7131295	   41.595612	  
Num_AromaticRings	   0.7248383	   0.81406126	   0.6912011	   22.524017	  
O_Count	   0.8782411	   0.45284146	   0.6735855	   10.741794	  
S_Count	   0.7923043	   0.02593264	   0.4822221	   4.077548	  
Cl_Count	   0.7362878	   -­‐0.37414425	   0.3897458	   2.297109	  
P_Count	   -­‐0.133703	   0.35386364	   0.1807093	   0.980051	  
N_Count	   1.3067688	   1.2609013	   1.0014388	   46.898305	  
Table	   S3	   Importance	   given	   to	   the	   PP_desc	   descriptors	   by	   Random	   Forest.	   High	   values	   on	   Mean	   Decrease	  
Accuracy	  and	  in	  Mean	  Decrease	  Gini	  indicate	  that	  this	  variable	  is	  important	  to	  discern	  between	  metabolites	  and	  














	   HMDB	   ZINC	   MeanDecreaseAccuracy	   MeanDecreaseGini	  
MDLPublicKeys.140	   1.24138956	   1.229133216	   0.941920823	   53.91841097	  
MDLPublicKeys.126	   0.83892897	   0.70907696	   0.663644388	   23.62313439	  
MDLPublicKeys.163	   0.78447704	   0.746221036	   0.640603474	   23.23559085	  
MDLPublicKeys.50	   1.17048163	   1.023474316	   0.885259239	   15.04553608	  
MDLPublicKeys.143	   0.69289234	   0.696664822	   0.593501328	   14.91132605	  
MDLPublicKeys.108	   0.99957857	   0.489609227	   0.713694188	   14.48014674	  
MDLPublicKeys.157	   0.63767173	   0.675822066	   0.603715398	   13.07839857	  
MDLPublicKeys.123	   0.58418556	   0.407174217	   0.474627005	   13.02194646	  
MDLPublicKeys.146	   0.87558184	   0.687488161	   0.703815276	   12.6453885	  
MDLPublicKeys.95	   0.79652399	   0.624375878	   0.637617052	   10.20590729	  
MDLPublicKeys.135	   0.90220951	   0.439277352	   0.637256942	   9.92262443	  
MDLPublicKeys.145	   0.62671793	   0.411886181	   0.50576454	   8.80818597	  
MDLPublicKeys.122	   0.56884211	   0.176402217	   0.42077643	   8.25408405	  
MDLPublicKeys.132	   0.70757544	   0.285691095	   0.519554788	   6.57286614	  
MDLPublicKeys.138	   0.5532357	   0.466305805	   0.478651557	   6.54776274	  
MDLPublicKeys.128	   0.57303747	   0.41742079	   0.494394286	   6.48147908	  
MDLPublicKeys.53	   0.8537977	   0.309679345	   0.609916532	   6.05340169	  
MDLPublicKeys.82	   0.72725636	   0.393078873	   0.547102936	   5.88552798	  
MDLPublicKeys.76	   0.46225838	   0.21721732	   0.368584167	   5.84646577	  
MDLPublicKeys.140	   1.24138956	   1.229133216	   0.941920823	   53.91841097	  
MDLPublicKeys.126	   0.83892897	   0.70907696	   0.663644388	   23.62313439	  
Table	  S4	   Importance	  given	  to	  the	  MDL	  Public	  Keys	  by	  Random	  Forest.	  High	  values	  on	  Mean	  Decrease	  Accuracy	  
and	   in	  Mean	   Decrease	   Gini	   indicate	   that	   this	   variable	   is	   important	   to	   discern	   between	  metabolites	   and	   non-­‐
metabolites.	  These	  importance	  values	  have	  been	  obtained	  from	  the	  Random	  Forest	  model	  built	  with	  the	  training	  
set.	  
Component	   Atom	  Counts	   PP_desc	   MDL	  Public	  Keys	  
1	   25.44165	   33.29614	   11.54531	  
2	   44.54251	   57.11561	   18.74551	  
3	   58.67426	   66.05534	   23.8788	  
4	   71.17018	   71.99137	   28.55269	  
5	   82.20865	   77.25728	   32.71371	  
6	   92.29973	   82.01365	   36.04002	  
7	   98.71144	   86.32577	   38.95153	  
8	   100	   90.20601	   41.51726	  
Table	  S5	  Cumulative	  percentage	  of	  variance	  explained	  of	  the	  first	  8	  principal	  components.	  PCA	  was	  performed	  on	  
the	  Atom	  Counts,	  PP_desc,	  and	  MDL	  Public	  Keys	  datasets.	  


































































































































































































































































































































































































































































































































































































Figure S4 Non-metabolites predicted as metabolites. Some non-metabolites from the test set that obtained a Metabolite-
likeness score greater than 50%, therefore being classified as metabolites, using the best model, MDL Public Keys and 





4 An automated 













An	  automated	  pipeline	   for	  de	  novo	  
metabolite	  identification	  using	  mass	  
spectrometry-­‐based	  metabolomics	  
	  
Metabolite	   identification	   is	   one	   of	   the	   biggest	   bottlenecks	   in	   metabolomics.	  
Identifying	  human	  metabolites	  poses	  experimental,	   analytical	  and	  computational	  
challenges.	   Here	   we	   present	   a	   pipeline	   of	   previously	   developed	   cheminformatic	  
tools	  and	  demonstrate	  how	  it	  facilitates	  metabolite	   identification	  using	  solely	  LC-­‐
MSn	   data.	   These	   tools	   process,	   annotate,	   and	   compare	   MSn	   data,	   and	   propose	  
candidate	   structures	   for	   unknown	   metabolites	   either	   by	   identity	   assignment	   of	  
identical	  mass	   spectral	   trees	   or	   by	   de	   novo	   identification	   using	   substructures	   of	  
similar	   trees.	   The	   working	   and	   performance	   of	   this	   metabolite	   identification	  
pipeline	   is	   demonstrated	   by	   applying	   it	   to	   LC-­‐MSn	   data	   of	   urine	   samples.	   From	  
human	  urine,	  30	  MSn	  trees	  of	  unknown	  metabolites	  were	  acquired,	  processed	  and	  
compared	   to	   a	   reference	   database	   containing	   MSn	   data	   of	   known	   metabolites.	  
From	  these	  30	  unknowns,	  we	  could	  assign	  a	  putative	  identity	  for	  10	  unknowns	  by	  
finding	   identical	   fragmentation	   trees.	   For	   11	  unknowns	  no	   similar	   fragmentation	  
trees	  were	  found	  in	  the	  reference	  database.	  Based	  on	  elemental	  composition	  only,	  
a	   large	   number	   of	   candidate	   structures/identities	   were	   possible,	   so	   these	  
unknowns	   remained	  unidentified.	   The	  other	  9	  unknowns	  were	  also	  not	   found	   in	  
the	   database,	   but	   metabolites	   with	   similar	   fragmentation	   trees	   were	   retrieved.	  
Computer	  assisted	  structure	  elucidation	  was	  performed	  for	  these	  9	  unknowns:	  for	  
4	  of	  them	  we	  could	  perform	  de	  novo	  identification	  and	  propose	  a	  limited	  number	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of	  candidate	  structures,	  and	  for	  the	  other	  5	  the	  structure	  generation	  process	  could	  
not	  be	  constrained	  far	  enough	  to	  yield	  a	  small	  list	  of	  candidates.	  The	  novelty	  of	  this	  
work	  is	  that	  it	  allows	  de	  novo	  identification	  of	  metabolites	  that	  are	  not	  present	  in	  
a	  database	  by	  using	  MSn	  data	  and	  computational	  tools.	  We	  expect	  this	  pipeline	  to	  
the	   basis	   for	   the	   computer-­‐assisted	   identification	   of	   new	   metabolites	   in	   future	  
metabolomics	   studies,	   and	   foresee	   that	   further	   additions	   will	   allow	   identifying	  
even	  a	  larger	  fraction	  of	  the	  unknown	  metabolites.	  
	  
Metabolomics	  is	  the	  study	  and	  characterization	  of	  metabolites,	  which	  are	  the	  small	  
molecules	  (molecular	  weight	  below	  1000	  Daltons)	  of	  an	  organism,	  biofluid,	  tissue,	  or	  
biocompartment.	  Metabolites	  are	  substrates	  or	  products	  of	  metabolic	  processes	  and	  
therefore	   describe	   accurately	   the	   phenotype	   of	   an	   organism.[1]	   Metabolite	  
identification	  is	  frequently	  cited	  as	  one	  of	  the	  major	  bottlenecks	  in	  metabolomics.[2–
4]	  Knowing	  the	   identity	  of	  the	  metabolites	  that	  are	  relevant	   in	  studies	   is	  necessary	  
for	   a	   proper	   biological	   interpretation	   of	   the	   results.	   This	   work	   focuses	   on	   Mass	  
Spectrometry	   (MS)	   only	   rather	   than	   including	  Nuclear	  Magnetic	   Resonance	   (NMR)	  
because	  the	  former	  is	  more	  sensitive	  than	  the	  latter.	  	  
	  
While	   no	   agreement	   exists	   on	   how	   to	   perform	   metabolite	   identification,	   some	  
guidelines	  do	  exist	  that	  define	  how	  to	  report	  identities	  of	  metabolites.[5]	  The	  highest	  
reporting	   level	   is	   Level	   1,	   where	   an	   identity	   is	   proposed	   and	   validated	   using	   two	  
independent	   and	   orthogonal	   data	   sources	   relative	   to	   an	   authentic	   compound	  
analyzed	   under	   identical	   experimental	   conditions,	   for	   instance	   accurate	  mass	   and	  
Multi	  Stage	  Mass	  Spectrometry	  (MSn)	  spectra	  or	  retention	  time	  and	  m/z	  or	  MSn	  data.	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Level	  2	   is	  used	  for	  putatively	  annotated	  compounds,	  where	  an	  identity	   is	  proposed	  
based	   on	   MS/MS	   or	   MSn	   spectral	   similarity	   of	   the	   unknown	   to	   the	   spectra	   of	   a	  
known	   compound	   present	   in	   a	   database,	   but	   the	   identity	   is	   not	   validated	   with	  
chemical	   reference	   standards.	   Level	   3	   includes	   putatively	   annotated	   compound	  
classes,	  based	  on	  spectral	  similarity	  of	  the	  unknown	  to	  known	  compounds	  belonging	  
to	  a	  certain	  chemical	  class.	  Level	  4	  includes	  unknown	  compounds	  that	  can	  be	  traced	  
and	   quantified	   using	   spectral	   data	   in	   different	   experiments,	   but	   no	   structural	  
information	  has	  been	  reported	  before.	  At	  the	  beginning	  of	  an	  identification	  project	  
the	   unknown	   compounds	   can	   be	   divided	   into	   “known	   unknowns”	   and	   “unknown	  
unknowns”.[6]	  A	  known	  unknown	  is	  a	  compound	  that	  has	  been	  previously	  described	  
for	  a	  certain	  analytical	  platform,	   for	   instance	  by	  a	  certain	  mass	  and	  retention	  time	  
window,	   but	   that	   has	   not	   yet	   been	   identified	   in	   the	   current	   study.	   An	   unknown	  
unknown	  is	  a	  new	  compound	  that	  has	  not	  been	  previously	  described	  or	  identified.	  
	  
MS	   experiments	   yield	   the	   m/z	   of	   the	   compound,	   from	   which	   the	   mass	   can	   be	  
derived.	   For	   each	  mass,	   one	  or	  multiple	   elemental	   compositions	   are	   possible;	   and	  
the	   more	   accurate	   the	   mass	   is	   determined	   the	   fewer	   candidate	   elemental	  
compositions	  are	  obtained.	  The	  mass	  accuracy	  depends	  on	  the	  instrument	  employed	  
and	  even	  for	  high	  accuracies,	  such	  as	  in	  the	  low	  part	  per	  million	  (ppm)	  or	  sub-­‐ppm	  
range,	  unique	  elemental	  compositions	  cannot	  always	  be	  obtained.[7]	  The	  number	  of	  
possible	   elemental	   compositions	   can	   be	   reduced	   by	   incorporating	   information	   on	  
the	  other	  molecules	  present	  in	  the	  sample	  and	  the	  possible	  biotransformations	  that	  
could	  have	  occured.[8]	  Additionally,	  a	  database	  of	  ionization	  products	  and	  frequent	  
neutral	   losses	   when	   MS/MS	   data	   are	   available,	   can	   be	   used	   to	   annotate	   the	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elemental	   compositions	   of	   metabolites.[9]	   In	   the	   case	   a	   unique	   elemental	  
composition	  is	  available,	  multiple	  molecules	  can	  still	  be	  found	  with	  that	  composition.	  
Additional	   information	   of	   the	   compound	   can	   be	   obtained	   by	   performing	   MS/MS	  
experiments,	   where	   the	   compound	   is	   fragmented	   and	   the	   m/z	   of	   the	   resulting	  
fragments	   can	   be	   measured.	   These	   spectra	   can	   then	   be	   matched	   with	   existing	  
spectra	  databases	  for	  identity	  assignment	  or	  similarity	  search.[10]	  	  
	  
As	  an	  alternative,	  MSn	  data	  can	  be	  used	  to	  characterize	  a	  compound	  in	  more	  detail	  
by	   fragmenting	   it,	   detecting	   its	   fragments,	   isolating	   them	   and	   fragmenting	   them	  
multiple	   times.[11]	   The	   resulting	   information	   is	   a	  mass	   spectral	   tree	   of	   fragments	  
connected	   hierarchically	   to	   the	   original	   parent	   ion,[11,	   12]	   which	   contains	   more	  
structural	  information	  of	  the	  unknown	  compound	  than	  regular	  MS	  and	  MS/MS	  data.	  
MSn	  data	  can	  be	  processed	  and	  enriched	  with	  open	  source	  tools	  like	  the	  Multistage	  
Elemental	  Formula	  (MEF),[13]	  which	  creates	  a	  fragmentation	  tree	  where	  the	  parent	  
ion	  and	  each	  fragment	  ion	  are	  annotated	  with	  their	  elemental	  composition,	  instead	  
of	  the	  mass	  and	  a	  tree	  of	  neutral	   losses	  representing	  the	  fragmentation	  pattern	  of	  
the	  compound.	  Actually,	   this	   tool	  can	  be	  used	  to	  exclude	  many	  possible	  elemental	  
compositions	  for	  a	  given	  MSn	  tree,	  so	  that	  often	  only	  one	  elemental	  composition	  for	  
a	  spectral	  tree	  is	  obtained.	  
	  
Different	  approaches	  have	  been	  recently	  presented	  to	  query	  and	  compare	  spectral	  
data,	  most	  of	   them	  relying	  on	  concepts	  of	   fingerprint	   similarity.	  A	   fingerprint	   from	  
the	   fragmentation	   tree	   of	   an	   unknown	   compound	   is	   an	   array	   of	   features	   like	   the	  
elemental	  compositions	  of	  the	  fragments	  and	  the	  different	  branches,	  and	  it	   is	  used	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to	   query	   a	   database	   of	   known	   compounds,	   for	   which	   a	   fragmentation	   tree	  
fingerprint	   has	   been	   previously	   computed.	   The	   assumption	   for	   using	   fingerprint	  
similarity	  is	  that	  similar	  fragmentation	  trees	  are	  produced	  by	  similar	  compounds.[14]	  
Hypothetical	  fragmentation	  trees	  have	  been	  derived	  using	  a	  probabilistic	  model	  not	  
from	  MSn	  data,	  but	   from	  HPLC-­‐MS/MS[15]	  or	  GC-­‐TOF-­‐MS,[16]	   and	  used	   to	  build	   a	  
fingerprint	   comparison	   method[17]	   that	   could	   assign	   the	   class	   of	   unknown	  
compounds	   and	   in	   some	   cases	   the	   identity.	   	   A	   different	   approach[18]	   involved	  
building	  a	  spectral	   fingerprint	  directly	   from	  the	  MS/MS	  spectrum	  and	  relate	   it	   to	  a	  
fingerprint	  containing	  structural	  information	  of	  the	  molecule.	  Recently,	  Rojas-­‐Chertó	  
et	  al[14]	  developed	  a	  similar	  approach	  using	  MSn	  data	  to	  build	  fingerprints	  and	  use	  
them	   to	   query	   experimental	   MSn	   data,	   where	   the	   hierarchical	   relations	   between	  
fragments	   in	   the	   fragmentation	   tree	   were	   measured	   experimentally	   instead	   of	  
computationally	   simulated.	   These	   fingerprints	   were	   implemented	   in	   the	   web	  
application	  MetiTree	  to	  process,	  handle,	  store	  and	  analyse	  MSn	  spectra.[19]	  
	  
In	  the	  best	  case,	  querying	  fragmentation	  trees	  using	  fingerprint	  similarity	  can	  return	  
a	  perfect	  match	  if	  the	  unknown	  was	  present	  in	  the	  database,	  which	  would	  be	  a	  level	  
1	   identification	   of	   a	   “known	   unknown”	   (if	   the	   unknown	   and	   the	   standard	   were	  
measured	  in	  the	  same	  conditions).	  In	  a	  less	  favorable	  case,	  the	  unknown	  is	  not	  in	  the	  
database	  and	  it	   is	  necessary	  to	  propose	  candidate	  structures	  via	  computer	  assisted	  
structure	  elucidation	   (CASE)	   like	  our	  open	   source	   structure	   generator	  OMG.[20]	   In	  
such	   situations,	  Rojas-­‐Chertó	  et	   al[14]	   suggested	   to	  use	   the	   chemical	   structures	  of	  
the	   similar	   trees	   in	   the	   fragmentation	   tree	   database	   to	   create	   the	   maximum	  
common	  substructure	  (MCSS)	  under	  the	  assumption	  that	  the	  unknown	  metabolite,	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which	  belongs	  to	  the	  same	  class,	  will	  possess	  the	  same	  moiety.	  This	  MCSS	  together	  
with	  the	  elemental	  composition	  of	  the	  unknown	  could	  be	  the	   input	   for	  a	  structure	  
generator	   that	   would	   produce	   all	   the	   possible	   molecules	   complying	   with	   these	  
criteria.	   CASE	   has	   been	   used	   to	   identify	   pollutants	   and	   toxic	   compounds	   in	  
environmental	   samples	   by	   generating	   candidates	   with	   a	   structure	   generator	   like	  
MOLGEN	   and	   filter	   or	   rank	   them	   using	   specific	   criteria	   related	   to	   the	   problem	   at	  
hand.[21]	  In	  a	  similar	  fashion,	  Schymanski	  et	  al[22]	  initially	  used	  gas	  chromatography	  
coupled	   with	   electron-­‐ionization	   mass	   spectrometry	   (GC/EI-­‐MS)	   and	   possible	  
filtering	   criteria	   were	   the	   prediction	   of	   spectra	   using	   tools	   like	   MetFrag,[23]	  
retention	  index	  prediction	  and	  steric	  energy	  calculation,	  and	  in	  a	  posterior	  study[24]	  
a	  consensus	  score	  combining	  these	  criteria	  was	  used	  to	  rank	  candidate	  molecules.	  	  
	   	  
MSn	   data	   and	   software	   tools	   to	   process	   and	   evaluate	   these	   data	   have	   been	  
presented	  as	  the	  key	  factors	  of	  success	  for	  the	  identification	  of	  small	  molecules.[25]	  
Many	  cheminformatics	  tools	  that	  contribute	  to	  the	  elucidation	  of	  compounds	  have	  
been	   developed,	   but	   in	   the	   field	   of	   metabolite	   identification,	   they	   require	   the	  
unknown	   metabolite	   to	   be	   present	   in	   a	   database	   like	   PubChem.[26–28]	  
Furthermore,	   no	   combination	   of	   tools	   in	   a	   pipeline	   has	   been	   used	   for	   de	   novo	  
metabolite	   identification	   as	   it	   was	   done	   for	   environmental	   pollutants,	   which	   used	  
MS/MS	   data.	   Previous	   studies[29]	   used	   MSn	   to	   identify	   plant	   metabolites,	   but	  
required	  manual	   intervention	   and	   concluded	   that	   there	   is	   a	   need	   for	   pipelines	   of	  
chemoinformatics	  to	  improve	  metabolite	  identification.	  In	  the	  work	  presented	  here,	  
we	   combine	   different	   tools	   in	   a	   pipeline	   that	   enables,	   for	   the	   first	   time,	   de	   novo	  
identification	   of	   metabolites	   from	   MSn	   data	   as	   well	   as	   identity	   assignment	   in	   an	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automated	   fashion.	   In	   order	   to	   demonstrate	   the	   use	   of	   such	   an	   identification	  
pipeline,	  we	  acquired	  30	  mass	  spectral	  trees	  of	  metabolites	  present	  in	  human	  urine	  
and	  attempted	  to	  identify	  them	  with	  this	  pipeline.	  
	  
Materials	  and	  methods	  
Mass	   spectral	   trees	   were	   acquired	   for	   the	   features	   measured	   in	   human	   urine	  
samples.	  Details	  on	  analytical	  methods	  are	  provided	  in	  Supplementary	  Information.	  
More	   than	   450	  metabolite	   features	   representing	  most	   probably	  metabolites	  were	  
detected	  with	  deconvolution	  (using	  the	  software	  Dissect,	  Bruker	  Daltonics,	  Bremen,	  
Germany)	   in	   urine.	   Mass	   spectral	   trees	   were	   acquired	   for	   the	   30	   most	   abundant	  
peaks	   (Table	   S1)	   and	   processed	   with	   the	   metabolite	   identification	   pipeline	  
presented.	  The	   identities	  of	   these	  30	   features	  and	  their	   trees	  were	  unknown	  upon	  
selection.	   Our	   approach	   did	   not	   attempt	   to	   provide	   a	   comprehensive	   analytical	  
coverage	   of	   urine	   metabolites.	   The	   aim	   of	   this	   study	   was	   to	   illustrate	   how	   the	  
software	   pipeline	   can	   improve	   the	   identification	   of	   “known	   unknowns”	   and	  
“unknown	  unknowns”	  in	  metabolomics.	  	  
	  
Mass	  Spectral	  Tree	  Processing	  and	  MSn	  Database	  
The	  first	  step	  in	  the	  pipeline	  (Figure	  1)	  is	  to	  process	  and	  annotate	  the	  mass	  spectral	  
trees	   into	   fragmentation	   trees.	  Mass	   spectral	   trees	  were	  processed	  using	   the	  MEF	  
tool,[13]	   which	   resolves	   a	   unique	   elemental	   composition	   for	   each	   parent	   and	  
fragment	   ion,	  as	  well	  as	   for	   the	  neutral	   losses.	  The	  result	  of	  using	   the	  MEF	  tool	   to	  
process	   a	  mass	   spectral	   tree	   is	   a	   fragmentation	   tree	   and	   a	   neutral	   loss	   tree	   with	  
elemental	  compositions	  assigned	  to	  the	  nodes	  of	  the	  tree.	  An	  in-­‐house	  library	  of	  MSn	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data	  of	  reference	  metabolites	  was	  used	  as	  described	  by	  Rojas-­‐Chertó	  et	  al.[14]	  This	  
database	   contains	   fragmentation	   trees	   and	   neutral	   loss	   trees	   of	   447	   human	  
metabolites	   and	  118	  plant	  polyphenolic	  metabolites.	  All	  MSn	   spectra	   in	   the	   library	  
were	  processed	  with	  MEF	  tool.	  	  
	  
Figure	  1	  Metabolite	  identification	  pipeline.	  Abbreviations:	  MEF,	  Multistage	  Elemental	  Formula;	  EC,	  Elemental	  
Composition;	  FT,	  Fragmentation	  Tree;	  MCSS,	  Maximum	  Common	  Substructure;	  Sim,	  Similarity.	  
	  
Data	  Comparison	  and	  Fragmentation	  Tree	  Similarity	  Search	  
The	   30	   unknown	  metabolites	  were	   compared	   to	   the	   known	  metabolites	   stored	   in	  
the	  MSn	  database	  using	  the	  fragmentation	  tree	  fingerprint	  and	  similarity	  calculation	  
presented	  by	  Rojas-­‐Chertó	  et	  al.[14]	  A	  10%	  similarity	  or	  more	  was	  considered	  to	  be	  
relevant	  for	  identification	  purposes	  by	  educated	  guess.[14]	  In	  the	  case	  an	  unknown	  
compound	   has	   100%	   similarity	   with	   a	   metabolite	   in	   the	   database,	   we	   assign	   the	  
identity	   to	  the	  “known	  unknown”,	  which	   in	  our	  case	   is	   level	  1	   identification.	  When	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no	  metabolite	   is	   found	  with	  100%	  similarity,	  we	  are	   facing	   the	   identification	  of	   an	  
“unknown	  unknown”.	  	  In	  such	  case,	  multiple	  metabolites	  can	  be	  found	  with	  a	  certain	  
degree	   of	   similarity,	   which	   is	   class	   assignment	   (level	   3	   identification)	   if	   these	  
metabolites	   belong	   to	   the	   same	   class.	   Additionally,	   we	   used	   these	   similar	  
compounds	   to	   calculate	   the	   maximum	   common	   substructure	   (MCSS)	   they	   shared	  
and	  assumed	  it	  to	  be	  present	  in	  the	  structure	  of	  the	  unknown	  metabolite.	  	  
	  
Candidate	  Structure	  Generation	  
We	  used	   the	   structure	   generator	  Open	  Molecule	  Generator	   (OMG)[20]	   to	   in	   silico	  
generate	  all	  possible	  	  candidate	  structures	  for	  the	  unknowns	  (Figure	  2),	  taking	  as	  an	  
input	   the	   elemental	   composition	  of	   the	  unknown.	  OMG	  generates	   all	   the	  possible	  
chemical	  structures	  containing	  exactly	  those	  atoms.	  This	  list	  of	  candidates,	  even	  for	  
small	   elemental	   compositions,	   tends	   to	   contain	   millions	   or	   billions	   of	   possible	  
molecules.	  Optionally,	  one	  can	  force	  the	  output	  molecules	  to	  contain	  one	  or	  multiple	  
non-­‐overlapping	  prescribed	  substructures,	  which	  reduces	  drastically	   the	  number	  of	  
candidate	   structures	   generated.	   The	   bigger	   the	   substructure	   or	   the	   more	  
substructures	  used,	   the	   fewer	   candidates	   are	  produced.	   In	   this	  work,	  we	  used	   the	  
MCSS	  found	  in	  the	  similarity	  search	  to	  be	  present	  in	  the	  generated	  structures.	  	  




Figure	  2	  Structure	  generation	  and	  candidate	  rejection.	  Abbreviations:	  EC,	  Elemental	  Composition;	  MCSS,	  
Maximum	  Common	  Substructure.	  
Candidate	  Structure	  Filtering	  
We	  used	   three	   filters	   (Figure	   2)	   to	   remove	  unlikely	   candidate	   chemical	   structures:	  
steric	   energy,	   metabolite-­‐likeness,	   and	   fragmentation	   prediction.	   While	   OMG	  
produces	  candidate	  structures	  that	  are	  valid	  according	  to	  the	  valence	  rule,	  many	  are	  
unstable	  and	  therefore,	  unlikely	  to	  be	  found	  in	  a	  biological	  system.	  First,	  we	  used	  the	  
component	   “Molecular	   Energy”	   from	   Pipeline	   Pilot	   Student	   Edition	   6.1	   [30]	   to	  
calculate	  the	   internal	  energy	  of	  the	  generated	  structures	  and	  those	  with	  an	  energy	  
value	   of	   100	   or	   above	   were	   removed.	   This	   threshold	   value	   was	   selected	   after	  
observing	   that	   all	   the	   metabolites	   present	   in	   the	   Human	   Metabolome	   Database	  
(HMDB)[31]	   have	   energy	   values	   below	   100	   when	   calculated	   with	   the	   same	  
component.	   In	   order	   to	   use	   the	   energy	   score	   for	   further	   candidate	   ranking,	   we	  
scaled	  energy	  values	  to	  unit	  range	  between	  0%	  (for	  a	  candidate	  with	  energy	  value	  of	  
100)	  and	  100%	  (for	  the	  candidate	  with	  the	  lowest	  energy	  value).	  Second,	  we	  used	  a	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predictive	  model	  of	  Metabolite-­‐Likeness[32]	  to	  remove	  candidate	  structures	  that	  are	  
unlikely	   to	   structurally	   resemble	   human	  metabolites.	  We	   reported	   that	   almost	   all	  
known	  human	  metabolites	  obtain	  a	  Metabolite-­‐Likeness	  of	  50%	  or	  more.	  Therefore,	  
we	   set	   a	   conservative	  minimum	   threshold	   of	   60%	  Metabolite-­‐Likeness	   to	   consider	  
structures	   for	   further	   identification.	   Third,	   we	   used	   the	   spectra	   prediction	   tool	  
MetFrag[23]	  to	  remove	  candidates	  that	  cannot	  explain	  many	  of	  the	  peaks	  observed	  
in	  the	  experimental	  spectra.	  MetFrag	  uses	  as	  an	  input	  a	  list	  of	  molecules	  and	  a	  list	  of	  
the	  experimental	  spectral	  peaks,	  defined	  by	  the	  m/z	  and	  intensities.	  By	  cleavage	  of	  
bonds,	  MetFrag	  fragments	  the	  molecules	  and	  computes	  for	  each	  one	  how	  many	  of	  
the	   provided	   spectral	   peaks	   can	   be	   explained	   by	   the	   fragments.	   With	   this	  
information,	   a	   score	   is	   built	   describing	   how	   well	   each	   candidate	   molecule	   can	  
describe	   the	   experimental	   spectra.	  We	   used	   the	   settings	   of	   [M+H]	  mode,	   positive	  
charge,	  0.01	  Mzabs	  and	  10	  Mzppm.	  We	  rejected	  candidate	   structures	   that	  did	  not	  
obtain	  at	  least	  50%	  MetFrag	  score.	  Lastly,	  we	  combined	  the	  three	  scores	  in	  a	  unique	  
consensus	   score,	   as	   proposed	   by	   Schymanski	   et	   al[24]	   to	   rank	   the	   remaining	  
structures	  in	  order	  and	  prioritize	  them	  for	  further	  manual	  identification	  by	  an	  expert.	  	  
	  
Results	  
MSn	   spectral	   trees	   of	   30	   unknown	   metabolites	   acquired	   in	   human	   urine	   were	  
analyzed	   with	   the	   metabolite	   identification	   pipeline	   described	   in	   the	   Methods	  
section.	   The	   fragmentation	   trees	   of	   the	   unknowns	   were	   used	   to	   query	   the	   MSn	  
database	   for	   identical	   or	   similar	   fragmentation	   trees.	   From	   the	   30	   unknown	  
metabolites,	  10	  obtained	  a	  100%	  fragmentation	  tree	  similarity	  match,	  9	   found	  one	  
or	  more	  similar	  trees	  (10%	  <	  similarity	  value	  <	  100%)	  and	  11	  did	  not	  obtain	  a	  single	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hit	   in	   the	  database.	  At	   this	  stage,	   for	   these	  11	  unknowns	  we	  could	  only	  derive	  the	  
elemental	  composition	  from	  the	  data.	  Using	  OMG	  to	  generate	  candidate	  structures	  
for	   them	  would	   return	   billions	   of	   structures,	   therefore,	   these	   unknowns	  were	   not	  
studied	   further	   and	   remained	   unidentified.	   This	   indicates	   that	   the	   MSn	   database	  
used	  in	  this	  study	  should	  be	  enriched	  with	  more	  and	  varied	  metabolites.	  
	  	  
Identity	  Search	  
The	   database	   query	   returned	   a	   100%	   similarity	  match	   for	   10	   fragmentation	   trees	  
(Table	   S2).	   This	   is	   the	   highest	   possible	   similarity	   score	   and	   implies	   that	   both	   the	  
fragmentation	   tree	  and	  neutral	   loss	   tree	  are	   identical	   for	   the	  unknown	  metabolite	  
and	   the	   standard	   compound	   in	   the	   database.	   These	   10	   identified	  metabolites	   are	  
creatinine,	   acetaminophen,	   phenylalanine,	   7-­‐methylxanthine,	   uric	   acid,	   hippuric	  
acid,	  paraxanthine,	  o-­‐tyrosine,	  l-­‐acetylcarnitine	  and	  tryptophan.	  	  
	  
Both	  the	  authentic	  standards	  present	  in	  the	  database	  and	  the	  unknown	  metabolites	  
from	  urine	  were	  acquired	  using	  high	   resolution	  MS	  and	  MSn	   in	   the	  same	   lab	  using	  
the	   same	   equipment	   (as	   described	   in	  Methods).	   Hence,	  we	   are	   confident	   to	   have	  
achieved	  a	  full	  Level	  1	  identification	  as	  proposed	  in	  the	  MSI[5]	  for	  these	  10	  unknown	  
compounds.	   	  The	  authentic	  standards	  were	  acquired	  by	  direct	   infusion,	   in	  order	  to	  
obtain	  deep	  and	  wide	  mass	  spectral	  trees,	  containing	  as	  much	  structural	  information	  
as	   possible.	   Therefore,	   they	   miss	   an	   associated	   retention	   time.	   Ideally,	   these	  
standards	  should	  be	  measured	  in	  the	  same	  HPLC	  system	  as	  the	  unknowns	  in	  order	  to	  
have	  an	  extra	  analytical	  technique	  to	  support	  the	  full	   identification.	  It	   is	   interesting	  
to	   mention	   that	   despite	   being	   characteristic	   of	   the	   chemical	   structure,	   a	   mass	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spectral	  tree	  could	  theoretically	  not	  be	  unique	  for	  a	  given	  molecule,	  i.e.	  two	  isomeric	  
structures	   with	   the	   same	   elemental	   composition	   but	   different	   structure	   could	  
produce	  the	  same	  mass	  spectral	  tree.	  Hence,	  the	  need	  of	  complementary	  analytical	  
methods,	  like	  NMR,	  to	  validate	  the	  identification	  of	  metabolites.	  	  
	  
Similarity	  Search	  
For	   9	   of	   our	   20	   remaining	   unknown	   metabolites,	   we	   found	   in	   the	   database	  
metabolites	   with	   similar	   fragmentation	   trees.	   Three	   metabolites	   only	   found	   one	  
similar	  metabolite	   in	  the	  database.	   In	  such	  cases,	  we	  were	  neither	  able	  to	  propose	  
the	  class	  of	  the	  unknown	  nor	  to	  extract	  a	  maximum	  common	  substructure,	  since	  we	  
would	   need	   at	   least	   two	   similar	  metabolites	   of	   the	   same	   class.	   The	   only	   possible	  
course	   of	   action	   according	   to	   our	   pipeline	   was	   to	   generate	   candidate	   structures	  
using	   OMG	   for	   the	   elemental	   composition.	   Additionally,	   candidate	  molecules	   that	  
are	  structurally	  dissimilar	  to	  the	  metabolite	  in	  the	  database	  could	  be	  removed	  using	  
a	   chemical	   similarity	   filter,	   but	   this	   was	   out	   of	   the	   scope	   of	   the	   current	   work,	  
because	  the	  resulting	  list	  of	  candidates	  would	  be	  too	  large.	  Unknown	  16	  returned	  21	  
similar	  metabolites,	  which	   produced	   a	   very	   small	  MCSS	   (C-­‐C).	   Such	   a	  MCSS,	  when	  
used	   in	   OMG	   would	   not	   constrain	   the	   generation	   process	   and	   return	   billions	   of	  
candidate	   structures.	   Therefore	  we	   did	   not	   proceed	  with	   the	   identification	   of	   this	  
unknown.	  	  
	  
Identification	  of	  unknowns	  
Five	   unknowns	   returned	   two	   or	   three	   similar	  metabolites	   in	   the	   database.	   All	   the	  
similar	  metabolites	   are	   found	   in	   urine	   according	   to	  HMDB.	  We	   calculated	   a	  MCSS	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from	  these	  metabolites,	  generated	  structures	  using	  OMG	  and	  filtered	  the	  candidates	  
using	   the	   three	   filtering	   criteria.	   For	   unknown	   28,	   similarity	   search	   returned	   two	  
similar	  metabolites,	  with	  25%	  to	  3-­‐methoxytyramine	  and	  11%	  to	  sinapic	  acid	  using	  
fragmentation	  tree	  similarity	  (Table	  1).	  	  
	  
Unknown	   28	   9	   17	   15	   27	  
Candidate	  
Structures	  
6.8M	   150M	   Billions	   Billions	   Billions	  
EC	   Hits	   C9H10O2	   2	   C7H7NO4	   2	   C6H6N4O3	   2	   C9H9NO4	   2	   C9H13NO4P2	   3	  
Similar	  
Structures	  
	   	   	   	   	   	   	   	   	  
	   	  
Similarity	   25%	   11%	   19%	   11%	   18%	   10%	   24%	   12%	   32%	   30%	   13%	  
MCSS	  








8	   2,312	   4	   5	   182	  (40)	  
Table	  1	  De	  novo	  metabolite	   identification	  of	  “unknown	  unknown”	  metabolites	  that	  are	  not	  present	   in	  the	  MSn	  
database,	  but	  have	  a	  degree	  of	   fragmentation	   tree	   similarity	  with	  one	  or	  more	   fragmentation	   trees	  of	   known	  
metabolites	  in	  the	  database.	  Candidate	  structures	  are	  generated	  with	  Open	  Molecule	  Generator	  using	  the	  EC	  and	  
MCSS	  and	  filtered	  using	  energy,	  Metabolite-­‐Likeness	  and	  MetFrag.	  
	  
The	  MCSS	  used	  as	  prescribed	  substructure	  in	  the	  candidate	  generation	  process	  with	  
OMG	   returned	   only	   82	   molecules,	   instead	   of	   6.8	   million	   molecules	   if	   only	   the	  
elemental	   composition	  was	   used.	   This	   list	   of	   candidate	   structures	  was	   reduced	   by	  
using	   energy,	  metabolite-­‐likeness	   and	  MetFrag	   filters.	   This	   resulted	   in	   8	   candidate	  






Energy	   Met	  likeness	   MetFrag	   Consensus	  Score	  Candidate	  
Structure	  
HMDB	  /	  InChIKey	  
-­‐1.35	  (100%)	   81.0%	   99.5%	   93.5%	  
1	  
	   None	  /	  XNKMCBYYBMXTPO-­‐UHFFFAOYSA-­‐N	  
-­‐1.24	  
(99.9%)	  
80.8%	   94.4%	   91.7%	  
2	  
	   HMDB13744	  	  /	  YOMSJEATGXXYPX-­‐UHFFFAOYSA-­‐N	  
12.42	  
(86.41%)	  
68.6%	   93.4%	   82.8%	  
3	  
	  
None	  /	  QTPWGUHKASDDHO-­‐UHFFFAOYSA-­‐N	  
57.76	  
(41.86%)	  
75.4%	   93.6%	   70.2%	  
4	  
	  
None	  /	  HUYRKDVFJCZQOM-­‐UHFFFAOYSA-­‐N	  
64.07	  
(35.45%)	  
72.2%	   90.2%	   66.0%	  
5	  
	   None	  /	  WNOKBMFZDXCSRN-­‐UHFFFAOYSA-­‐N	  
61.54	  
(37.95%)	  
61.8%	   93.3%	   64.4%	  
6	  
	   None	  /	  YOYNEOCOGAQSSV-­‐UHFFFAOYSA-­‐N	  
83.35	  
(16.43%)	  
66.6%	   93.6%	   58.9%	  
7	  
	  
None	  /	  QVXRGADGDBVPIE-­‐UHFFFAOYSA-­‐N	  
94.26	  
(5.66%)	  
77.2%	   93.4%	   58.9%	  
8	  
	  
None	  /	  SYCBYIPPZGRLQD-­‐UHFFFAOYSA-­‐N	  
Table	  2	  Candidate	  structures	  for	  unknown	  28	  
	  
For	   unknown	   9,	   the	   database	   query	   returned	   two	   similar	   metabolites,	   with	  
fragmentation	   tree	   similarity	   of	   19%	   to	   hippuric	   acid	   and	   11%	   to	   isovalerylglycine	  
(Table	   1).	   OMG	   generates	   more	   than	   150	   million	   molecules	   for	   the	   elemental	  
composition	   of	   this	   unknown	   and	   using	   the	   MCSS	   derived	   from	   the	   similar	  
metabolites,	   this	   list	   is	   reduced	  to	  65,445	  compounds	  and	   filtered	   further	   to	  2,312	  
candidate	   structures,	  of	  which	  1,279	  obtained	  a	  CS	  of	  90%	  or	  higher.	   This	  made	  a	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selection	   of	   smaller	   list	   of	   candidate	   structures	   not	   feasible.	   For	   unknown	   17	   two	  
metabolites	  with	  similar	  fragmentation	  trees,	  18%	  similarity	  to	  1,3-­‐dimethyluric	  acid	  
and	   10%	   to	   1,3,7-­‐trimethyluric,	   were	   found	   in	   the	   database	   (Table	   1).	   OMG	  
generated	   a	  much	   smaller	   list	   of	   candidate	   structures,	   only	   4,	   using	   the	  MCSS	   as	  
constraint	  (Table	  3).	  	  
Energy	   Met	  likeness	   MetFrag	   Consensus	  Score	  Candidate	  
Structure	  
HMDB	  /	  InChIKey	  
18.91	  
(100%)	  	  
98.4%	   100%	   99.4%	  
1	  
	  
HMDB01970	  /	  ODCYDGXXCHTFIR-­‐UHFFFAOYSA-­‐N	  
21.09	  
(97.31%)	  
97.6%	   100%	   98.3%	  
2	  
	  
HMDB01973	  /	  XJEJWDFDVPDMAS-­‐UHFFFAOYSA-­‐N	  
21.49	  
(96.82%)	  
96.2%	   100%	   97.	  7%	  
3	  
	  
HMDB11107	  /	  YHNNPKUFPWLTOP-­‐UHFFFAOYSA-­‐N	  
18.98	  
(99.91%)	  
98.4%	   89.7%	   96.0%	  
4	  
	  
HMDB03099	  /	  QFDRTQONISXGJA-­‐UHFFFAOYSA-­‐N	  
Table	  3	  Candidate	  structures	  for	  unknown	  17	  
	  
Similarity	  search	  returned	  2	  metabolites	  similar	  to	  unknown	  15,	  with	  fragmentation	  
tree	  similarity	  of	  24%	  to	  hippuric	  acid	  and	  12%	  to	   isovalerylglycine.	  At	  this	  step	  we	  
observed	   three	   things:	   i)	   the	   elemental	   composition	   of	   the	   unknown	   was	   the	  
elemental	   composition	   of	   to	   hippuric	   acid	   with	   an	   extra	   oxygen	   atom;	   ii)	   the	  
fragmentation	   tree	   similarity	  of	   24%	  was	  due	   to	   the	  neutral	   loss	   tree,	  which	  were	  
identical	   for	   the	  unknown	  and	  the	  compound	   in	  the	  database,	   indicating	  that	  both	  
compounds	  had	  a	  similar	  structure	  and	  fragmentation	  pattern;	  iii)	  the	  fragmentation	  
tree	  measured	   for	   the	   unknown	  was	   almost	   identical	   to	   the	   one	   in	   the	   database,	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except	   for	   an	   additional	   oxygen	   atom	   in	   each	  of	   the	   fragment	   ions.	   This	   indicated	  
that	  the	  chemical	  structure	  of	  the	  unknown	  was	  the	  structure	  of	  hippuric	  acid,	  which	  
we	   used	   as	   MCSS	   (Table	   1),	   with	   an	   additional	   oxygen	   atom.	   OMG	   generated	   8	  
candidate	  molecules	  using	  the	  MCSS	  as	  constraint	  (Table	  4),	  which	  result	  of	  adding	  
one	   oxygen	   atom	   in	   all	   possible	   ways	   to	   hippuric	   acid.	   Further	   filtering	   using	   our	  
three	  criteria	  removed	  candidates	  6,	  7	  and	  8,	  which	  despite	  having	  favorable	  values	  
of	   energy	   score	   and	   metabolite-­‐likeness,	   were	   not	   able	   to	   explain	   any	   of	   the	  
experimental	   fragments	  and	   therefore	  MetFrag	  assigned	   them	  a	  0%	  score.	  A	  close	  
examination	   of	   the	   in	   silico	   fragments	   proposed	   by	  MetFrag	   for	   the	   experimental	  
fragment	  revealed	  that	  all	  of	   them	  contained	  a	  phenol	  group,	  a	   feature	  that	   is	  not	  
present	   in	   the	   three	   rejected	   candidates.	   Therefore,	  we	  propose	   that	  unknown	  15	  
has	   the	   same	   structure	   as	   a	   compound	   with	   an	   oxygen	   atom	   attached	   to	   the	  
benzene	   ring.	   The	   position	   of	   the	   oxygen	   in	   the	   phenol	   group	   remains	   unknown.	  
Additionally,	   NMR	   measurements	   of	   standards	   could	   be	   used	   to	   elucidate	   the	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Energy	   Met	  likeness	   MetFrag	   Consensus	  Score	  Candidate	  
Structure	   HMDB	  /	  InChIKey	  
-­‐1.51	  
(100%)	  
96.8%	   100%	   98.9%	  
1	  
	   HMDB06116	  /	  XDOFWFNMYJRHEW-­‐UHFFFAOYSA-­‐N	  
-­‐1.51	  
(100%)	  
96.8%	   100%	   98.9%	  
2	  
	  
HMDB06116	  /	  XDOFWFNMYJRHEW-­‐UHFFFAOYSA-­‐N	  
-­‐1.49	  
(99.99%)	  
96.8%	   100%	   98.9%	  
3	  
	  
HMDB13678	  /	  ZMHLUFWWWPBTIU-­‐UHFFFAOYSA-­‐N	  
-­‐1.39	  
(99.88%)	  
94.6%	   100%	   98.1%	  
4	  
	  
HMDB00840	  /	  ONJSZLXSECQROL-­‐UHFFFAOYSA-­‐N	  
-­‐1.39	  
(99.88%)	  
94.6%	   100%	   98.1%	  
5	  
	  
HMDB00840	  /	  ONJSZLXSECQROL-­‐UHFFFAOYSA-­‐N	  
-­‐1.11	  
(99.61%)	  
96.2%	   0%	   65.2%	  
6	  
	  
None	  /	  NVVKRZSRWCCEAU-­‐UHFFFAOYSA-­‐N	  
-­‐0.53	  
(99.03%)	  
98.2%	   0%	   65.7%	  
7	  
	  
HMDB02404	  /	  GCWCVCCEIQXUQU-­‐MRVPVSSYSA-­‐N	  
1.04	  
(97.49%)	  
87%	   0%	   61.5%	  
8	  
	  
None	  /	  FMYVYJPEMYKYRE-­‐UHFFFAOYSA-­‐N	  
Table	  4	  Candidate	  structures	  for	  unknown	  15	  
Similarity	   search	   for	   unknown	   27	   returned	   three	   metabolites	   with	   fragmentation	  
tree	  similarity	  of	  32%	  to	   l-­‐tyrosine,	  30%	  to	  o-­‐tyrsine,	  and	  13%	  to	  dl-­‐dopa	  (Table	  1).	  
OMG	   generated	   a	   list	   of	   281	   candidate	   structures	   using	   the	   MCSS,	   which	   was	  
reduced	  to	  182	  after	  filtering.	  We	  observed	  that	  two	  of	  the	  similar	  metabolites	  in	  the	  
database	  had	  a	  phenol	  (benzene	  ring	  with	  an	  attached	  oxygen	  atom)	  and	  the	  third	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one	  a	  catechol,	  (benzene	  ring	  with	  two	  attached	  oxygen	  atoms).	  Hence,	  we	  assumed	  
that	  our	  unknown	  also	  had	  at	  least	  one	  oxygen	  atom	  attached	  to	  the	  benzene	  ring.	  
We	  selected	  from	  the	  182	  candidates	  those	  that	  contained	  a	  phenol,	  which	  resulted	  
in	  a	  final	  list	  of	  40	  candidate	  structures.	  A	  P-­‐P	  bond	  was	  present	  in	  all	  the	  candidates,	  
which	  despite	  being	  a	  rarity	  among	  known	  metabolites	  did	  not	  penalize	  the	  scores	  
obtained	  by	   the	  molecules.	  This	  P-­‐P	  moiety	  would	   immediately	   raise	  an	  alarm	   flag	  
for	   any	  metabolite	   identification	   expert.	   It	   could	   be	   caused	   by	   poor	   experimental	  
acquisition	  of	  the	  mass	  spectral	  tree	  or	  by	  an	  incorrect	  assignment	  of	  the	  elemental	  
composition	   by	   MEF.	   Inspection	   by	   an	   expert	   determined	   that	   for	   a	   m/z	   of	  
262.03809	  MEF	   should	  produce	  an	  elemental	   composition	   like	  C9H13NO6P,	  which	  
belongs	  to	  phosphotyrosine,	  instead	  of	  C9H14NO4P2.	  Therefore,	  we	  confirmed	  that	  
the	  analytical	  conditions	  were	  identical	  for	  this	  unknown	  as	  for	  the	  other	  compounds	  
and	   that	   all	   the	   elemental	   compositions	   generated	   and	   forced	   MEF	   to	   use	   the	  
elemental	  composition	  C9H13NO6P	  for	  the	  parent	  ion,	  but	  it	  failed	  to	  annotate	  the	  
elemental	   compositions	   of	   the	   fragments.	   In	   other	   words,	   this	   elemental	  
composition	   could	   not	   explain	   the	   fragment	   ions	   measured	   experimentally.	   As	   a	  
result,	   we	   considered	   the	   experimental	   data	   and	   the	   elemental	   composition	  
C9H14NO4P2	   to	   be	   valid	   and	   all	   40	   candidates	   to	   be	   possible.	   Ideally,	   authentic	  
standards	  of	  them	  should	  be	  measured	  and	  compared	  with	  the	  spectral	  data	  of	  the	  
unknown.	  
	  
Tentative	  validation	  of	  MCSS	  assignment	  
We	   assessed	  whether	   the	   use	   of	   the	  MCSS	   and	   the	   filtering	   can	   lead	   to	   a	   wrong	  
identification	  or	   to	  miss	   the	   good	  molecule	   in	   the	   list	   of	   candidate	   structures.	  We	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applied	   the	   structure	   generation	   and	   filtering	   strategy	   to	   the	   10	   identified	  
metabolites.	   For	   only	   four	   of	   these	   metabolites	   similar	   trees	   were	   found	   in	   the	  
database	  and	  a	  MCSS	  could	  be	  generated	  	  (Table	  S3).	  We	  observed	  in	  each	  of	  these	  
four	  cases	  that	  the	  MCSS	  found	  is	  a	  substructure	  of	  the	  metabolite,	  with	  which	  OMG	  
generated	  among	  others	  the	  good	  structure.	  The	  filtered	  list	  of	  candidate	  structures	  
always	   contained	   the	   good	   molecule,	   which	   was	   ranked	   high	   according	   to	   the	  
consensus	   score	   in	   three	   of	   the	   four	   cases.	   In	   previous	  work[14],	   it	  was	   observed	  
that	  with	  a	  tree	  similarity	  below	  20%	  the	  MCSS	  obtained	  was	  not	  very	  informative.	  In	  
these	  four	  examples,	  the	  MCSS	  used	  were	  informative	  enough	  when	  obtained	  from	  
metabolites	  with	  at	  least	  12%	  tree	  similarity.	  When	  including	  metabolites	  with	  tree	  
similarity	  between	  12%	  and	  10%	  the	  MCSS	  was	  a	  carboxylic	  acid	   for	  unknowns	  22,	  
12,	   and	   18.	   For	   unknown	   28	   it	   was	   a	   benzene	   ring.	   These	   MCSS	   belong	   to	   the	  
metabolite,	  but	  OMG	  would	  return	  millions	  of	  candidates,	  therefore	  we	  did	  not	  use	  
them	   for	   further	   confirmation.	   From	   this	  we	  conclude	   that	   the	  use	  of	   the	  pipeline	  
can	  provide	   good	   candidate	   structures.	   Further	   validation	   should	   be	   performed	   to	  




The	   results	   presented	  demonstrate	  how	   this	  metabolite	   identification	  pipeline	   can	  
be	   used	   to	   identify	   metabolites	   using	   MSn	   data	   from	   human	   urine	   samples.	   This	  
workflow	  could	  be	  adapted	  to	  work	  with	  MS/MS	  data,	  although	  data	  processing	  and	  
similarity	   search	  of	   spectra	   should	  be	   then	  modified.	  Here	  we	  only	  used	  MSn	  data	  
and	  applied	  it	  to	  those	  features	  for	  which	  a	  similar	  fragmentation	  tree	  was	  present	  in	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the	  MSn	  database.	  Such	  MSn	  database	  can	  be	  used	   locally,	  MetiTree,[19]	  or	  online,	  
Massbank[33]	  and	  MzCloud.	  The	  number	  of	  metabolites	  that	  can	  be	  identified	  in	  this	  
way	   depends	   on	   how	   comprehensive	   the	   database	   of	   MSn	   is.	   Furthermore,	   we	  
showed	   for	   the	   first	   time	   how	   metabolites	   not	   present	   in	   a	   database	   could	   be	  
identified.	  	  
	  
Having	   substructure	   information	   is	   crucial	   to	   identify	  unknown	  metabolites.	   In	  our	  
case,	   we	   observed	   that	   using	   a	   large	   MCSS	   (or	   alternative	   multiple	   prescribed	  
substructures)	   reduced	   significantly	   the	   number	   of	   candidate	   structures,	   therefore	  
future	  work	   should	   focus	  on	  developing	  more	   reliable	  ways	  of	  generating	  more	  or	  
larger	  MCSS.	   In	  the	  case	  of	  unknown	  9,	   the	  MCSS	  found	  was	   linear,	  which	  allowed	  
for	  the	  formation	  of	  many	  rings	  and	  therefore,	  a	   list	  of	  more	  than	  2,000	  candidate	  
structures.	   For	   the	   same	   unknown	   and	   for	   unknown	   28	   we	   observed	   that	   the	  
filtering	  using	  energy,	  metabolite-­‐likeness	  and	  MetFrag	  yielded	  a	  10-­‐fold	   reduction	  
in	   the	   number	   of	   candidates,	   proving	   the	   value	   of	   incorporating	   these	   criteria.	   In	  
those	  cases	  where	  the	  MCSS	  described	  most	  of	  the	  structure	  of	  the	  unknown,	  OMG	  
produced	  a	   short	   list	  of	   candidates	  and	   this	  was	  not	   significantly	   reduced	  with	   the	  
filters,	  since	  most	  of	  the	  structures	  were	  acceptable.	  Additionally,	  more	  filters	  could	  
be	   added	   in	   the	   future	   depending	   on	   the	   data	   available,	   like	   retention	   time	  
prediction[34–36].	   Fragmentation	   prediction	   by	   MetFrag	   proved	   to	   be	   useful	   at	  
rejecting	   candidates,	   like	   for	   unknown	   15,	   that	   did	   not	   have	   an	   oxygen	   atom	  
attached	  to	  a	  ring	  but	  to	  a	  chain.	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The	  use	  of	  mass	  spectral	  trees	  was	  crucial	  to	  assign	  identities	  and	  to	  derive	  structural	  
information	  of	  the	  unknown	  metabolite	  from	  similar	  metabolites.	  We	  observed	  that	  
very	  similar	  metabolites	  could	  have	  low	  fragmentation	  tree	  similarity,	  because	  their	  
fragmentation	   trees	   were	   different.	   	   Fortunately,	   the	   structural	   resemblance	   was	  
captured	  in	  the	  neutral	   loss	  trees,	  which	  in	  some	  cases	  were	  identical	  between	  the	  
unknown	  and	  a	  similar	  metabolite,	  despite	  having	  different	  fragmentation	  trees.	  This	  
shows	  the	  importance	  of	  including	  neutral	  loss	  information	  in	  the	  fragmentation	  tree	  
fingerprint	   approach	   and	   encourages	   future	   research	   on	   how	   to	   better	   combine	  
fragmentation	  tree	  and	  neutral	  loss	  tree	  information	  for	  similarity	  search.	  	  
	  
Conclusion	  
In	   this	   work	   we	   have	   presented	   a	   pipeline	   that	   enables	   metabolite	   identification	  
using	  MSn	  data	  and	  that	  can	  be	  used	  in	  metabolomics	  studies	  involving	  experimental	  
data.	  Starting	  from	  the	  experimental	  MSn	  data	  of	  unknown	  metabolites,	  this	  pipeline	  
processes,	  annotates,	  and	  compares	  MSn	  data,	  and	  assigns	  the	  identity	  or	  provides	  a	  
few	  putative	  identities	  for	  de	  novo	  identification	  of	  unknown	  metabolites.	  	  
	  
By	  means	  of	  fragmentation	  tree	  similarity,	  this	  pipeline	  can	  assign	  the	  identity	  to	  an	  
unknown	  metabolite,	  provided	  its	  MSn	  spectra	  have	  been	  previously	  measured	  and	  
stored	  in	  a	  database.	  In	  the	  case	  this	  metabolite	  is	  not	  in	  the	  database,	  this	  pipeline	  
is	  capable	  of	  doing	  de	  novo	  metabolite	  identification	  by	  extracting	  common	  moieties	  
in	   similar	   compounds	   and	   using	   structure	   generation	   to	   propose	   candidate	  
structures.	  De	  novo	  identification	  is	  in	  itself	  the	  biggest	  contribution	  of	  this	  work	  to	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the	  field	  of	  metabolomics	  as	  the	  pipeline	  does	  not	  require	  the	  unknown	  metabolite	  
to	  be	  present	  in	  any	  database	  to	  propose	  a	  handful	  of	  possible	  structures.	  	  
	  
While	  the	  unknown	  is	  not	  required	  to	  be	  in	  a	  database	  to	  be	  identified,	  the	  number	  
of	   the	   candidate	   structures	   returned	  will	   be	   fewer,	   provided	   substructures	   of	   the	  
unknown	  can	  be	  discovered.	  Ideally,	  these	  substructures	  could	  be	  found	  by	  matching	  
subtrees	   of	   the	   unknown	   with	   a	   database	   of	   annotated	   MSn	   trees,	   i.e.	   where	   a	  
structure	  has	   been	   assigned	   to	   the	   fragment	   ions.	  Unfortunately,	   these	   annotated	  
databases	  are	  not	  yet	  available	  for	  MSn	  data,	  and	  therefore	  we	  searched	  for	  similar	  
metabolites	  to	  the	  unknown	  in	  the	  MSn	  database	  and	  generated	  the	  MCSS.	  On	  the	  
one	  hand,	   it	  appears	  necessary	  to	  enrich	  MSn	  databases	  with	  experimental	  data	  of	  
more	  and	  varied	  metabolites	  to	  increase	  the	  chances	  of	  finding	  similar	  metabolites.	  
On	   the	  other	  hand,	   finding	   too	  many	   compounds	  with	   similar	   fragmentation	   trees	  
can	   produce	   a	   small	  MCSS	   if	   the	   chemical	   structures	   are	   different,	   which	  will	   not	  
constrain	  enough	  the	  generation	  of	  candidate	  molecules.	  Therefore,	  it	  is	  interesting	  
to	   study	   better	   ways	   to	   find	   similar	   compounds,	   like	   an	   initial	   clustering	   of	   the	  
known	   metabolites	   and	   a	   posterior	   MCSS	   calculation	   within	   each	   cluster	   could	  
benefit	  de	  novo	  identification.	  Additionally,	  the	  similarity	  threshold	  of	  fragmentation	  
trees	   could	   be	   modified	   in	   order	   to	   obtain	   less	   similar	   compounds	   and	   as	  
consequence	  a	  larger	  MCSS,	  provided	  we	  have	  a	  rich	  and	  comprehensive	  database.	  
	  
To	   the	   best	   of	   our	   knowledge	   this	   is	   the	   first	   implementation	   of	   a	   metabolite	  
identification	   pipeline	   that	   enables	   identity	   assignment	   and	   de	   novo	   metabolite	  
identification	  and	  that	  makes	  use	  solely	  of	  LC-­‐	  MSn	  data,	  and	  we	  foresee	  that	  further	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additions	  such	  the	  ones	  proposed	  above	  will	  allow	  to	  identify	  even	  a	  larger	  fraction	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All	  reagents	  and	  chemicals	  were	  of	  HPLC	  grade	  purity	  or	  higher	  and	  purchased	  from	  
Sigma-­‐Aldrich.	  
	  
Human	  urine	  samples	  
Urine	  samples	  were	  collected	  from	  healthy	  volunteers	  (3	  males	  and	  2	  females)	  in	  the	  
morning.	  The	  samples	  were	  individually	  diluted	  with	  water	  in	  a	  ratio	  of	  1:1	  (v/v)	  to	  a	  
final	  volume	  of	  2	  mL.	  The	  samples	  were	  subsequently	  centrifuged	  at	  16,100	  rpm	  for	  
10	  min	  at	  10	  0C.	  The	  supernatant	  was	  collected.	  
	  
HPLC-­‐MS	  
LC	   separation	   was	   carried	   out	   on	   an	   Agilent	   1200	   LC	   system.	   Samples	   were	  
separated	  in	  an	  Atlantis	  C18	  T3	  column	  (Waters,	  100	  x	  2.1	  mm,	  3	  µm)	  using	  a	  mobile	  
phase	   linear	   gradient	   from	   98%	  water/2%	   acetonitrile	   +	   0.1%	   formic	   acid	   to	   98%	  
acetonitrile/2%	  water	   +	   0.1%	   formic	   acid.	   The	   injection	   volume	  was	   5	   µL	   and	   the	  
flow	  250	  µL/min.	  
	  
MS	   detection	   was	   carried	   out	   on	   a	   Finnigan	   LTQ-­‐Orbitrap	   XL	   instrument	   (Thermo	  
Electron	   Corp.).	   Electrospray	   ionization	   was	   carried	   out	   in	   the	   positive	   ionization	  
mode.	  Mass	  spectra	  were	  acquired	  in	  the	  centroid	  mode	  in	  the	  range	  m/z	  60-­‐1000	  at	  




The	   LTQ-­‐Orbitrap	   was	   adapted	   with	   a	   chip-­‐based	   nano-­‐electrospray	   ionization	  
source/fractionation	   robot	   (NanoMate	   Triversa,	   Advion	   BioSciences).	   The	   eluent	  
flow	  was	  split	  by	  the	  NanoMate,	  at	  249.075	  µL/min	  to	  the	  fraction	  collector	  and	  925	  
nL/min	  to	   the	  nano-­‐electrospray	  source.	  LC-­‐fractions	  were	  collected	  every	  5	  s	   (i.e.,	  
21	  µL)	  into	  a	  384	  wells	  plate	  (Twin	  tec,	  Eppendorf),	  cooled	  at	  100C.	  	  
	  	  	  
Mass	  spectral	  tree	  acquisition	  
The	   chip-­‐based	   nano-­‐electrospray	   ionization	   source	   (Triversa	   NanoMate,	   Advion	  
Biosciences)	   was	   also	   used	   for	   automated	   direct	   sample	   infusion	   of	   the	   collected	  
fractions	   into	   the	   LTQ-­‐Orbitrap.	  MSn	   data	  of	   the	   collected	   fractions	  were	   recorded	  
using	  a	  data-­‐dependent	  scanning	  function	  with	  the	  criteria	  to	  select	  the	  highest	  peak	  
and	  from	  this	  the	  five	  most	  intense	  ions	  detected	  for	  MS2	  and	  the	  three	  most	  intense	  
ions	  for	  the	  rest	  of	  the	  MSn	  levels.	  For	  signal	  averaging,	  the	  mass	  spectrometer	  was	  
set	   with	   five	   microscans.	   The	   Orbitrap	   was	   operated	   at	   30,000	   resolution,	   a	  
normalized	  collision	  energy	  of	  35%	  and	  an	  isolation	  window	  of	  1	  Th.	  
Unknown	   m/z	   Elemental	  Composition	  [M+H]	   Depth	  of	  tree	  #	  fragments	  
1	   227.0775	   C8H11N4O4	   MS4	   16	  
2	   243.13405	   C11H19N2O4	   MS5	   33	  
3	   271.07492	   C11H15N2O4S	   MS5	   36	  
4	   313.08582	   C13H17N2O5S	   MS5	   132	  
5	   447.10675	   C21H23N2O5S2	   MS5	   28	  
6	   146.08102	   C6H12NO3	   MS3	   5	  
7	   152.07057	   C8H10NO2	   MS2	   2	  
8	   167.05627	   C6H7N4O2	   MS2	   2	  
9	   170.04449	   C7H8NO4	   MS4	   8	  
10	   181.06073	   C8H9N2O3	   MS4	   11	  
11	   265.11835	   C13H17N2O4q	   MS5	   40	  
12	   180.06531	   C9H10NO3	   MS4	   7	  
13	   204.12299	   C9H18NO4	   MS3	   8	  
14	   197.06703	   C7H9N4O3	   MS4	   9	  
15	   196.06024	   C9H10NO4	   MS4	   7	  
16	   185.09195	   C8H13N2O3	   MS4	   17	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17	   183.05112	   C6H7N4O3	   MS3	   6	  
18	   182.08107	   C9H12NO3	   MS5	   19	  
19	   169.03558	   C5H5N4O3	   MS4	   10	  
20	   205.09718	   C11H13N2O2	   MS5	   10	  
21	   181.07181	   C7H9N4O2	   MS3	   4	  
22	   166.08606	   C9H12NO2	   MS4	   9	  
23	   268.1	   C10H14N5O4	   MS2	   2	  
24	   114.06562	   C4H8N3O	   MS2	   1	  
25	   144.10164	   C7H14NO2	   MS2	   2	  
26	   195.06522	   C4H12N4O3P	   MS4	   12	  
27	   262.03809	   C9H14NO4P2	   MS5	   34	  
28	   151.07513	   C9H11O2	   MS3	   8	  
29	   271.16553	   C13H23N2O4	   MS5	   38	  
30	   310.20163	   C17H28NO4	   MS4	   40	  
Table	  S1	  30	  MSn	  	  trees	  of	  unknown	  metabolites	  acquired	  from	  human	  urine,	  with	  retention	  time,	  m/z,	  elemental	  
composition,	  MS	  level	  achieved	  and	  number	  of	  fragments	  in	  the	  fragmentation	  tree.	  
	  
 
Unknown	   24	   7	   22	   8	   19	   12	   21	   18	   13	   20	  












































	   	   	   	   	   	   	   	   	   	  
Table	  S2	  10	  Identified	  metabolites	  that	  are	  found	  in	  the	  MSn	  database	  with	  100%	  fragmentation	  tree	  similarity.	  












Unknown	   22	   12	   18	   20	  
Structure	  
	   	   	   	  
EC	   Hits	   C9H10O2	   11	   C9H9NO3	   2	   C9H11NO3	   8	   C11H12N2O2	   4	  
Similar	  
Structures	  
	   	   	   	   	   	   	   	   	   	  
Similarity	   27%	   15%	   24%	   12%	   86%	   19%	   12%	   44%	   15%	   13%	  
MCSS	  








43	   419	   8	   952	  
Rank	   4th	   1st	   7th	   217th	  
Table	   S3	   Validation	   of	   the	  MCSS	   assignment	   on	   4	   identified	   metabolites.	   The	   metabolite	   contains	   the	  MCSS	  
















De	   novo	   identification	   of	  
metabolites	   with	   open	   molecule	  
generator	  for	  metabolomics	  
	  
Metabolite	   identification	   is	   a	   major	   bottleneck	   in	   metabolomics.	   Proposing	  
chemical	  structures	  for	  unknown	  metabolites	  is	  essential	  to	  give	  interpretation	  to	  
scientific	  results	  and	  it	  requires	  new	  software	  tools.	  We	  have	  implemented	  PMG,	  
an	  open	  source	  parallel	  structure	  generator,	  especially	  designed	  for	  metabolomics.	  
It	   is	   an	  extended	  version	  of	  OMG,	   the	  earlier	   released	   structure	  generator.	  PMG	  
produces	   molecules	   faster	   than	   OMG,	   it	   accommodates	   multiple	   prescribed	  
substructures	   and	   it	   removes	   unstable	   structures	   using	   a	   bad	   list	   of	   rings	   and	  
substructures	   that	  are	  not	   found	   in	  human	  metabolites.	   These	   substructures	   can	  
be	   obtained	   from	   different	   sources	   like	   MSn,	   NMR,	   and	   manual	   annotation	   or	  
library	   search.	   PMG	   has	   been	   tested	   using	   elemental	   compositions	   and	  
substructures	  of	  known	  human	  metabolites	  as	  well	  as	  unknown	  metabolites	  found	  
in	  human	  urine.	  The	  new	  PMG	  algorithm	  represents	  a	  100-­‐fold	   increase	   in	  speed	  
versus	  OMG	  in	  most	  cases,	  while	  the	  use	  of	  bad	  rings	  and	  bad	  substructures	  yields	  
a	  10-­‐fold	  reduction	  of	  candidate	  structures	  in	  the	  best	  cases.	  In	  all	  of	  the	  test	  cases	  
the	   good	   chemical	   structure	   is	   returned	   in	   the	   list	   of	   candidate	   structures.	   We	  
expect	   PMG	   in	   its	   current	   form	   to	   significantly	   contribute	   to	   the	   de-­‐novo	  
identification	  of	  metabolites	  and	  due	  to	  its	  open	  source	  nature,	  to	  be	  the	  core	  of	  
future	  metabolomics	  identification	  software.	  In	  addition,	  PMG	  can	  be	  also	  used	  for	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the	  de-­‐novo	  identification	  of	  other	  molecules	  than	  metabolites	  or	  applied	  in	  other	  
applications	  requiring	  a	  structure	  generator.	  
	  
One	   of	   the	   major	   bottlenecks	   in	   metabolomics	   is	   metabolite	   identification,	   the	  
precise	   elucidation	   of	   the	   chemical	   structure	   of	   a	   metabolite.[1–3]	   When	   an	  
unknown	   metabolite	   is	   not	   present	   in	   reference	   molecular	   databases,	   a	   de	   novo	  
identification	   of	   the	   metabolite	   is	   necessary,	   and	   one	   needs	   other	   tools	   and	  
algorithms	   than	   library	   searches.	  Mass	   spectrometry	   (MS)	   is	   a	   common	   analytical	  
tool	  used	  in	  metabolomics.	  It	  returns	  the	  mass	  over	  charge	  ratio	  (m/z)	  of	  an	  ion	  (or	  
more	  ions)	  after	  ionization	  of	  a	  molecule,	  from	  which	  elemental	  compositions	  (ECs)	  
can	  be	  derived.	   In	  addition	  multi	   stage	  mass	   spectrometry	   (MSn)	  has	  been	  used	   in	  
metabolite	   identification	   [4,	   5]	   since	   it	   offers	   substructure	   information	   of	   the	  
unknown	  molecule	  by	  fragmenting	  ions	  subsequently	  	  into	  smaller	  ions.	  With	  such	  a	  
strategy,	  the	  information	  obtained	  for	  an	  unknown	  molecule	  is	  its	  EC	  and	  sometimes	  
one	   or	  more	   substructures.	   In	   order	   to	   generate	   candidate	   chemical	   structures	   of	  
the	   unknown	  metabolite	   the	   use	   of	   a	   structure	   generator	   (ideally	   open	   source)[6]	  
like	  the	  recently	  introduced	  Open	  Molecule	  Generator	  (OMG)[7]	  is	  obviously	  a	  very	  
attractive	  option.	  	  
	  
A	  structure	  generator	  receives	  as	   input	  the	  elemental	  composition	  of	  the	  unknown	  
and	   optional	   constraints,	   like	   wanted	   and	   unwanted	   substructures,	   to	   limit	   the	  
search	   space.	   Ideally,	   a	   structure	   generator	   produces	   all	   the	   possible	   molecules	  
without	  duplicates.	  Structure	  generation	  is	  a	  combinatorial	  problem	  that	  can	  lead	  to	  
a	   computational	   explosion	   in	   order	   to	   get	   complete	   results.	   In	   practice,	   it	   is	  more	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desirable	   to	   get	   a	   short	   list	   of	   realistic	   candidate	   structures,[4]	   which	   in	   any	   case	  
contains	   the	   structure	   of	   the	   unknown,	   at	   the	   cost	   of	   longer	   computational	   time,	  
than	  a	  long	  list	  of	  (mostly)	  unrealistic	  structures.[8]	  A	  short	  list	  of	  candidates	  is	  easier	  
to	   check	   manually	   by	   an	   expert	   and	   to	   filter	   computationally.	   Ultimately,	   the	  
structure	  generator	  should	  return	  one	  or	  a	  handful	  of	  candidate	  structures,	  allowing	  
the	  experimental	  validation	  of	  the	  proposed	   identity	  of	  the	  unknown	  molecule.	  On	  
the	  downside,	   including	  more	   constraints	   in	   the	   generation	  process	   requires	  more	  
computation	   time.	   Some	   constraints	   can	   be	   evaluated	   for	   non-­‐finished	  molecules	  
during	   the	   generation	   process	   and	   other	   constraints	   can	   be	   evaluated	   only	   for	  
complete	  molecules.	  In	  either	  case,	  these	  checks	  add	  to	  the	  number	  of	  computations	  
performed	   per	   molecule.	   The	   use	   of	   faster	   computers	   or	   faster	   algorithms	   can	  
circumvent	  the	  impact	  of	  this	  increase	  in	  computation	  time.	  
	  
In	  our	  earlier	  work	  with	  OMG	  [7]	  we	  observed	  that	  executing	  in	  parallel	  the	  structure	  
generator	  calculations	  was	  possible	  but	  would	  not	  be	  the	  ultimate	  solution	   for	   the	  
poor	  speed	  performance	  of	  OMG	  compared	  to	  the	  commercial	  structure	  generator	  
MOLGEN[9].	   The	   original	   OMG	   code	   generated	   molecules	   using	   the	   canonical	  
augmentation	   path	   approach,	   which	   required	   the	   calculation	   of	   the	   canonical	  
representative	  of	   each	   graph	   (two	   isomorphic	   graphs	  or	  molecules	   have	   the	   same	  
canonical	  representative).	   	   It	   is	  known	  in	  graph	  theory	  that	  obtaining	  the	  canonical	  
representative	  of	  a	  graph	  is	  more	  complex	  than	  checking	  if	  the	  graph	  is	  the	  canonical	  
representative.[10,	   11]	   Therefore,	   removing	   the	   use	   of	   the	   graph	   canonizer	   and	  
using	   a	   computationally	   cheaper	   canonicity	   test	  was	   a	   logical	  way	   to	   improve	   the	  
performance	  of	  our	  algorithm.	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In	  computer	  assisted	  structure	  elucidation,	  constraints	  like	  prescribed	  substructures	  
or	   required	   physicochemical	   properties	   are	   often	   used	   to	   reduce	   the	   number	   of	  
generated	   molecules	   at	   the	   expense	   of	   increasing	   the	   computation	   time.	   Such	  
constraints	  can	  be	  used	  to	  reject	  unwanted	  molecules	  while	  they	  are	  generated	  or	  
after	  all	   the	  molecules	  have	  been	  produced,	  the	  former	  being	   less	  computationally	  
demanding	   than	   the	   latter.	   In	   a	   previous	   metabolomics	   study,[4]	   substructure	  
information	   was	   indispensable	   to	   turn	   the	   identification	   of	   unknown	   metabolites	  
into	  a	  tractable	  problem.	  In	  addition,	  posterior	  filtering	  of	  unstable	  molecules	  based	  
on	   high	   values	   of	   force	   field	   internal	   energy	   and	   on	   low	   metabolite-­‐likeness[12]	  
prediction	  yielded	  a	  short	  list	  of	  candidate	  structures.	  	  
	  
This	  work	  extends	  upon	  previous	  studies	  in	  which	  we	  introduced	  OMG,[7]	  and	  upon	  
lessons	  learned	  after	  attempting	  to	  identify	  human	  metabolites	  using	  an	  automated	  
pipeline	   of	   software	   tools	   and	   MSn	   data.[4]	   We	   observed	   the	   need	   for	   a	   faster	  
algorithm,	   which	   should	   as	   well	   accommodate	   more	   constraints	   derived	   from	  
metabolomics	  analytical	  data	  to	  generate	  a	  shorter	  list	  of	  candidate	  structures.	  Here	  
we	  present	  Parallel	  Molecular	  Generator	  (PMG),	  an	  improved	  OMG,	  a	  generic	  open	  
source	   multi-­‐core	   structure	   generator	   for	   metabolomics.	   It	   takes	   as	   an	   input	   the	  
elemental	   composition	   of	   the	   unknown,	   and	   optionally	   several	   prescribed	  
substructures,	   a	   list	   of	   bad	   rings	   and	   lists	   of	   good	   and	   bad	   substructures.	   PMG	  
accommodates	  a	  faster	  canonization	  algorithm	  and	  allows	  the	  use	  of	  multiple	  CPUs.	  
Its	   open	   source	   nature	   allows	   users	   to	   implement	   other	   constraints	   that	   are	  
adequate	   for	   their	   requirements.	   We	   assessed	   the	   speed	   improvement	   and	   the	  
effect	   of	   (i)	   using	   multiple	   cores	   generating	   candidate	   structures	   for	   elemental	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compositions,	   (ii)	   constraining	  with	   bad	   rings	   and	   bad	   substructures,	   and	   (iii)	  with	  
and	   without	   prescribed	   substructures.	   In	   order	   to	   demonstrate	   how	   the	   input	   of	  
elemental	  compositions	  and	  substructures	  are	  used	  by	  PMG,	  two	  different	  test	  sets	  
were	  used.	  The	  first	  set	  contained	  elemental	  compositions	  from	  known	  metabolites	  
present	   in	   the	   Human	   Metabolome	   Database	   (HMDB)[13]	   and	   the	   substructures	  
were	   drawn	   using	   Marvin.[14]	   The	   second	   set	   contained	   known	   and	   unknown	  
metabolites	   measured	   in	   human	   urine,	   for	   which	   the	   elemental	   composition	   was	  
obtained	   using	   the	   Multi-­‐stage	   Elemental	   Formula	   (MEF)	   tool[15]	   and	   the	  
substructures	   were	   derived	   using	  MSn	   data,	   fragmentation	   tree	   similarity[16]	   and	  
the	  maximum	  common	  substructure	  (MCSS)	  approach.	  We	  present	  the	  effect	  in	  time	  
and	   number	   of	   generated	  molecules	  when	   using	   PMG	   in	  multiple	   processors	  with	  
and	  without	  constraints.	  We	  demonstrate	  how	  PMG	  can	  contribute	  to	  transform	  the	  
identification	  challenge	  of	  an	  unknown	  metabolite	  into	  a	  solvable	  problem.	  	  
	  
Materials	  and	  methods	  
Structure	  Generation	  Via	  Orderly	  Generation	  
There	  are	  many	  approaches	  to	  generate	  a	  complete	  set	  of	  non-­‐duplicate	  molecules,	  
like	  the	  homomorphism	  principle	  used	  by	  MOLGEN,	  the	  orderly	  generation	  [17,	  18]	  
and	   the	   canonical	   augmentation	   path	   proposed	   by	   McKay[19].	   Brinkman[20],	  
Faulon[21]	  	  and	  Meringer[22]	  provided	  a	  simple	  description	  of	  these	  methods.	  
	  
Structure	   generation	  with	  OMG[7]	   can	  be	   regarded	   as	   a	   search	   tree	  with	  multiple	  
levels	   where	   the	   root	   contains	   the	   atoms	   of	   the	   elemental	   composition	   without	  
bonds	   and	   the	   leaves	   or	   end	   points	   of	   the	   tree	   represent	   complete	  molecules.	   It	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follows	   an	   algorithm	   first	   proposed	   by	   Faulon[21],	   where	   at	   each	   level	   a	   bond	   is	  
added	   to	   the	   intermediate	   molecules.	   The	   structure	   generator	   should	   return	   all	  
possible	   valid	  molecules	  without	   duplicates.	   In	   order	   to	   improve	   the	   speed	   of	   the	  
algorithm	  used	  in	  OMG	  two	  strategies	  are	  devised:	  i)	  usage	  of	  faster	  computational	  
techniques	  to	  check	  for	  and	  remove	  duplicates	  and	  ii)	  in	  some	  cases,	  make	  use	  of	  (a	  
priori)	   constraints	   that	   can	   be	   applied	   early	   in	   the	   search	   tree	   to	   prune	   branches,	  
since	  the	  less	  branches	  in	  the	  tree	  the	  less	  duplicate	  check	  and	  removal	  is	  needed.	  
	  
The	  choice	  of	  algorithm	  to	  generate	  molecules	  determines	  the	  completeness	  of	  the	  
results	  and	  the	  speed	  of	  obtaining	  them.	  In	  the	  current	  approach	  followed	  for	  PMG,	  
we	  use	  orderly	  generation	  and	  consider	  a	  special	  ordering	  on	  graphs,	  such	  that	  for	  
every	   two	   graphs	   (with	   the	   same	   number	   of	   vertices,	   bonds	   and	   degree),	  we	   can	  
determine	   the	  bigger	  and	   the	  smaller	  one.	  Among	   isomorphic	  graphs,	  we	  consider	  
the	   smallest	   (minimal)	   one	   as	   the	   canonical	   one.	   Each	   node	   (atom)	   is	   given	   a	  
number,	   and	   therefore	   each	   edge	   (bond)	   can	   be	   represented	   as	   a	   triplet	   <x,y,d>	  
where	   x	   and	   y	   (x<y)	   are	   the	   numbers	   associated	   to	   the	   connected	   atoms	   and	   d	  
shows	  the	  degree	  of	  the	  bond.	  An	  edge	  <x,y,d>	  is	  smaller	  than	  the	  edge	  <x',	  y',	  d'>	  if	  :	  
x	  <	  x';	  or,	  
x	  =	  x'	  and	  y	  <	  y';	  or,	  
x	  =	  x'	  and	  y	  =	  y'	  and	  d	  >	  d'.	  
This	  is,	  if	  the	  labeling	  of	  the	  atoms	  is	  smaller,	  or	  for	  a	  similar	  labeling,	  the	  degree	  of	  
the	  edge	  is	  smaller.	  In	  orderly	  generation,	  we	  start	  from	  the	  smallest	  possible	  graph,	  
i.e.,	  a	  graph	  with	  vertices	  but	  no	  edges	  (which	  can	  be	  seen	  as	  a	  triplet	  <0,0,0>),	  and	  
continue	  adding	  edges	  following	  this	  principle:	  we	  can	  only	  add	  an	  edge	  to	  a	  graph	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which	  is	  bigger	  than	  all	  the	  edges	  already	  in	  the	  graph.	  Furthermore,	  we	  only	  keep	  
growing	  a	  graph	  if	   it	   fulfills	  a	  criterion,	   like	  being	  semi-­‐canonical	  or	  minimal.	  Graph	  
theory	  will	  then	  guarantee	  us	  that	  in	  the	  end	  we	  will	  generate	  all	  possible	  graphs	  and	  
exactly	  one	  instance	  of	  them.	  
	  
Generating	   the	   edges	   in	   ascending	   order	   already	   removes	   some	   intermediate	  
possible	  structures	  and	  therefore	  increases	  speed.	  However,	  the	  test	  for	  minimality	  
is	   computationally	   expensive.	   Nevertheless,	   testing	   for	   minimality	   is	   still	   less	  
computationally	   expensive	   than	   generating	   the	   equivalent	   minimal	   graph.	  
Generating	  the	  minimal	  graph,	  which	  is	  equivalent	  to	  canonizing	  the	  graph,	  was	  the	  
approach	   used	   in	   OMG.	   We	   expect	   that	   substitution	   the	   canonicity	   test	   for	   the	  
minimality	   test	   will	   increase	   the	   speed	   of	   the	   algorithm.	   An	   alternative	   to	   the	  
minimality	  test	  to	  speed	  up	  the	  computation	  is	  to	  use	  a	  simpler	  though	  not	  complete	  
test,	  called	  semi-­‐canonicity,	   for	   intermediate	  structures	  and	  test	  minimality	  only	   in	  
complete	  structures.[23]	  By	  using	   this	   test	   instead	  of	   the	   full	  minimality	  check,	  we	  
can	  very	  quickly	  reject	  most	  of	  the	  non-­‐minimal	  structures.	  However,	  we	  may	  end	  up	  
with	   some	   duplicate	   structures.	   Therefore,	   we	   still	   need	   to	   do	   the	   full	  minimality	  
check	  on	  the	  final	  structures	  to	  keep	  only	  the	  canonical	  structures.	  The	  ideal	  solution	  
is	  to	  combine	  the	  two	  approaches	  above.	  More	  precisely,	  we	  can	  first	  apply	  the	  very	  
quick	  semi-­‐canonicity	  check	  to	  reject	  most	  of	  the	  non-­‐minimal	  structures,	  and	  then	  
apply	   immediately	   the	   full	   minimality	   check	   on	   the	   remaining	   intermediate	  
structures.	   Alternatively,	   intermediate	   tests	   are	   performed	   once	   blocks	   in	   the	  
adjacency	  matrix	  that	  stores	  the	  graph	  are	  filled,	  for	  further	  details	  we	  refer	  to	  the	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work	  of	  Meringer.[22,	  23]	  This	  way,	  we	  will	  end	  up	  performing	  the	  costly	  operation	  
of	  minimality	  test	  less.	  	  
	  
PMG	  implements	  three	  structure	  generation	  modes:	  (default	  mode)	  semi-­‐canonicity	  
and	   minimality	   tests	   combined,	   (mode	   0)	   semi-­‐canonicity	   test	   for	   intermediate	  
molecules	  and	  minimality	  test	  for	  finished	  molecules,	  and	  (mode	  1)	  minimality	  test	  
for	   intermediate	   and	   finished	   molecules.	   All	   three	   modes	   generate	   the	   same	  
molecules,	  but	  they	  require	  a	  different	  amount	  of	  time	  depending	  if	  the	  input	  is	  only	  
the	  EC	  or	  also	  prescribed	  substructures.	  On	  the	  one	  hand,	  semi-­‐canonicity	  is	  faster	  to	  
check	  than	  minimality,	  but	  it	  removes	  less	  intermediate	  molecules,	  which	  results	  in	  
more	   branches	   in	   the	   search	   tree.	   On	   the	   other	   hand,	   minimality,	   yet	   more	  
computationally	   demanding,	   constrains	  more	   and	   produces	   fewer	   branches	   in	   the	  
search	  tree.	  The	  effect	  on	  computation	  time	  of	  performing	  a	  faster	  test	  more	  times	  
(semi-­‐canonicity)	  versus	  a	  slower	  test	   less	  times	  (minimality)	  needs	  to	  be	  assessed.	  
Additionally	  we	  assess	  the	   impact	  of	  using	  or	  not	  using	  good	  and	  bad	  substructure	  




The	  algorithm	  used	   for	  OMG	  allowed	   theoretically	  parallel	   execution,	  but	   this	  was	  
not	   implemented	   as	   such.	   In	   the	   current	   PMG	   we	   have	   implemented	   the	   new	  
algorithm	  in	  a	  thread-­‐safe	  way	  to	  allow	  its	  execution	  in	  parallel.	  We	  tested	  how	  well	  
the	   three	  execution	  modes	  and	  the	  different	  multi-­‐core	  setups	   (increasing	  number	  
of	  cores)	  performed.	  	  In	  order	  to	  show	  how	  PMG	  can	  be	  applied	  in	  a	  metabolomics	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context,	   we	   used	   the	   elemental	   compositions	   and	   prescribed	   substructures	   used	  
in[7]	  and	  compared	  the	  results,	  both	  in	  time	  and	  structures	  generated,	  by	  PMG	  with	  
those	  obtained	  by	  OMG.	  
	  
Priori	  Constraints	  
PMG,	   as	   OMG	   did,	   accepts	   prescribed	   non-­‐overlapping	   substructures.	   These	   are	  
substructures	   that	   should	  be	  present	   in	   the	   finished	  molecules	  and	   they	   fix	  how	  a	  
part	   of	   the	   whole	   structure	   is	   connected,	   reducing	   drastically	   the	   number	   of	  
generated	  molecules.	  In	  our	  previous	  work	  we	  obtained	  prescribed	  substructures	  for	  
unknown	   metabolites	   by	   finding	   metabolites	   with	   similar	   MSn	   spectra	   to	   the	  
unknown,	  and	  calculating	  their	  maximum	  common	  substructure	  (MCSS).	  The	  MCSS	  is	  
the	  biggest	  part	  of	  the	  chemical	  structures	  that	  they	  share.	  The	  assumption	  was	  that	  
our	   unknown	  would	   have	   a	   chemical	   structure	   that	   is	   similar	   to	   the	   structures	   of	  
metabolites	  having	  similar	  spectra.	  We	  demonstrated	  that	  removing	  molecules	  with	  
a	   high	   force	   field	   energy	   value	   significantly	   reduced	   the	   number	   of	   candidate	  
structures.	   Additionally,	   we	   observed	   that	   certain	   ring	   moieties	   contribute	  
significantly	   to	   an	   increase	  of	   the	   energy	   value	  of	   a	  molecule.	   Therefore,	  we	  have	  
implemented	  an	  efficient	  way	   to	   test	   if	   certain	  unrealistic	  molecular	   rings	  and	   ring	  
systems	   (Figure	   1)	   are	   present	   in	   our	   intermediate	   molecules.	   The	   bad	   rings	  
implemented	   in	  PMG	  are:	   a	   ring	  of	   any	   size	  with	   a	   triple	  bond;	   an	  atom	  with	   two	  
double	  bonds,	  which	  are	  in	  a	  ring;	  two	  three	  member	  rings	  fused	  together;	  a	  three	  
member	  ring	  with	  a	  double	  bond;	  a	  four	  member	  ring	  with	  two	  double	  bonds.	  When	  
a	  double	  or	  triple	  bond	   is	  created,	  or	  a	  ring	   is	  closed	  we	  test	   if	  whether	  unwanted	  
rings	  are	  present	   in	  the	  molecule.	  These	  bad	  rings	  match	  all	   types	  of	  heavy	  atoms,	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i.e.	   they	   are	   not	   specific	   for	   carbon	   atoms.	   Rejecting	   intermediate	  molecules	  with	  
bad	   rings	   reduces	   the	   number	   of	   finished	   candidate	   structures	   and	   speeds	   up	   the	  
execution	  of	  PMG.	  	  
	  
Figure	  1	  Bad	  rings	  used	  as	  prior	  constraint	  in	  PMG.	  
	  
Posterior	  Constraints	  
Not	  all	  constraints	  can	  be	  applied	  from	  the	  beginning	  to	  intermediate	  structures	  to	  
reduce	  the	  search	  space.	  Therefore,	  these	  constraints	  need	  to	  be	  applied	  on	  finished	  
molecules	   before	   they	   are	   considered	   as	   acceptable	   candidates.	   As	   mentioned	  
above,	   prescribed	   substructures	   should	   not	   overlap.	   In	   metabolomics	   studies	   it	   is	  
possible	   to	   have	  multiple	   substructures	   that	  we	  want	   our	   candidate	   structures	   to	  
contain,	  but	  we	  cannot	  know	  if	  they	  overlap	  or	  not.	  In	  such	  a	  situation,	  the	  biggest	  
(more	   constraining)	   substructure	   is	   provided	   as	   prescribed	   substructure	   (a	   priori	  
constrain)	  and	  the	  smaller	  substructures	   (which	  we	  refer	   to	  as	  good	   list)	   tested	  on	  
finished	   molecules	   (posterior	   constrain).	   PMG	   makes	   use	   of	   the	   Small	   Molecule	  
Subgraph	  Detector	   (SMSD)	   library[24]	   to	  query	   if	   the	  substructures	   in	   the	  good	   list	  
are	   present	   in	   the	   finished	   molecules.	   Finished	   molecules	   will	   only	   be	   accepted	  




When	   multiple	   substructures	   are	   available	   and	   it	   is	   not	   possible	   to	   know	   if	   they	  
overlap,	  the	  biggest	  substructure	  should	  be	  provided	  as	  prescribed	  and	  the	  smaller	  
substructures	  as	  good	  list.	  These	  substructures	  can	  be	  obtained	  from	  analytical	  data,	  
for	  instance,	  by	  matching	  MS/MS	  spectra	  with	  a	  database	  of	  annotated	  spectra[25],	  
by	  manual[26]	  or	  automated[27]	  interpretation	  of	  MSn	  data,	  by	  calculating	  the	  MCSS	  
of	  metabolites	  with	  similar	  MSn	  spectra,[16]	  or	  by	   interpreting	  NMR	  spectra.[28]	   If	  
an	  analytical	  method	  has	  been	  used	  that	  includes	  derivatization	  of	  metabolites,	  the	  
attached	  moiety	  can	  be	  provided	  as	  well	  in	  the	  good	  list.	  Alternatively	  the	  good	  list	  
can	  be	  built	   using	  biological	   knowledge,	   for	   instance,	   if	   the	  unknown	  belongs	   to	   a	  
metabolic	  pathway	  where	  all	  its	  metabolites	  share	  common	  substructures.	  	  
	  
Apart	   from	   rejecting	   molecules	   that	   contain	   bad	   rings	   and	   do	   not	   contain	  
substructures	  from	  the	  good	  list,	  we	  implemented	  a	  bad	  list	  rejection	  option	  in	  PMG	  
using	  SMSD.	  Here,	  the	  user	  can	  provide	  other	  substructures	  different	  than	  the	  bad	  
rings	   that	   he	   does	   not	   want	   in	   his	   finished	  molecules.	   Finished	  molecules	   will	   be	  
rejected	  if	  they	  contain	  one	  of	  the	  unwanted	  substructures	  in	  the	  bad	  list.	  We	  offer	  
an	  example	  of	  a	  bad	   list	  containing	  benzene	  and	  cyclopentane	  fused	  with	  3	  and	  4-­‐
membered	   rings	   (Figure	   2).	   These	   ring	   systems	   are	   energetically	   unfavorable	   and	  
unstable,	   thus	  not	   likely	  present	   in	  metabolites.	   To	   support	   this	   claim,	  we	  queried	  
these	  ring	  systems	  in	  HMDB	  and	  we	  did	  not	  find	  human	  metabolites	  that	  contained	  
them.	  Alternatively,	  different	  unwanted	  substructures	  can	  be	  drawn	  with	  a	  chemical	  
editor	  (like	  Marvin	  Sketch	  or	  ISIS/	  ChemDraw),	  stored	  as	  an	  SD	  file	  and	  provided	  as	  
bad	  list.	  Again,	  biological	  knowledge	  can	  be	  used	  to	  derive	  a	  bad	  list.	  For	  example,	  a	  
certain	  metabolic	  pathway	  is	  studied	  and	  all	  the	  metabolites	  involved,	  including	  the	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unknown,	   do	   not	   contain	   rings.	   To	   prevent	   PMG	   of	   generating	   ring	   containing	  
molecules	  a	  bad	  list	  could	  be	  assembled	  with	  different	  rings.	  
	  
Figure	  2	  Bad	  list	  of	  substructures	  used	  as	  posterior	  constraint	  in	  PMG.	  
	  
We	   evaluated	   the	   effect	   and	   the	   suitability	   for	   metabolite	   identification	   of	   the	  
improvements	  in	  PMG.	  Firstly,	  to	  test	  the	  speed	  improvement	  of	  PMG,	  we	  used	  the	  
same	  elemental	  compositions	  (Tables	  1	  and	  2)	  and	  fragments	  (Table	  3)	  employed	  in	  
the	   original	   OMG	   publication.[7]	   These	   elemental	   compositions	   belong	   to	   human	  
metabolites	  found	  in	  HMDB.	  The	  fragments,	  manually	  sketched,	  were	  present	  in	  the	  
metabolites	  and	  likely	  to	  be	  found	  in	  experimental	  MSn	  data.	  We	  assessed	  the	  speed	  
gain	  of	  the	  new	  algorithm	  by	  comparing	  the	  total	  time	  per	  elemental	  composition	  of	  
the	  single	  core	  execution	  of	  the	  three	  modes	  in	  PMG	  with	  OMG,	  when	  the	  input	  is	  
only	   an	   elemental	   composition	   or	   an	   elemental	   composition	   and	   prescribed	  
substructures.	   Secondly,	   we	   also	   assessed	   the	   effect	   of	   using	   multiple	   cores	   by	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comparing	   the	   number	   of	  molecules	   generated	   per	   second	  when	   using	   one,	   two,	  
four,	  seven	  and	  ten	  cores.	  Lastly,	  we	  used	  elemental	  compositions	  and	  substructures	  
of	   real	   unknown	  metabolites	   found	   in	  human	  urine	   to	   test	   the	   effect	   of	   using	   the	  
filters	  of	  prescribed	  substructures,	  bad	  rings,	  good	  and	  bad	  lists.	  MSn	  data	  of	  known	  
and	   unknown	  metabolites	   present	   in	   human	   urine	  were	   acquired,	   processed	  with	  
MEF	   and	   compared	   to	   a	   spectral	   database	   of	   known	   metabolites.	   From	   those	  
metabolites	   in	   the	   database	   found	   to	   be	   similar	   to	   the	   unknowns,	   a	   MCSS	   was	  
calculated	   and	   proposed	   as	   a	   prescribed	   substructure.	   Additionally,	   the	  
fragmentation	   trees	   of	   these	   unknowns	   underwent	  manually	   annotation,	  which	   in	  
some	  cases	  provided	  additional	  substructures,	  which	  were	  used	  as	  good	  list	  for	  the	  
evaluation	  of	  PMG.	  	  
	  
Results	  and	  discussion	  
The	   speed	   of	   the	   three	   algorithms	   implemented	   in	   PMG	   is	   compared	   for	   some	  
typical	  metabolites,	  which	  we	  detected	  earlier	  in	  urine[4]	  with	  the	  original	  results	  of	  
OMG.	  PMG	  was	  executed	  in	  the	  same	  computer	  and	  under	  the	  same	  conditions	  used	  
to	   obtain	   the	   results	   for	   OMG	   in	   out	   previous	   work.	   All	   three	   algorithms	   in	   PMG	  
outperform	   OMG	   when	   using	   only	   elemental	   formulas	   containing	   carbon,	   oxygen	  
and	  hydrogen	  atoms	  (Table	  1)	  and	  other	  additional	  elements	  like	  nitrogen,	  phosphor	  
or	  sulfur	  (Table	  2).	  For	  elemental	  compositions	  with	  a	  small	  number	  of	  elements	  like	  
C3H4O3	   and	   C2H5NO2,	   OMG	   and	   PMG	   need	   approximately	   the	   same	   amount	   of	  
computation	   time.	   When	   the	   elemental	   composition	   has	   more	   elements	   and	   the	  
structure	  generators	   should	  produce	   thousands	  or	  millions	  of	  molecules,	  PMG	  can	  
be	  40	  times	  faster	  than	  OMG	  using	  only	  one	  core.	  From	  the	  three	  algorithms,	  semi-­‐
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canonicity	   &	   minimality	   combined	   appeared	   to	   be	   the	   fastest,	   followed	   by	  
minimality	   and	   finally	   by	   semi-­‐canonicity.	   The	   test	   for	   minimality	   is	   more	   time	  
expensive	   than	   the	   test	   for	   semi-­‐canonicity	   but	   at	   the	   same	   time	   it	   is	   more	  
constraining.	  With	  these	  results	  we	  conclude	  that	   it	   is	  helpful	  to	  use	  the	  combined	  
semi-­‐canonicity	   &	   minimality	   mode	   when	   the	   only	   input	   is	   the	   elemental	  
composition.	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Table	  1	  Number	  of	  candidate	  substructures	  produced	  by	  PMG	  using	  only	  an	  elemental	  composition	  (only	  C,H,O)	  
and	   the	   time	   in	   seconds	   to	   generate	   them	   using	   1	   or	   10	   cores.	   Abbreviations:	   SC-­‐Min,	   Semi-­‐canonicity	   &	  
minimality	  combined;	  SC,	   semi-­‐canonicity;	  Min,	  minimality.	  SC-­‐Min	  outperforms	  the	  other	   two	  methods	  and	   is	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Table	  2	  Number	  of	  candidate	  substructures	  produced	  by	  PMG	  using	  only	  an	  elemental	  composition	  and	  the	  time	  
in	  seconds	  to	  generate	  them	  using	  1	  or	  10	  cores.	  Abbreviations:	  SC-­‐Min,	  Semi-­‐canonicity	  &	  minimality	  combined;	  
SC,	   semi-­‐canonicity;	   Min,	   minimality.	   SC-­‐Min	   and	  Min	   perform	   equally	   well.	   SC-­‐Min	   is	   the	   preferred	   method	  
when	   only	   using	   elemental	   compositions	   as	   input,	   since	   it	   performs	   better	   than	   Min	   when	   the	   elemental	  
compositions	  contain	  only	  C,H	  and	  O.	  
	  
The	   speed	   improvement	   becomes	   more	   significant	   when	   we	   provide	   prescribed	  
substructures	  to	  the	  structure	  generator	  (Table	  3).	  In	  this	  case,	  PMG	  using	  the	  semi-­‐
canonicity	  &	  minimality	  mode	  achieves	   in	  some	  cases	  a	  100-­‐fold	   increase	   in	  speed	  
compared	   to	   OMG.	   We	   observe	   this	   for	   both	   small	   metabolites	   with	   prescribed	  
substructures	  (phenylalanine)	  and	  large	  metabolites	  with	  substructures	  (cholic	  acid).	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In	  some	  other	  cases,	   like	  malic	  acid,	  PMG	  only	  achieved	  a	  4-­‐fold	   improvement.	  We	  
also	  see	  that	  the	  semi-­‐canonicity	  &	  minimality	  mode	  performs	  similarly	  to	  the	  semi-­‐
canonicity	  mode	  and	  both	  outperform	   the	  minimality	  mode.	   In	   all	   cases	   the	   same	  
number	   of	   candidate	   structures	  were	   obtained	  with	   the	   three	   PMG	  modes.	   Since	  
semi-­‐canonicity	  &	  minimality	   is	   the	  best	  performing	  algorithm	  with	  only	  elemental	  
compositions	   and	   also	   when	   substructures	   are	   provided,	   we	   conclude	   that	   semi-­‐
canonicity	  &	  minimality	   is	   the	  best	   generic	   algorithm	   for	   structure	   generation	   and	  
should	  be	  used	  as	  default.	  We	  also	  observe	  that,	  in	  some	  cases,	  PMG	  produces	  more	  
molecules	  than	  OMG	  when	  using	  prescribed	  substructures.	  This	  had	  to	  do	  with	  the	  
way	   the	   original	   OMG	   algorithm	   handled	   atom	   elements	   of	   multiple	   valences	   (N	  
valence	  3	  and	  5;	  S	  valence	  2,4,	  and	  6;	  P	  valence	  3	  and	  5)	  when	  using	  substructures.	  
PMG	   improved	   this	   and	   generates	   all	   possible	   and	   valid	   valances	   when	   using	  
prescribed	  substructures.	  































C9H11NO2	   	  
107,155	   19,386	   119,955	   356	   356	   2,002	  
	   	  
	  
595	   271	   595	   3.47	   3.47	   5.56	  
	   	  
	  
289	   172	   289	   2.48	   2.38	   2.39	  
	   	  
	  




C24H40O5	   	  
334	   120	   334	   0.77	   0.78	   0.88	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C5H4N4O3	   	  
6,069,863	   155,828	   7,357,453	   9,593	  
*	  not	  	  
available	  








26,164	   163	   29,580	   24.97	   24.89	   570	  
	   	  
	  





C7H8O4S	   	  
13,177	   63.05	   13,177	   12.78	   57.33	   10.34	  
	   	  
	  
17,232	   1,204	   19,132	   64.85	   110	   989	  
Table	  3	  Number	  of	  candidate	  substructures	  produced	  by	  PMG	  using	  an	  elemental	  composition	  and	  prescribed	  
substructures	  and	  the	  time	  in	  seconds	  to	  generate	  them	  using	  1	  core.	  Abbreviations:	  SC-­‐Min,	  Semi-­‐canonicity	  &	  
minimality	  combined;	  SC,	  semi-­‐canonicity;	  Min,	  minimality.	  SC-­‐Min	  performs	  similar	  to	  SC	  and	  outperforms	  Min,	  
therefore	  SC-­‐Min	  is	  the	  preferred	  method	  when	  only	  using	  elemental	  compositions	  as	  input.	  
The	   impact	   of	   running	   PMG	   on	   multiple	   cores	   for	   the	   structure	   generation	   of	  
molecules	  where	  only	  the	  elemental	  compositions	  is	  provided,	  is	  presented	  in	  Figure	  
3,	  and	  for	  those	  with	  given	  elemental	  compositions	  and	  prescribed	  substructures	  in	  
Figure	   4.	   The	   results	   are	   presented	   in	  molecules	   per	   second	   (in	   logarithmic	   scale)	  
using	   the	   semi-­‐canonicity	   &	  minimality	   combined	  method.	  We	   see	   for	   both	   cases	  
about	   a	   10-­‐fold	   improvement	   from	   OMG	   to	   PMG	   in	   the	   number	   of	   molecules	  
generated	   per	   second	   for	   a	   single	   core	   execution	   (Figures	   3	   &	   4).	   When	   only	  
elemental	  compositions	  are	  used	  as	  input,	  the	  speed	  of	  generation	  of	  molecules	  with	  
PMG	   increase	   rather	   linear	  with	   the	  number	  of	   cores.	  When	  using	  also	  prescribed	  
substructures	   as	   input,	   we	   observe	   a	   comparable	   improvement	   in	   the	   speed	   of	  
generation	  of	  molecules	  with	  the	  increasing	  the	  number	  of	  cores	  only	  for	  half	  of	  the	  
examples,	  and	  especially	  for	  those	  that	  need	  longer	  computation	  times.	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Figure	  3	  Number	  of	  molecules	  generated	  (logarithmic	  scale)	  only	  with	  elemental	  compositions	  using	  OMG	  and	  
PMG	   in	   single	   core,	   and	   PMG	   in	   multiple	   cores.	   PMG	   in	   single	   core	   is	   10	   times	   faster	   than	   OMG.	  Multicore	  
execution	  of	  PMG	  achieves	  near	  linear	  speed	  up.	  
	  
	  
Figure	   4	   Number	   of	   molecules	   generated	   (logarithmic	   scale)	   with	   elemental	   compositions	   and	   prescribed	  
substructures	  using	  OMG	  and	  PMG	  in	  single	  core,	  and	  PMG	  in	  multiple	  cores.	  In	  most	  of	  the	  cases,	  PMG	  in	  single	  
core	   achieves	  more	   than	  50-­‐fold	   increase	   in	   speed	   compared	   to	  OMG.	   	  Multicore	   execution	  of	   PMG	  achieves	  
























Semicanonicity	  +	  Minimality	  Using	  Only	  Elemental	  



































Semicanonicity	  +	  Minimality	  Using	  Elemental	  















The	   results	   of	   using	   bad	   rings	   as	   a	   prior	   constraint	   and	   a	   bad	   list	   as	   posterior	  
constraint	   are	   presented	   in	   Table	   4:	   the	   number	   of	  molecules	   generated	   by	   PMG	  
unconstrained	   are	   compared	   with	   PMG	   using	   the	   above	   constraints,	   where	   both	  
executions	  used	  the	  semi-­‐canonicity	  &	  minimality	  combined	  method	  and	  10	  cores.	  
We	  observed	   that	   in	   some	  cases	   (C2H5NO2,	  C7H14O7,	  C6H10O7)	  PMG	  only	   rejected	  a	  
few	   molecules,	   or	   in	   other	   cases	   no	   rejection	   of	   structures	   at	   all	   was	   achieved	  
(C5H10O5,	   C6H12O6).	   The	   reason	   for	   this	   is	   that	   the	   number	   of	   hydrogen	   atoms	   in	  
these	   formulas	   impedes	   rings	   to	   be	   formed,	   therefore	   no	   bad	   rings	   or	   bad	  
substructures	  can	  be	  found.	  For	  formulas	  that	  allow	  ring	  formation,	  PMG	  using	  the	  
constraints	  removes	   in	  some	  cases	  82%	  (C4H5N3O),	  62%	  (C4H7N3O)	  or	  61%	  (C5H9N3)	  
of	  the	  candidate	  structures.	  In	  these	  cases,	  constraining	  the	  generation	  of	  molecules	  
in	   PMG	   with	   bad	   rings	   and	   bad	   list	   of	   substructures	   can	   provide	   a	   significant	  






#	  Candidate	  Structures	  
	  
Calculation	  time	  (s)	  	  
Formula	  
Without	  constraints	   With	  bad	  rings	  and	  bad	  list	  constraints	  
C2H5NO2	   97	   0.35	   95	   0.69	  
C4H7NO3	   26,530	   1.75	   21,329	   6.70	  
C9H11NO2	   516,741,797	   17,254.80	   235,017,993	   77,723	  
C5H9NO4	   685,392	   22.17	   582,745	   168	  
C3H4O3	   152	   0.35	   129	   0.80	  
C4H6O5	   8,070	   2.24	   7,464	   4.00	  
C3H5O6P	   83,977	   4.45	   74,422	   23.63	  
C9H10O3	   48,496,265	   877	   28,468,157	   8,065	  
C4H7N3O	   303,601	   15.36	   115,475	   25.32	  
C3H7N3O2	   124,808	   9.16	   78,753	   22.43	  
C4H5N3O	   491,299	   16.77	   88,400	   23.51	  
C5H9N3	   134,278	   9.25	   52,574	   12.41	  
C3H7NO2S	   15,978	   2.07	   12,054	   4.62	  
C5H10O5	   18,092	   1.74	   18,092	   7.01	  
C6H12O6	   267,258	   13.27	   267,258	   74,571	  
C7H14O7	   4,106,823	   427	   4,106,823	   1,201	  
C6H10O7	   3,183,337	   129	   3,057,256	   836	  
Table	  4	  Number	  of	  candidate	  structures	  generated	  by	  PMG	  with	  and	  without	  bad	  rings	  and	  bad	  list	  constraints	  
and	  the	  time	  in	  seconds	  to	  generate	  them	  using	  1	  core.	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We	   tested	   further	   the	   use	   of	   prior	   and	   posterior	   constraints	   in	   addition	   to	   the	  
elemental	   compositions	   and	   prescribed	   substructures	   (Table	   5)	   of	   unknown	  
metabolites	   found	   in	   human	   urine	   in	   our	   earlier	   work.[4]	   Some	   prescribed	  
substructures	  were	  obtained	  using	   the	   fragmentation	   tree	   similarity[16]	   and	  MCSS	  
methods.	   Other	   prescribed	   substructures	   and	   the	   good	   list	   substructures	   were	  
annotated	  by	  an	  expert	  after	  manual	   interpretation	  of	  the	  MSn	  trees.	  For	  unknown	  
28,	  PMG	  produces	  86	  candidate	  structures	  using	  a	  prescribed	  substructure	  and	  only	  
12	   using	   the	   same	   prescribed	   substructure	   and	   the	   bad	   rings	   constraint.	   This	  
reduction	  is	  comparable	  to	  the	  one	  obtained	  by	  OMG	  and	  a	  posterior	  filtering	  based	  
on	  energy,	  metabolite-­‐likeness[12]	  and	  fragmentation	  prediction.[29]	  In	  other	  cases,	  
like	   unknown	   9,	   using	   prescribed	   substructure	   and	   good	   list	   results	   in	   PMG	  
generating	   one	   unique	   candidate	   structure.	   For	   unknown	   27,	   prescribed	  
substructures	   and	   good	   list	   produced	   45	   structures,	   which	   was	   reduced	   to	   3	  
candidates	  using	  the	  bad	  rings	  constraints.	  As	  we	  can	  see,	  only	  in	  a	  few	  cases	  the	  use	  
of	  bad	  rings	  and	  bad	   list	   filtering	  reduces	   further	  the	  number	  of	  candidates.	  But	   in	  
those	  cases,	  the	  effect	  is	  similar	  to	  removing	  molecules	  with	  high	  force	  field	  energy	  
and	  low	  metabolite-­‐likeness.	  It	  also	  has	  to	  be	  taken	  into	  account	  that	  the	  prescribed	  
substructure	  fixes	  a	  big	  part	  of	  the	  chemical	  structure,	  making	  it	  difficult	  to	  produce	  
bad	   rings	   with	   the	   remaining	   atoms.	   The	   combination	   in	   PMG	   of	   prescribed	  
substructures,	  good	  list,	  bad	  list	  and	  bad	  rings	  achieves	  a	  significant	  reduction	  in	  the	  






#	  Candidate	  Structures	  







bad	  rings	  and	  bad	  list	  constraints	  
7	   C8H9NO2	  
	   	  
32	   32	  
7	   C8H9NO2	  
	   	  
1	   1	  
7	   C8H9NO2	   	   	  
270	   270	  
7	   C8H9NO2	   	   	  
42	   42	  
12	   C9H9NO3	  
	  
	   121,363	   50,003	  
18	   C9H11NO3	   	   	  
4,251	   4,245	  
20	   C11H12N2O2	  
	  
	   1,891	   1,748	  
22	   C9H11NO2	  
	   	  
165	   165	  
28	   C9H10O2	  
	  
	   86	   12	  
9	   C7H7NO4	  
	  
	   80,489	   53,194	  
9	   C7H7NO4	  
	   	  
1	   1	  
9	   C7H7NO4	  
	  
	   17,680	   14,800	  
15	   C9H9NO4	  
	  
	   5	   5	  
15	   C9H9NO4	  
	  
	   5	   5	  
27	   C9H13NO4P2	  
	  
	  
45	   3	  
27	   C9H13NO4P2	  
	  
	   281	   264	  
Table	  5	  Number	  of	  candidate	  structures	  generated	  by	  PMG	  (SC-­‐Min;	  10	  cores)	  applied	  to	  the	   identification	  of	  
unknown	  metabolites	  in	  urine	  using	  prescribed	  substructures,	  good	  list,	  and	  with/without	  bad	  rings	  and	  bad	  list	  
constraints.	  
	  
In	  previous	  work	  we	  used	  OMG	  to	  identify	  unknown	  metabolites	  in	  human	  urine.[4]	  
After	  the	  generation	  step	  we	  used	  an	  internal	  energy	  filter	  and	  a	  metabolite-­‐likeness	  
filter	   to	   reduce	   further	   the	   list	  of	   candidates.	  The	  use	  of	   these	   filters	  after	  PMG	   is	  
obviously	   possible,	   but	  was	   not	   in	   the	   scope	   of	   this	  work.	   However,	  we	   observed	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that	  using	  the	  bad	  rings	  and	  bad	  substructures	  constraints	  was	  rather	  equivalent	  to	  
remove	  energetically	  unfavorable	  molecules.	  	  
	  
Conclusion	  
We	  presented	  PMG,	   an	  open	   source	  multi-­‐core	   structure	   generator	   developed	   for	  
de-­‐novo	  metabolite	  identification.	  We	  implemented	  a	  new	  algorithm	  based	  on	  semi-­‐
canonicity	  and	  minimality	  tests,	  with	  a	  multi-­‐core	  architecture.	  This	  implementation	  
generates	   candidate	   structures	  up	   to	  100	   times	   faster	   than	  our	  previous	   structure	  
generator	  OMG.	  Next	  to	  the	  elemental	  composition,	  PMG	  allows	  as	  input	  prescribed	  
substructures	  and	  bad	  and	  good	  lists	  of	  substructures.	  The	  use	  of	  good	  substructures	  
limits	   the	   search	   space	   while	   the	   bad	   rings	   removes	   energetically	   unfavorable	  
molecules.	   This	   results	   in	   a	   short	   list	   of	   candidate	   structures,	   without	  missing	   the	  
correct	  structure.	  We	  have	  used	  substructures	  obtained	  from	  MSn	  spectra,	  derived	  
by	  manual	  annotation	  and	  using	  cheminformatic	  tools,	  to	  illustrate	  the	  use	  of	  PMG.	  
Alternatively,	  these	  substructures	  could	  have	  originated	  from	  NMR	  or	  from	  database	  
search.	  	  
	  
We	   are	   convinced	   that	   PMG	   will	   improve	   de-­‐novo	   metabolite	   identification	   by	  
providing	  a	  short	  yet	  correct	  list	  of	  candidate	  structures	  at	  a	  high-­‐speed.	  Obviously,	  
PMG	   can	   be	   also	   applied	   to	   the	   identification	   of	   also	   other	   molecules	   than	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perspectives 
Conclusions	  and	  perspectives	  
	  
Metabolite	  identification	  is	  still	  one	  of	  the	  biggest	  bottlenecks	  in	  metabolomics.	  The	  
de	   novo	   structure	   elucidation	   of	   metabolites	   is	   very	   time	   consuming	   and	   poses	  
several	   challenges.	   However,	   without	   the	   identity	   of	   a	   peak	   detected	   with	   mass	  
spectrometry-­‐based	  metabolomics	  methods	  its	  biological	  role	  cannot	  be	  interpreted.	  
In	   addition,	   effective	   integration	   with	   other	   ‘omics’	   data	   such	   as	   genomics	   and	  
proteomics	  requires	  the	  identity	  of	  metabolites.	  Therefore	  there	  is	  a	  huge	  need	  for	  
more	   efficient	   strategies	   to	   identify	   metabolites.	   Multi-­‐stage	   mass	   spectrometry	  
(MSn)	   is	   a	   promising	   type	   of	   mass	   spectrometry	   from	   which	   information	   on	   the	  
fragmentation	  pattern	  of	  the	  metabolite	  can	  be	  obtained.	  
	  
In	  this	  thesis	  new	  algorithms	  and	  methods	  that	  enable	  the	  de	  novo	  identification	  of	  
metabolites	   have	   been	   developed.	   The	   aim	   was	   to	   find	   methods	   to	   propose	  
candidate	   structures	   for	   unknown	   metabolites	   using	   MSn	   data	   as	   starting	   point.	  
Ideally	   this	   list	   of	   candidate	   identities	   should	   be	   as	   short	   as	   possible	   by	   using	  
additional	   constraints	   so	   that	   an	   expert	   can	   easily	   inspect	   it	   and	   select	   some	  
structures	   for	   further	   validation.	   The	   algorithms	   and	   methods,	   which	   have	   been	  
developed	  in	  this	  thesis	  and	  a	  parallel	  project,	  have	  been	  integrated	  to	  into	  a	  semi-­‐
automated	   pipeline	   to	   identify	   new	   metabolites	   starting	   from	   multi-­‐stage	   mass	  
spectrometry.	  The	  focus	   in	  this	  thesis	  was	  on	  human	  metabolites.	  The	  discovery	  of	  
new	  metabolites	  will	  improve	  our	  capability	  to	  understand	  disease	  via	  its	  metabolic	  
fingerprint,	   to	   develop	   personalized	   treatments	   and	   to	   discover	   new	   drugs.	   In	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addition,	   the	   cheminformatics	   methods	   presented	   in	   this	   thesis	   increase	   our	  
understanding	  on	  the	  properties	  of	  human	  metabolites.	  
	  
In	   Chapter	   2	   a	   structure	   generator,	   the	   Open	   Molecule	   Generator	   (OMG),	   was	  
developed.	   This	   tool	   allowed	   generating	   candidate	   structures	   for	   unknown	  
metabolites	  with	  a	  certain	  elemental	  composition	  and	  known	  substructure(s).	  While	  
research	  in	  computer	  assisted	  structure	  elucidation	  (CASE)	  dates	  back	  to	  the	  1960s,	  
recent	  developments	  have	  been	  scarce.	  The	  most	  notable	  example	  was	  MOLGEN,	  an	  
efficient,	   but	   at	   the	   same	   time	   “black	   box”	   commercial	   structure	   generator.	  
Therefore	   the	   in	   Chapter	   2	   developed	   structure	   generator	   was	   customizable	   and	  
open	  source:	  this	  allowed	  to	  implement	  methods	  and	  algorithms	  that	  were	  relevant	  
to	   the	   envisioned	   identification	   pipeline	   as	   described	   in	   Chapter	   5.	   Being	   open	  
source,	  OMG	  permits	  other	  scientists	  to	  improve	  it	  further	  and	  to	  adapt	  it	  to	  future	  
needs.	  	  
	  
The	   efficiency	   of	   the	   generation	   of	   structure	   candidates	   for	   a	   given	   elemental	  
composition	   (EC)	   and	   substructure(s)	   was	   demonstrated	   for	   a	   number	   of	  
metabolites.	  The	  results	  showed	  that	  OMG	  produced	  all	  possible	  chemical	  structures	  
for	  a	  given	  input	  (EC	  and/or	  substructure(s)).	  These	  results	  only	  contained	  chemically	  
valid	   structures	   according	   to	   the	   valence	   rule,	   whereas	   MOLGEN	   could	   produce	  
some	  unwanted	  atom	  types:	  for	  instance,	  for	  P	  valence	  5,	  MOLGEN	  would	  generate	  
P	   atoms	   with	   a	   triple	   and	   a	   double	   bond.	   OMG	   allowed	   also	   to	   use	   several	  
substructures	   as	   constrain,	   whereas	   MOLGEN	   allows	   only	   one	   substructure	   as	  
constrain.	  The	  use	  of	  prescribed	  substructures	  constrained	  significantly	  the	  number	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of	   candidate	   structures	   obtained.	   They	   reduced	   for	   example	   a	   list	   of	   hundreds	   of	  
millions	   of	   molecules	   (unconstrained	   generation)	   to	   a	   few	   thousand	   structures	  
(constrained	   generation).	   While	   this	   is	   a	   significant	   reduction,	   reducing	   the	   list	  
further	  using	  additional	  constraints	  appeared	  essential	   to	   turn	   the	   identification	  of	  
unknowns	   into	   a	   tractable	   problem.	   In	   conclusion,	   a	   structure	   generator	   was	  
developed	  which	  was	   superior	   to	  MOLGEN	   in	   several	   aspects.	  However,	  OMG	  was	  
slow	  when	  generating	  many	  molecules.	  The	  reason	  was	  that	   the	  algorithm	  used	   in	  
OMG	  was	   based	   on	   the	   canonical	   augmentation	   path.	   This	   algorithm	   produces	   all	  
possible	   molecules	   without	   duplicates,	   but	   it	   requires	   the	   use	   of	   a	   canonizer	   for	  
duplicate	   removal.	   This	   canonizer	   calculates	   the	   canonical	   representative	   for	   each	  
intermediate	  (unfinished)	  molecule.	  This	  conversion	  from	  a	  molecule	  to	  its	  canonical	  
representative	   is	   computationally	   time	   expensive.	   We	   concluded	   that	   a	   better	  
algorithm	   with	   a	   better	   duplicate	   removal	   approach	   was	   required	   to	   speed	   up	  
calculations	  and	  make	  the	  tool	  more	  attractive	  for	  practical	  use.	  Such	  an	  algorithm	  
was	  developed	  in	  Chapter	  5.	  	  
	  
In	  Chapter	  3	  we	  studied	  the	  nature	  of	  human	  metabolites.	  The	  aim	  was	  two-­‐fold:	  (i)	  
to	  learn	  what	  characteristics	  differentiate	  metabolites	  from	  other	  small	  (<	  1000	  Da)	  
non-­‐metabolite	  molecules	   and	   (ii)	   to	   predict	   the	  metabolite-­‐likeness	  of	   a	   chemical	  
structure,	   i.e.	   how	   likely	   it	   is	   to	   be	   a	   human	   metabolite.	   In	   the	   classification	   of	  
molecules,	   as	   in	   many	   machine-­‐learning	   problems,	   one	   has	   to	   deal	   with	   an	  
interpretability	   trade	  off.	  While	  easy	   to	  understand	  molecule	  descriptions	   (such	  as	  
physicochemical	  properties	  or	  scaffolds)	  combined	  with	  easy	  to	  interpret	  predictive	  
models	   mostly	   provide	   poor	   predictive	   results,	   complex	   descriptions	   (structural	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fingerprints)	   together	   with	   difficult	   to	   interpret	   models	   provide	   often	   better	  
predictions.	  In	  other	  words,	  if	  we	  want	  to	  accurately	  predict	  metabolite-­‐likeness	  we	  
will	   probably	   not	   be	   able	   to	   easily	   understand	   in	   chemical	   terms	   what	   these	  
predictions	  are	  based	  on.	  	  
	  
We	   observed	   that	   metabolites	   are	   a	   heterogeneous	   family	   of	   compounds	   and	  
compared	   to	   non-­‐metabolites,	   metabolites	   have	   simpler	   structures,	   less	   ring	  
systems,	  more	  hydrophilic	  groups,	  less	  nitrogen	  and	  sulfur	  atoms,	  and	  more	  oxygen	  
and	  phosphor	  atoms.	  These	  easy	  to	  interpret	  features	  were	  not	  complex	  enough	  to	  
be	   used	   in	   a	   model	   that	   would	   discern	   between	   metabolite	   and	   non-­‐metabolite	  
molecules.	  Therefore,	  we	  developed	  and	  validated	  a	  metabolite-­‐likeness	  predicting	  
model,	  which	  used	  the	  molecular	  descriptor	  MDL	  Public	  Keys	  and	  the	  Random	  Forest	  
classification	   algorithm	   to	   assign	   a	   metabolite	   score	   to	   a	   molecule.	   This	   model	  
achieved	   the	   highest	   classification	   accuracy	   at	   the	   expense	   of	   low	   interpretability.	  
The	   model	   was	   effectively	   used	   in	   Chapter	   4	   to	   reject	   non-­‐metabolite	   candidate	  
structures	   for	   unknown	   metabolites,	   demonstrating	   that	   metabolite-­‐likeness	  
prediction	  is	  one	  of	  the	  tools	  that	  can	  be	  routinely	  used	  in	  metabolite	  identification	  
studies.	  
	  
In	  Chapter	  4	  the	  tools	  developed	  in	  Chapters	  2	  and	  3	  of	  this	  thesis	  and	  developed	  in	  
a	  parallel	  project	  within	  the	  Netherlands	  Metabolomics	  Centre	  [69–71]	  were	  integrated	  
into	  a	  pipeline	  to	  identify	  metabolites.	  This	  pipeline	  was	  composed	  of	  four	  modules.	  
The	   first	   module	   annotated	   MSn	   data	   to	   obtain	   a	   fragmentation	   tree	   comprising	  
fragment	   ions	   and	   neutral	   losses	   of	   known	   elemental	   composition	   using	   the	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Multistage	   Elemental	   Formula	   (MEF)	   tool	   [69].	   The	   second	  module	   compared	   this	  
fragmentation	   tree	   of	   an	   unknown	   with	   the	   fragmentation	   trees	   of	   known	  
metabolites	   in	  a	  home-­‐build	  database.	   If	  a	   fragmentation	  tree	  with	  100%	  similarity	  
was	  found,	  the	  identity	  of	  the	  unknown	  was	  provisionally	  assigned.	  If	  more	  than	  one	  
fragmentation	  tree	  was	  found	  with	  less	  than	  100%	  similarity,	  a	  substructure	  of	  that	  
unknown	  metabolite	  was	  calculated	  via	  the	  maximum	  common	  substructure	  (MCSS)	  
from	  the	  metabolites	  being	  similar	  to	  the	  fragmentation	  tree.	  The	  third	  module	  was	  
the	   OMG	   structure	   generator,	   using	   as	   input	   the	   elemental	   composition	   and,	   if	  
found,	   a	   substructure	  of	   that	  metabolites.	   The	   fourth	  module	  used	   three	   filters	   to	  
reduce	   the	   list	   of	   candidates	   generated	   by	   OMG:	   (i)	   a	   Metabolite-­‐likeness	   filter,	  
which	   kept	   only	   molecules	   resembling	   human	   metabolites,	   (ii)	   a	   internal	   energy	  
filter,	   which	   kept	   only	   energetically	   stable	   molecules	   and	   (iii);	   the	   MetFrag	   filter,	  
which	  predicted	  the	  mass	  spectral	   fragmentation	  of	  molecules	  and	  kept	  only	  those	  
candidate	   molecules	   that	   could	   explain	   half	   of	   the	   fragments	   observed	  
experimentally.	  
	  
This	   metabolite	   identification	   pipeline	   was	   tested	   for	   the	   identification	   of	   30	  
different	  MSn	  spectra	  obtained	  from	  unknown	  metabolites	  in	  a	  human	  urine	  sample	  
For	  10	  of	  the	  30	  unknowns	  a	  perfect	  match	  of	  the	  acquired	  fragmentation	  tree	  and	  a	  
fragmentation	  tree	  of	  a	  known	  metabolite	  in	  the	  database	  was	  found,	  and	  therefore,	  
these	  metabolites	  were	  provisionally	   identified.	  For	  9	  unknown	  metabolites	  two	  or	  
more	   similar	   metabolites	   were	   found	   in	   the	   MSn	   database,	   which	   allowed	   the	  
calculation	  of	  a	  maximum	  common	  substructure	  as	  input	  to	  constrain	  the	  number	  of	  
structures	  obtained	  by	  the	  OMG	  structure	  generator.	  For	  3	  out	  of	  these	  9	  unknowns,	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OMG	  and	  the	  different	  filters	  provided	  a	  short	  list	  of	  8	  or	  less	  candidate	  structures.	  
For	  6	  out	  of	  these	  9	  unknowns,	  the	  list	  of	  candidates	  was	  excessively	  large,	  i.e.	  larger	  
than	  40	  candidates.	   Lastly,	  11	  unknowns	   remained	  unidentified	  because	  no	  similar	  
metabolite	  was	  found	  in	  the	  database	  and	  therefore	  OMG	  using	  only	  the	  elemental	  
composition	  provided	  more	  than	  one	  million	  of	  candidate	  structures.	  
	  
In	  summary,	  the	  developed	  identification	  pipeline	  proved	  to	  be	  useful	  at	  identifying	  
unknown	   metabolites	   using	   only	   MSn	   data.	   If	   a	   metabolite	   is	   already	   in	   a	   MSn	  
database,	  the	  metabolites	  can	  be	  well	  provisionally	  identified	  based	  only	  on	  the	  MSn	  
spectrum;	   obviously,	   in	   this	   manner	   only	   metabolites	   already	   known	   can	   be	  
identified.	  In	  order	  to	  identify	  truly	  new	  metabolites,	  i.e.	  de	  novo	  identification,	  one	  
needs	  to	  produce	  a	  short	  list	  of	  candidate	  structures	  for	  a	  given	  fragmentation	  tree,	  
and	   that	   is	   only	   possible	   if	   sufficient	   substructure	   information	   is	   available	   and	  
powerful	   filters	   are	   used.	   This	   actually	   depends	   heavily	   on	   the	   availability	   of	  
comprehensive	  MSn	  database	  of	  known	  metabolites	  from	  which	  similar	  metabolites	  
can	  be	  found	  and	  a	  maximum	  common	  substructure	  can	  be	  derived.	  It	  would	  be	  very	  
beneficial	   if	   annotated	   subtrees	   in	   the	   database	   with	   their	   corresponding	  
substructures	   would	   be	   available.	   This	   would	   allow	   finding	   multiple	   annotated	  
subtrees	  with	  their	  substructures	  for	  a	  MSn	  tree	  of	  an	  unknown	  metabolites	  in	  such	  a	  
database.	   This	   would	   provide	   multiple	   prescribed	   substructures	   as	   input	   for	   the	  
structure	   generator.	   Such	   multiple	   substructures	   as	   input	   are	   only	   possible	   using	  
manual	   interpretation	   of	   a	   MSn	   tree.	   The	   three	   filters	   used	   (Metabolite-­‐Likeness,	  
internal	   energy	  and	   fragmentation	  prediction)	  proved	   to	  be	  useful	   at	   reducing	   the	  
number	  of	  candidates	  to	  an	  amount	  that	  could	  be	  inspected	  by	  an	  expert	  for	  further	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validation.	   Obviously	   this	   identification	   pipeline	   for	   known	   and	   fully	   unknown	  
molecules	   (i.e.	   not	   reported	   in	   any	   database)	   does	   not	   only	   apply	   to	   human	  
metabolites,	   but	   can	   be	   applied	   also	   to	   plant	   metabolites	   or	   other	   types	   of	  
molecules.	  	  
	  
In	  Chapter	  5,	  we	   implemented	  and	   tested	   the	  Parallel	  Molecule	  Generator	   (PMG).	  
This	  structure	  generator	  addresses	  some	  of	  the	  lessons	  learned	  in	  Chapter	  2	  (OMG)	  
and	   Chapter	   4	   (metabolite	   identification	   pipeline).	   Firstly	   in	   both	   chapters	   we	  
observed	   that	   using	   multiple	   substructures	   as	   constraints	   could	   make	   many	  
identification	   problems	   feasible	   using	   the	   in	   Chapter	   4	   developed	   identification	  
pipeline.	   Secondly,	   OMG	   should	   be	   improved	   by	   using	   a	   faster	   algorithm,	   by	  
reducing	   the	   need	   for	   a	   full	   canonizer,	   i.e.	   use	   a	   less	   computationally	   demanding	  
method	  to	  remove	  duplicate	  structures,	  and	  by	  parallel	  execution	  of	  the	  algorithm.	  
Lastly,	   in	   Chapter	   4	   we	   have	   learned	   that	   filters	   like	   removing	   energetically	  
unfavorable	  structures	  are	  important	  and	  they	  should	  be	  already	  incorporated	  in	  the	  
structure	  generating	  process.	  The	  rationale	   for	   implementing	  such	  filters	   in	  PMG	  is	  
that	   providing	   a	   short	   list	   of	   candidates	   produced	   slowly	   is	  more	   desirable	   than	   a	  
long	   list	  of	  candidates	  produced	  quickly,	  since	  a	  shorter	   list	  of	  candidates	  brings	  us	  
closer	  to	  the	  identification	  of	  the	  unknown	  metabolite.	  We	  achieved	  a	  reduction	  in	  
the	  number	  of	  possible	   candidate	   structures	   for	  a	  given	  elemental	   composition	  by	  
including	  several	  constraints,	  i.e.	  using	  prescribed	  substructures,	  good	  and	  bad	  lists,	  
exclusion	  of	  energetically	  unfavorable	  bad	  rings.	  In	  addition,	  we	  reduced	  the	  impact	  
on	   the	   computational	   time	   of	   including	   these	   constraints	   in	   the	   method	   by	  
implementing	   two	   new	   algorithms.	   These	   run	   in	   parallel,	   therefore	   they	   produce	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results	   faster,	   they	   can	   accommodate	   more	   constraints	   and	   their	   results	   are	   as	  
complete	  as	  those	  the	  original	  OMG	  algorithm.	  	  
	  
The	  increase	  in	  speed	  using	  PMG	  compared	  to	  the	  OMG	  was	  evaluated	  for	  the	  same	  
elemental	  compositions	  and	  associated	  substructures	  as	  we	  used	  for	  the	  validation	  
of	   the	   OMG	   in	   Chapter	   2.	   In	   terms	   of	   generating	   molecules	   using	   a	   single	   core	  
computing,	  PMG	  provided	  all	  possible	  structures	  about	  40-­‐fold	   faster	  compared	   to	  
OMG	  with	  elemental	  compositions	  as	  only	   input.	  The	  speed	  increases	  was	  even	  up	  
to	   100-­‐fold	   for	   PMG	   compared	   to	   OMG	  when	   also	   prescribed	   substructures	  were	  
provided	   as	   input.	   The	   time	   to	   generate	   molecules	   could	   be	   further	   reduced	   by	  
executing	  PMG	  in	  multiple	  cores,	  which	  OMG	  does	  not	  allow,	  represents	  an	  almost	  
linear	  speed	  up	  increase	  as	  more	  cores	  are	  added.	  	  
	  
The	   efficiency	   in	   reducing	   the	   number	   of	   structures	   obtained	   with	   the	   additional	  
constrains	  was	  tested	  for	  the	  unknown	  metabolites	  found	  in	  human	  urine	  of	  Chapter	  
4.	   An	   expert	   annotated	   manually	   30	  MSn	   spectral	   trees,	   of	   unknown	  metabolites	  
found	   in	   human	   urine,	   which	   provided	   substructures	   for	   the	   good	   list.	   For	   the	  
unknowns	   for	  which	   the	   elemental	   composition	   allowed	   structures	  with	   rings,	   the	  
use	   of	   all	   additional	   constraints	   as	   introduced	   in	   PMG	   removed	   up	   to	   82%	   of	   the	  
candidate	   structures.	   In	   conclusion,	   PMG	   is	   a	   further	   improvement	   in	   the	  efficient	  
generation	  of	  candidate	  structures	  for	  a	  given	  elemental	  composition,	  substructures	  
and	   using	   additional	   constraints.	  We	   expect	   that	   the	   open	   source	   nature	   of	   PMG	  
allows	  further	  improvements	  by	  other	  researchers,	  especially	  when	  more	  knowledge	  
over	  the	  type	  of	  molecules	  to	  be	  identified	  is	  known.	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Metabolomics	   is	  a	  growing	   field	   that	   still	   suffers	   from	  some	   limitations	   specific	   for	  
metabolites,	   and	   some	   limitations	   that	   are	   also	   observed	   for	   other	   ‘omics’	   areas	  
such	   as	   proteomics.	   So	   far	   no	   generic	   procedure	   is	   available	   that	   allows	   the	  
identification	  and	  quantification	  of	  all	  metabolites	  present	  in	  a	  sample	  compared	  to	  
sequencing	  of	  a	  full	  genome,	  which	  is	  possible	  for	  currently	  just	  a	  few	  thousands	  of	  
euros.	   One	   challenge	   is	   that	   databases	   containing	   metabolites	   and	   experimental	  
data	  such	  as	  MS,	  MSn,	  and	  NMR	  spectra	  of	  metabolites	  have	  been	  for	  many	  decades	  
kept	   in-­‐house	   of	   companies	   or	   research	   groups,	   and	   the	   available	   databases	   are	  
containing	   only	   a	   fraction	   of	   the	   metabolites	   being	   expected.	   Fortunately,	   more	  
international	   consortia	   are	   being	   established	   to	   tackle	   the	   challenges	   in	  
metabolomics.	  
	  
The	   research	   described	   in	   this	   thesis	   has	   shown	   that	   the	   success	   of	   de	   novo	  
metabolite	   identification	   relies	   on	   the	   synergy	   between	   analytical	   chemistry	  
methods	   (i.e.	   LC-­‐MSn)	   and	   cheminformatics	   tools.	   It	   can	   be	   expected	   that	   the	  
analytical	  instrumentation	  and	  methods	  will	  further	  develop	  and	  faster	  methods	  will	  
require	   less	  amount	  of	  sample	  and	  will	  detect	  more	  metabolites,	   for	  which	  masses	  
and	  fragment	  ions	  will	  be	  detected	  with	  mass	  spectrometry	  with	  more	  accuracy	  and	  
better	  reproducibility.	  The	  key	  factor	  for	  the	  success	  of	  MS	  as	  a	  standard	  technique	  
for	   metabolite	   identification	   is	   its	   ability	   to	   produce	   substructure	   information	   for	  
many	   analytes.	   Important	   will	   be	   also	   to	   obtain	   MSn	   spectra	   on-­‐the-­‐flight,	   i.e.	  
without	  the	  need	  of	  fractionation	  prior	  to	  direct	  infusion	  into	  the	  MS.	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In	   this	   thesis	   it	   has	   been	   presented	   that	   knowing	   the	   elemental	   composition	   and	  
certain	   substructures	   of	   an	   unknown	   metabolite	   allows	   to	   limit	   the	   number	   of	  
possible	   structures	   of	   that	   unknown.	   In	   this	   thesis	   the	   concept	   of	   the	   maximum	  
common	   substructure	   (MCSS)	   from	   similar	   MSn	   spectra	   was	   used	   to	   derive	   a	  
substructure	   for	   the	   unknown	   metabolites.	   However,	   better	   alternative	   to	  
determine	   substructures	   in	   an	   unknown	  metabolite	   should	   be	   developed	   as	   there	  
are	   cases	   that	  not	   the	   correct	   substructure	  was	  obtained,	  or	   the	   substructure	  was	  
too	  small.	  A	  better	  alternative	  could	  be	  to	  relate	  shared	  branches	  or	  subtrees	  among	  
metabolites	   with	   shared	   substructures,	   i.e.	   the	   building	   block	   principle.	   	   Or,	   even	  
better,	  an	  MSn	  database	  of	  known	  metabolites	  should	  have	  annotated	  the	  branches	  
and	  subtrees	  of	  the	  metabolites	  with	  their	  corresponding	  substructures.	   In	  such	  an	  
approach,	   matching	   a	   subtree	   of	   the	   unknown	   metabolite	   with	   and	   annotated	  
subtrees	  in	  the	  database	  will	  provide	  a	  higher	  confidence	  that	  the	  unknown	  contains	  
that	  substructure(s).	  And	  as	  shown	  in	  this	  thesis	  the	  more	  substructures	  are	  used	  as	  
constraints	  for	  the	  structure	  generator	  the	  fewer	  candidate	  structures	  are	  obtained.	  
Having	   an	  MSn	   database	   with	   tens	   of	   thousands	   of	   annotated	  metabolites	   would	  
allow	  the	  identification	  of	  metabolites	  in	  a	  semi	  high-­‐throughput	  fashion.	  	  
	  
Generally	   high	   benefits	   can	   be	   expected	   from	   the	   computerization	   of	   human	  
expertise,	  as	  was	  for	  example	  demonstrated	  for	  chess	  playing	  supercomputers	  and	  
artificial	  intelligence	  software.	  However,	  for	  metabolite	  identification	  in	  the	  current	  
situation	  also	  for	  the	  in	  this	  thesis	  developed	  pipeline	  the	  input	  of	  a	  human	  expert	  is	  
still	   required.	   Human	   expertise	   is	   necessary	   at	   different	   steps	   of	   the	   metabolite	  
identification	   process.	   Humans	   are	   required	   to	   evaluate	   the	   correctness	   of	   the	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analytical	   data	   acquired	   from	   biological	   samples.	   It	   does	   not	   matter	   how	   good	   a	  
software	  pipeline	   is,	   if	   the	   initial	   input	   is	   of	   bad	  quality,	   the	  output	  will	   be	  of	   bad	  
quality.	   Software	   helps	   us	   at	   performing	   repetitive	   tasks	   more	   efficiently.	   Where	  
software	  underperforms	  humans	   is	  at	  detecting	  anomalies	   in	  a	  pipeline.	  An	  expert	  
can	   use	   tools	   like	   common	   sense	   and	   intuition	   to	   detect	   that	   results	   are	   overly	  
optimistic,	  on	  the	  one	  hand,	  or	  to	  focus	  on	  those	  candidates	  that	  have	  more	  chances	  
of	   succeeding.	   	  However,	   it	   can	  be	  expected	   that	  with	   the	   further	  development	  of	  
the	  identification	  pipeline	  the	  required	  input	  from	  a	  human	  expert	  will	  become	  less	  






































Metabolomics	   is	   één	   van	   de	   ‘omics’	   disciplines	   die	   gebruikt	  wordt	   om	   biologische	  
systemen	  beter	   te	   begrijpen.	  Het	   is	   uitermate	   geschikt	   om	   variatie	   op	   fenotypisch	  
niveau	   te	   begrijpen	  die	   niet	   volledig	   op	   genetische	  basis	   verklaard	   kan	  worden.	   In	  
metabolomics	   worden	   metabolieten	   bestudeerd.	   Dit	   zijn	   kleine	   moleculen	   die	  
betrokken	   zijn	   bij	   allerlei	   metabolische	   processen.	   Terwijl	   genen	   gedurende	   de	  
levensduur	   van	   een	   organisme	   niet	   significant	   veranderen,	   veranderen	   metabole	  
processen,	   en	   de	   daarbij	   betrokken	   metabolieten,	   continu.	   Vandaar	   dat	  
metabolieten	  ideale	  markers	  zijn	  voor	  de	  staat	  waarin	  een	  organisme	  zich	  bevindt.	  
	  
Een	   klassiek	   voorbeeld	   van	   het	   gebruik	   van	   metabolieten	   binnen	   biomedisch	  
onderzoek	  is	  het	  vinden	  van	  metabolieten	  die	  verschillend	  zijn	  tussen	  een	  groep	  van	  
zieke	  en	  gezonde	  patiënten.	  De	  significante	  aanwezigheid	   (of	  afwezigheid)	  van	  een	  
bepaald	  metaboliet	  (of	  een	  groep	  van	  metabolieten)	  in	  de	  zieke	  groep	  kan	  gebruikt	  
worden	   als	   indicator,	   ook	   wel	   biomarker	   genoemd,	   voor	   die	   ziekte.	   Voordat	  
metabolieten	  gebruikt	  kunnen	  worden	  om	  de	  biologie	  beter	  te	  begrijpen,	  moet	  eerst	  
de	   chemie	   van	  metabolieten	   begrepen	  worden.	  Met	   andere	  woorden,	  wat	   zijn	   de	  
chemische	   structuren	   van	   de	  metabolieten	   die	   indicatoren	   zijn	   voor	   een	   bepaalde	  
ziekte?	  Het	  beantwoorden	  van	  deze	  vraag	   is	  het	  doel	   van	  Metaboliet	   Identificatie,	  




In	   dit	   proefschrift	   heb	   ik	   gewerkt	   aan	   het	   maken	   van	   een	   aaneenschakeling	   van	  
software	  tools	  die	  het	  mogelijk	  maken	  om	  chemisch	  structuren	  te	  identificeren	  van	  
nieuwe	   metabolieten	   gevonden	   in	   humane	   monsters	   waarbij	   alleen	   LC-­‐MSn	   data	  
wordt	  gebruikt.	  
	  
Identificatie	  van	  nieuwe	  metabolieten	  wordt	  een	  uitdaging	  als	  de	  structuur	  van	  de	  
metabolieten	   niet	   terug	   te	   vinden	   is	   in	   een	   database	   of	   wanneer	   deze	   niet	  
vergeleken	   kunnen	   worden	   met	   de	   structuren	   van	   chemische	   standaard	  
verbindingen.	   Vandaar	   dat	   de	   structuur	   voorspeld	   moet	   worden.	   In	   Hoofdstuk	   2	  
beschrijf	   ik	   de	  ontwikkeling	   van	  de	  Open	  Molecule	  Generator	   (OMG).	  OMG	   is	   een	  
open-­‐source	   structuur	   generator	   die	   voor	   een	   onbekend	   metaboliet,	   gegeven	   de	  
elementaire	   compositie,	   een	   volledige	   lijst	   met	   mogelijke	   chemische	   structuren	  
produceerd.	   De	   gebruikte	   kanonische	   augmentatie	   aanpak	   (origineel	   binnen	   de	  
graaftheorie	  ontwikkeld	  om	  grafen	  te	  genereren)	  is	  daarvoor	  zodanig	  aangepast	  dat	  
alle	   mogelijke	   molecuulstructuren	   zonder	   duplicaten	   worden	   gegenereert.	   Tevens	  
accepteert	   de	   generator	   als	   additionele	   invoer	   substructuren	   die	   de	   uiteindelijke	  
structuren	   van	   de	   onbekende	   metabolieten	   moeten	   bevatten.	   OMG	   genereert	  
miljoenen	   kandidaat	   structuren	   gegeven	   de	   elementaire	   atoomsamenstelling	   van	  
gangbare	  humane	  metabolieten,	  zelfs	  wanneer	  substructuren	  als	  additionele	  invoer	  
worden	   gebruikt	   om	   het	   aantal	   mogelijkheden	   te	   beperken.	   Additionele	   stappen	  
waren	  nodig	  om	  deze	  lijst	  met	  mogelijke	  structuren	  te	  verkleinen	  zodat	  uiteindelijk	  




In	   Hoofdstuk	   3	   implementeerde	   ik	   een	   model	   dat	   voorspelt	   in	   hoeverre	   een	  
molecuul	   met	   een	   bepaalde	   chemische	   structuur	   lijkt	   op	   een	   metaboliet,	   de	  
Metabolite-­‐likeness.	  Met	  andere	  woorden,	  het	  model	  bepaalt	  hoe	  waarschijnlijk	  een	  
molecuul	   een	   humaan	   metaboliet	   is.	   Twee	   mogelijke	   redenen	   zijn	   aan	   te	   geven	  
betreffende	   de	   toepassing	   van	   deze	   tool.	   Ten	   eerste,	   om	   beter	   de	   intrinsieke	  
eigenschappen	   van	   humane	   metabolieten	   te	   begrijpen	   en	   ten	   tweede	   om	   de	  
Metabolite-­‐likeness	   te	   gebruiken	   als	   een	   filter	   om	   kandidaat	   structuren	  
geproduceerd	  door	  OMG,	  die	  niet	  op	  humane	  metabolieten	  lijken,	  te	  verwijderen.	  Ik	  
heb	  daarvoor	  humane	  metabolieten	  uit	   de	  Human	  Metabolome	  Database	   (HMDB)	  
vergeleken	  met	  niet-­‐metaboliet	  moleculen	  uit	  de	  ZINC	  database.	  Ik	  heb	  verschillende	  
klassificatie	  modellen	  en	  chemische	  descriptoren	  getest	  en	  gezien	  dat	  uiteindelijk	  de	  
combinatie	   van	   de	   Random	   Forest	   klassificatie	   methode	   met	   MDL	   Public	   Keys	  
descriptoren	  het	  beste	  Metabolite-­‐likeness	  voorspelden.	  	  
	  
In	   Hoofdstuk	   4	   creëerde	   ik	   een	   metaboliet	   identificatie	   pipeline	   door	   OMG	   en	  
Metabolite	   Likeness	   te	   koppelen	   aan	   twee,	   ook	   op	   dezelfde	   afdeling	   ontwikkelde,	  
tools,	  de	  Multistage	  Elemental	   Formula	   (MEF)	   tool	  en	  een	  algoritme	  die	  MSn	  data	  
met	  elkaar	  vergelijkt	  samen	  met	  een	  energie	  en	  een	  fragmentatie	  voorspeller	  filter.	  
Het	   idee	   was	   om	   een	   pipeline	   van	   tools	   te	   hebben	   die	   als	   invoer	   MSn	   data	   van	  
onbekende	  metabolieten	  gebruikte	  om	  ze	  vervolgens	  te	   identificeren	  of	  een	  kleine	  
lijst	  met	  kandidaat	  structuren	  te	  genereren.	  Deze	  pipeline	  werd	  getest	  aan	  de	  hand	  
van	   een	   humaan	   urine	   monster	   waarvoor	   MSn	   spectra	   van	   30	   onbekende	  
metabolieten	   was	   opgenomen.	   Van	   deze	   30	   onbekenden	   werden	   er	   10	  
geïdentificeerd	  doordat	  hun	  spectra	  samenvielen	  met	  spectra	   in	  een	  database	  met	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bekende	  metabolieten.	  Voor	  3	  onbekenden	  werd	  een	  relatief	  korte	  lijst	  met	  minder	  
dan	  8	  kandidaat	   structuren	  verkregen.	  Voor	  6	  andere	  onbekenden	  werd	  een	   lange	  
lijst	  met	  kandidaten	  verkregen.	  Ten	  slotte	  kon	  voor	  de	  overige	  11	  onbekenden	  geen	  
lijst	  met	  kandidaten	  gegenereerd	  worden.	  Deze	  resultaten	  ondersteunden	  het	   idee	  
dat	   metaboliet	   identificatie	   mogelijk	   is	   gebruikmakende	   van	   alleen	   MSn	   data	   in	  
combinatie	  met	  slimme	  cheminformatica	  tools,	  maar	  dat	  er	  nog	  steeds	  ruimte	  voor	  
het	  aanbrengen	  van	  verbeteringen	  is.	  	  
	  
Deze	   verbeteringen	   werden	   ingevoerd	   in	   Hoofdstuk	   5	   in	   de	   vorm	   van	   de	   Parallel	  
Molecule	   Generator	   (PMG).	   In	   hoofstuk	   4	   leerden	   we	   dat	   het	   verkrijgen	   van	   een	  
korte	  lijst	  met	  kandidaten	  essentieel	  is	  om	  nieuwe	  metabolieten	  te	  identificeren.	  Dit	  
is	   de	   reden	   waarom	   wij	   in	   PMG	   meer	   chemische	   randvoorwaarden	   toevoegden,	  
zoals	   de	   verwijdering	   van	   moleculen	   die	   instabiele	   ringstructuren	   en	   ongewenste	  
substructuren	  bevatten,	  om	  de	   lijst	  met	  kandidaat	  structuren	  verder	   te	  verkleinen.	  
Omdat	   de	   berekening	   van	   deze	   additionele	   randvoorwaarden	   extra	   computertijd	  
kost,	  werd	  PMG	  zodanig	  geïmplementeerd	  dat	  het	  parallel	  kon	  draaien	  in	  een	  multi-­‐
core	  omgeving.	  Deze	  verbetering	  resulteerde	  in	  een	  significante	  afname	  van	  de	  tijd	  
nodig	  om	  de	  kandidaatlijst	  te	  genereren.	  PMG	  was	  gemiddeld	  100	  maal	  sneller	  dan	  
OMG	   voor	   onbekende	   metabolieten	   waarvoor	   een	   lijst	   met	   substructuren	  
voorhanden	  was.	  	  
	  
Kortom,	  dit	  proefschrift	  laat	  zien	  dat	  het	  succes	  van	  de-­‐novo	  metaboliet	  identificatie	  
sterk	   bepaald	   wordt	   door	   een	   goede	   synergie	   tussen	   de	   analytische	   chemische	  
methoden	   en	   de	   cheminformatica	   tools.	   Tevens	   werd	   gepresenteerd	   dat	   als	   de	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elementaire	  compositie	  en	  bepaalde	  substructuren	  van	  een	  onbekende	  metaboliet	  
bekend	   zijn,	   het	   mogelijk	   is	   om	   de	   hoeveelheid	   mogelijke	   structuren	   voor	   de	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